|
US2008526A
(en)
|
1932-11-03 |
1935-07-16 |
Wappler Frederick Charles |
Method and means for treating living tissue
|
|
US2588623A
(en)
|
1948-05-10 |
1952-03-11 |
Eliscu Frank |
Surgical instrument for intradermal injection of fluids
|
|
US3467096A
(en)
|
1966-04-12 |
1969-09-16 |
Ferrell S Horn |
Multiple hypodermic syringe arrangement
|
|
US3572336A
(en)
|
1968-04-30 |
1971-03-23 |
Daniel R Hershberg |
Syringe
|
|
BE757653A
(fr)
|
1969-10-21 |
1971-04-16 |
Ugine Kuhlmann |
Nouveaux medicaments derives d'acides nucleiques et procedes pour leur preparation
|
|
BE786542A
(fr)
|
1971-07-22 |
1973-01-22 |
Dow Corning |
Dispositif d'aspiration permettant d'obtenir des echantillons de cellules
|
|
US3906092A
(en)
|
1971-11-26 |
1975-09-16 |
Merck & Co Inc |
Stimulation of antibody response
|
|
US4270537A
(en)
|
1979-11-19 |
1981-06-02 |
Romaine Richard A |
Automatic hypodermic syringe
|
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4458066A
(en)
|
1980-02-29 |
1984-07-03 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
US5132418A
(en)
|
1980-02-29 |
1992-07-21 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
US4500707A
(en)
|
1980-02-29 |
1985-02-19 |
University Patents, Inc. |
Nucleosides useful in the preparation of polynucleotides
|
|
US4411657A
(en)
|
1980-05-19 |
1983-10-25 |
Anibal Galindo |
Hypodermic needle
|
|
US4415732A
(en)
|
1981-03-27 |
1983-11-15 |
University Patents, Inc. |
Phosphoramidite compounds and processes
|
|
US4668777A
(en)
|
1981-03-27 |
1987-05-26 |
University Patents, Inc. |
Phosphoramidite nucleoside compounds
|
|
US4973679A
(en)
|
1981-03-27 |
1990-11-27 |
University Patents, Inc. |
Process for oligonucleo tide synthesis using phosphormidite intermediates
|
|
US4401796A
(en)
|
1981-04-30 |
1983-08-30 |
City Of Hope Research Institute |
Solid-phase synthesis of polynucleotides
|
|
US4373071A
(en)
|
1981-04-30 |
1983-02-08 |
City Of Hope Research Institute |
Solid-phase synthesis of polynucleotides
|
|
US4474569A
(en)
|
1982-06-28 |
1984-10-02 |
Denver Surgical Developments, Inc. |
Antenatal shunt
|
|
JPS5927900A
(ja)
|
1982-08-09 |
1984-02-14 |
Wakunaga Seiyaku Kk |
固定化オリゴヌクレオチド
|
|
US4737462A
(en)
|
1982-10-19 |
1988-04-12 |
Cetus Corporation |
Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
|
|
US4588585A
(en)
|
1982-10-19 |
1986-05-13 |
Cetus Corporation |
Human recombinant cysteine depleted interferon-β muteins
|
|
FR2540122B1
(fr)
|
1983-01-27 |
1985-11-29 |
Centre Nat Rech Scient |
Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application
|
|
US4605735A
(en)
|
1983-02-14 |
1986-08-12 |
Wakunaga Seiyaku Kabushiki Kaisha |
Oligonucleotide derivatives
|
|
US4948882A
(en)
|
1983-02-22 |
1990-08-14 |
Syngene, Inc. |
Single-stranded labelled oligonucleotides, reactive monomers and methods of synthesis
|
|
US4824941A
(en)
|
1983-03-10 |
1989-04-25 |
Julian Gordon |
Specific antibody to the native form of 2'5'-oligonucleotides, the method of preparation and the use as reagents in immunoassays or for binding 2'5'-oligonucleotides in biological systems
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4587044A
(en)
|
1983-09-01 |
1986-05-06 |
The Johns Hopkins University |
Linkage of proteins to nucleic acids
|
|
US5118800A
(en)
|
1983-12-20 |
1992-06-02 |
California Institute Of Technology |
Oligonucleotides possessing a primary amino group in the terminal nucleotide
|
|
US5118802A
(en)
|
1983-12-20 |
1992-06-02 |
California Institute Of Technology |
DNA-reporter conjugates linked via the 2' or 5'-primary amino group of the 5'-terminal nucleoside
|
|
US4579849A
(en)
|
1984-04-06 |
1986-04-01 |
Merck & Co., Inc. |
N-alkylguanine acyclonucleosides as antiviral agents
|
|
US4957735A
(en)
|
1984-06-12 |
1990-09-18 |
The University Of Tennessee Research Corporation |
Target-sensitive immunoliposomes- preparation and characterization
|
|
FR2567892B1
(fr)
|
1984-07-19 |
1989-02-17 |
Centre Nat Rech Scient |
Nouveaux oligonucleotides, leur procede de preparation et leurs applications comme mediateurs dans le developpement des effets des interferons
|
|
US5258506A
(en)
|
1984-10-16 |
1993-11-02 |
Chiron Corporation |
Photolabile reagents for incorporation into oligonucleotide chains
|
|
US5430136A
(en)
|
1984-10-16 |
1995-07-04 |
Chiron Corporation |
Oligonucleotides having selectably cleavable and/or abasic sites
|
|
US4828979A
(en)
|
1984-11-08 |
1989-05-09 |
Life Technologies, Inc. |
Nucleotide analogs for nucleic acid labeling and detection
|
|
US4959314A
(en)
|
1984-11-09 |
1990-09-25 |
Cetus Corporation |
Cysteine-depleted muteins of biologically active proteins
|
|
US5036006A
(en)
|
1984-11-13 |
1991-07-30 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
US5116943A
(en)
|
1985-01-18 |
1992-05-26 |
Cetus Corporation |
Oxidation-resistant muteins of Il-2 and other protein
|
|
CA1288073C
(en)
|
1985-03-07 |
1991-08-27 |
Paul G. Ahlquist |
Rna transformation vector
|
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
EP0204401A1
(en)
|
1985-04-09 |
1986-12-10 |
Biogen, Inc. |
Method of improving the yield of polypeptides produced in a host cell by stabilizing mRNA
|
|
US4762779A
(en)
|
1985-06-13 |
1988-08-09 |
Amgen Inc. |
Compositions and methods for functionalizing nucleic acids
|
|
US5017691A
(en)
|
1986-07-03 |
1991-05-21 |
Schering Corporation |
Mammalian interleukin-4
|
|
US5317098A
(en)
|
1986-03-17 |
1994-05-31 |
Hiroaki Shizuya |
Non-radioisotope tagging of fragments
|
|
US5153319A
(en)
|
1986-03-31 |
1992-10-06 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
US4695273A
(en)
|
1986-04-08 |
1987-09-22 |
I-Flow Corporation |
Multiple needle holder and subcutaneous multiple channel infusion port
|
|
US4879111A
(en)
|
1986-04-17 |
1989-11-07 |
Cetus Corporation |
Treatment of infections with lymphokines
|
|
JPS638396A
(ja)
|
1986-06-30 |
1988-01-14 |
Wakunaga Pharmaceut Co Ltd |
ポリ標識化オリゴヌクレオチド誘導体
|
|
CA1283827C
(en)
|
1986-12-18 |
1991-05-07 |
Giorgio Cirelli |
Appliance for injection of liquid formulations
|
|
GB8704027D0
(en)
|
1987-02-20 |
1987-03-25 |
Owen Mumford Ltd |
Syringe needle combination
|
|
US4904582A
(en)
|
1987-06-11 |
1990-02-27 |
Synthetic Genetics |
Novel amphiphilic nucleic acid conjugates
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US6090591A
(en)
|
1987-07-31 |
2000-07-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Selective amplification of target polynucleotide sequences
|
|
JP2774121B2
(ja)
|
1987-07-31 |
1998-07-09 |
ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ |
標的ポリヌクレオチド配列の選択的増幅
|
|
US5585481A
(en)
|
1987-09-21 |
1996-12-17 |
Gen-Probe Incorporated |
Linking reagents for nucleotide probes
|
|
US5525465A
(en)
|
1987-10-28 |
1996-06-11 |
Howard Florey Institute Of Experimental Physiology And Medicine |
Oligonucleotide-polyamide conjugates and methods of production and applications of the same
|
|
DE3738460A1
(de)
|
1987-11-12 |
1989-05-24 |
Max Planck Gesellschaft |
Modifizierte oligonukleotide
|
|
JP2846018B2
(ja)
|
1988-01-21 |
1999-01-13 |
ジェネンテク，インコーポレイテッド |
核酸配列の増幅および検出
|
|
CA1340807C
(en)
|
1988-02-24 |
1999-11-02 |
Lawrence T. Malek |
Nucleic acid amplification process
|
|
JP2650159B2
(ja)
|
1988-02-24 |
1997-09-03 |
アクゾ・ノベル・エヌ・ベー |
核酸増幅方法
|
|
US5082830A
(en)
|
1988-02-26 |
1992-01-21 |
Enzo Biochem, Inc. |
End labeled nucleotide probe
|
|
AU3353989A
(en)
|
1988-03-04 |
1989-09-22 |
Cancer Research Campaign Technology Limited |
Improvements relating to antigens
|
|
US5339163A
(en)
|
1988-03-16 |
1994-08-16 |
Canon Kabushiki Kaisha |
Automatic exposure control device using plural image plane detection areas
|
|
KR900700134A
(ko)
|
1988-04-15 |
1990-08-11 |
원본미기재 |
Il-2 수용체-특이적 키메릭 항체
|
|
US5109124A
(en)
|
1988-06-01 |
1992-04-28 |
Biogen, Inc. |
Nucleic acid probe linked to a label having a terminal cysteine
|
|
US5021335A
(en)
|
1988-06-17 |
1991-06-04 |
The Board Of Trustees Of The Leland Stanford Junior University |
In situ transcription in cells and tissues
|
|
US5168038A
(en)
|
1988-06-17 |
1992-12-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
In situ transcription in cells and tissues
|
|
US5130238A
(en)
|
1988-06-24 |
1992-07-14 |
Cangene Corporation |
Enhanced nucleic acid amplification process
|
|
US5262536A
(en)
|
1988-09-15 |
1993-11-16 |
E. I. Du Pont De Nemours And Company |
Reagents for the preparation of 5'-tagged oligonucleotides
|
|
US5759802A
(en)
|
1988-10-26 |
1998-06-02 |
Tonen Corporation |
Production of human serum alubumin A
|
|
FR2638359A1
(fr)
|
1988-11-03 |
1990-05-04 |
Tino Dalto |
Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
|
|
US5512439A
(en)
|
1988-11-21 |
1996-04-30 |
Dynal As |
Oligonucleotide-linked magnetic particles and uses thereof
|
|
US5047524A
(en)
|
1988-12-21 |
1991-09-10 |
Applied Biosystems, Inc. |
Automated system for polynucleotide synthesis and purification
|
|
US5262530A
(en)
|
1988-12-21 |
1993-11-16 |
Applied Biosystems, Inc. |
Automated system for polynucleotide synthesis and purification
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5457183A
(en)
|
1989-03-06 |
1995-10-10 |
Board Of Regents, The University Of Texas System |
Hydroxylated texaphyrins
|
|
US5599923A
(en)
|
1989-03-06 |
1997-02-04 |
Board Of Regents, University Of Tx |
Texaphyrin metal complexes having improved functionalization
|
|
US6673776B1
(en)
|
1989-03-21 |
2004-01-06 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human
|
|
US5693622A
(en)
|
1989-03-21 |
1997-12-02 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
|
|
ATE165516T1
(de)
|
1989-03-21 |
1998-05-15 |
Vical Inc |
Expression von exogenen polynukleotidsequenzen in wirbeltieren
|
|
US6214804B1
(en)
|
1989-03-21 |
2001-04-10 |
Vical Incorporated |
Induction of a protective immune response in a mammal by injecting a DNA sequence
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US6867195B1
(en)
|
1989-03-21 |
2005-03-15 |
Vical Incorporated |
Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected
|
|
US5012818A
(en)
|
1989-05-04 |
1991-05-07 |
Joishy Suresh K |
Two in one bone marrow surgical needle
|
|
IE66597B1
(en)
|
1989-05-10 |
1996-01-24 |
Akzo Nv |
Method for the synthesis of ribonucleic acid (RNA)
|
|
US5240855A
(en)
|
1989-05-12 |
1993-08-31 |
Pioneer Hi-Bred International, Inc. |
Particle gun
|
|
US5332671A
(en)
|
1989-05-12 |
1994-07-26 |
Genetech, Inc. |
Production of vascular endothelial cell growth factor and DNA encoding same
|
|
US5391723A
(en)
|
1989-05-31 |
1995-02-21 |
Neorx Corporation |
Oligonucleotide conjugates
|
|
US4958013A
(en)
|
1989-06-06 |
1990-09-18 |
Northwestern University |
Cholesteryl modified oligonucleotides
|
|
CA2020958C
(en)
|
1989-07-11 |
2005-01-11 |
Daniel L. Kacian |
Nucleic acid sequence amplification methods
|
|
US5451463A
(en)
|
1989-08-28 |
1995-09-19 |
Clontech Laboratories, Inc. |
Non-nucleoside 1,3-diol reagents for labeling synthetic oligonucleotides
|
|
US5254469A
(en)
|
1989-09-12 |
1993-10-19 |
Eastman Kodak Company |
Oligonucleotide-enzyme conjugate that can be used as a probe in hybridization assays and polymerase chain reaction procedures
|
|
US5591722A
(en)
|
1989-09-15 |
1997-01-07 |
Southern Research Institute |
2'-deoxy-4'-thioribonucleosides and their antiviral activity
|
|
US5545522A
(en)
|
1989-09-22 |
1996-08-13 |
Van Gelder; Russell N. |
Process for amplifying a target polynucleotide sequence using a single primer-promoter complex
|
|
ATE269870T1
(de)
|
1989-10-24 |
2004-07-15 |
Isis Pharmaceuticals Inc |
2'-modifizierte oligonukleotide
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
NO904633L
(no)
|
1989-11-09 |
1991-05-10 |
Molecular Diagnostics Inc |
Amplifikasjon av nukleinsyrer ved transkriberbar haarnaalsprobe.
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5215899A
(en)
|
1989-11-09 |
1993-06-01 |
Miles Inc. |
Nucleic acid amplification employing ligatable hairpin probe and transcription
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5292873A
(en)
|
1989-11-29 |
1994-03-08 |
The Research Foundation Of State University Of New York |
Nucleic acids labeled with naphthoquinone probe
|
|
US5633076A
(en)
|
1989-12-01 |
1997-05-27 |
Pharming Bv |
Method of producing a transgenic bovine or transgenic bovine embryo
|
|
US5697901A
(en)
|
1989-12-14 |
1997-12-16 |
Elof Eriksson |
Gene delivery by microneedle injection
|
|
US5486603A
(en)
|
1990-01-08 |
1996-01-23 |
Gilead Sciences, Inc. |
Oligonucleotide having enhanced binding affinity
|
|
US7037646B1
(en)
|
1990-01-11 |
2006-05-02 |
Isis Pharmaceuticals, Inc. |
Amine-derivatized nucleosides and oligonucleosides
|
|
US5646265A
(en)
|
1990-01-11 |
1997-07-08 |
Isis Pharmceuticals, Inc. |
Process for the preparation of 2'-O-alkyl purine phosphoramidites
|
|
US5670633A
(en)
|
1990-01-11 |
1997-09-23 |
Isis Pharmaceuticals, Inc. |
Sugar modified oligonucleotides that detect and modulate gene expression
|
|
US5578718A
(en)
|
1990-01-11 |
1996-11-26 |
Isis Pharmaceuticals, Inc. |
Thiol-derivatized nucleosides
|
|
US6783931B1
(en)
|
1990-01-11 |
2004-08-31 |
Isis Pharmaceuticals, Inc. |
Amine-derivatized nucleosides and oligonucleosides
|
|
US5214136A
(en)
|
1990-02-20 |
1993-05-25 |
Gilead Sciences, Inc. |
Anthraquinone-derivatives oligonucleotides
|
|
AU7579991A
(en)
|
1990-02-20 |
1991-09-18 |
Gilead Sciences, Inc. |
Pseudonucleosides and pseudonucleotides and their polymers
|
|
GB9009980D0
(en)
|
1990-05-03 |
1990-06-27 |
Amersham Int Plc |
Phosphoramidite derivatives,their preparation and the use thereof in the incorporation of reporter groups on synthetic oligonucleotides
|
|
EP0745689A3
(en)
|
1990-05-11 |
1996-12-11 |
Microprobe Corporation |
A dipstick for a nucleic acid hybridization assay
|
|
US5194370A
(en)
|
1990-05-16 |
1993-03-16 |
Life Technologies, Inc. |
Promoter ligation activated transcription amplification of nucleic acid sequences
|
|
JPH06500014A
(ja)
|
1990-07-25 |
1994-01-06 |
シンジーン，インコーポレイテッド |
多数の核酸相補体を生成させる環状伸長法
|
|
US5138045A
(en)
|
1990-07-27 |
1992-08-11 |
Isis Pharmaceuticals |
Polyamine conjugated oligonucleotides
|
|
US5688941A
(en)
|
1990-07-27 |
1997-11-18 |
Isis Pharmaceuticals, Inc. |
Methods of making conjugated 4' desmethyl nucleoside analog compounds
|
|
US5602240A
(en)
|
1990-07-27 |
1997-02-11 |
Ciba Geigy Ag. |
Backbone modified oligonucleotide analogs
|
|
US5489677A
(en)
|
1990-07-27 |
1996-02-06 |
Isis Pharmaceuticals, Inc. |
Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms
|
|
US5218105A
(en)
|
1990-07-27 |
1993-06-08 |
Isis Pharmaceuticals |
Polyamine conjugated oligonucleotides
|
|
US5608046A
(en)
|
1990-07-27 |
1997-03-04 |
Isis Pharmaceuticals, Inc. |
Conjugated 4'-desmethyl nucleoside analog compounds
|
|
US5245022A
(en)
|
1990-08-03 |
1993-09-14 |
Sterling Drug, Inc. |
Exonuclease resistant terminally substituted oligonucleotides
|
|
US5190521A
(en)
|
1990-08-22 |
1993-03-02 |
Tecnol Medical Products, Inc. |
Apparatus and method for raising a skin wheal and anesthetizing skin
|
|
US5512667A
(en)
|
1990-08-28 |
1996-04-30 |
Reed; Michael W. |
Trifunctional intermediates for preparing 3'-tailed oligonucleotides
|
|
US6140496A
(en)
|
1990-10-09 |
2000-10-31 |
Benner; Steven Albert |
Precursors for deoxyribonucleotides containing non-standard nucleosides
|
|
KR930702373A
(ko)
|
1990-11-08 |
1993-09-08 |
안토니 제이. 페이네 |
합성 올리고누클레오티드에 대한 다중 리포터(Reporter)그룹의 첨합
|
|
US5527288A
(en)
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
|
US6100024A
(en)
|
1991-02-08 |
2000-08-08 |
Promega Corporation |
Methods and compositions for nucleic acid detection by target extension and probe amplification
|
|
EP1681305A3
(en)
|
1991-03-18 |
2008-02-27 |
New York University |
Monoclonal and chimeric antibodies specific for human tumor necrosis factor
|
|
US5426180A
(en)
|
1991-03-27 |
1995-06-20 |
Research Corporation Technologies, Inc. |
Methods of making single-stranded circular oligonucleotides
|
|
DK0628639T3
(da)
|
1991-04-25 |
2000-01-24 |
Chugai Pharmaceutical Co Ltd |
Rekonstitueret humant antistof mod human interleukin-6-receptor
|
|
US5539082A
(en)
|
1993-04-26 |
1996-07-23 |
Nielsen; Peter E. |
Peptide nucleic acids
|
|
US5719262A
(en)
|
1993-11-22 |
1998-02-17 |
Buchardt, Deceased; Ole |
Peptide nucleic acids having amino acid side chains
|
|
US5714331A
(en)
|
1991-05-24 |
1998-02-03 |
Buchardt, Deceased; Ole |
Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
|
|
US5169766A
(en)
|
1991-06-14 |
1992-12-08 |
Life Technologies, Inc. |
Amplification of nucleic acid molecules
|
|
US5371241A
(en)
|
1991-07-19 |
1994-12-06 |
Pharmacia P-L Biochemicals Inc. |
Fluorescein labelled phosphoramidites
|
|
US5199441A
(en)
|
1991-08-20 |
1993-04-06 |
Hogle Hugh H |
Fine needle aspiration biopsy apparatus and method
|
|
GB9118204D0
(en)
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
|
SE9102652D0
(sv)
|
1991-09-13 |
1991-09-13 |
Kabi Pharmacia Ab |
Injection needle arrangement
|
|
DE59208572D1
(de)
|
1991-10-17 |
1997-07-10 |
Ciba Geigy Ag |
Bicyclische Nukleoside, Oligonukleotide, Verfahren zu deren Herstellung und Zwischenprodukte
|
|
US5298422A
(en)
|
1991-11-06 |
1994-03-29 |
Baylor College Of Medicine |
Myogenic vector systems
|
|
US5359044A
(en)
|
1991-12-13 |
1994-10-25 |
Isis Pharmaceuticals |
Cyclobutyl oligonucleotide surrogates
|
|
US5824307A
(en)
|
1991-12-23 |
1998-10-20 |
Medimmune, Inc. |
Human-murine chimeric antibodies against respiratory syncytial virus
|
|
US5565552A
(en)
|
1992-01-21 |
1996-10-15 |
Pharmacyclics, Inc. |
Method of expanded porphyrin-oligonucleotide conjugate synthesis
|
|
US5595726A
(en)
|
1992-01-21 |
1997-01-21 |
Pharmacyclics, Inc. |
Chromophore probe for detection of nucleic acid
|
|
CA2128616A1
(en)
|
1992-01-23 |
1993-08-05 |
Gary H. Rhodes |
Ex vivo gene transfer
|
|
FR2687679B1
(fr)
|
1992-02-05 |
1994-10-28 |
Centre Nat Rech Scient |
Oligothionucleotides.
|
|
US5328483A
(en)
|
1992-02-27 |
1994-07-12 |
Jacoby Richard M |
Intradermal injection device with medication and needle guard
|
|
JP3368603B2
(ja)
|
1992-02-28 |
2003-01-20 |
オリンパス光学工業株式会社 |
遺伝子治療用処置具
|
|
ES2149768T3
(es)
|
1992-03-25 |
2000-11-16 |
Immunogen Inc |
Conjugados de agentes enlazantes de celulas derivados de cc-1065.
|
|
US6174666B1
(en)
|
1992-03-27 |
2001-01-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of eliminating inhibitory/instability regions from mRNA
|
|
US6132419A
(en)
|
1992-05-22 |
2000-10-17 |
Genetronics, Inc. |
Electroporetic gene and drug therapy
|
|
US5514545A
(en)
|
1992-06-11 |
1996-05-07 |
Trustees Of The University Of Pennsylvania |
Method for characterizing single cells based on RNA amplification for diagnostics and therapeutics
|
|
EP0577558A2
(de)
|
1992-07-01 |
1994-01-05 |
Ciba-Geigy Ag |
Carbocyclische Nukleoside mit bicyclischen Ringen, Oligonukleotide daraus, Verfahren zu deren Herstellung, deren Verwendung und Zwischenproduckte
|
|
US6670178B1
(en)
|
1992-07-10 |
2003-12-30 |
Transkaryotic Therapies, Inc. |
In Vivo production and delivery of insulinotropin for gene therapy
|
|
US5272250A
(en)
|
1992-07-10 |
1993-12-21 |
Spielvogel Bernard F |
Boronated phosphoramidate compounds
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
CA2141450A1
(en)
|
1992-07-31 |
1994-02-17 |
Maureen Laney |
Method for introducing defined sequences at the 3' end of polynucleotides
|
|
US5273525A
(en)
|
1992-08-13 |
1993-12-28 |
Btx Inc. |
Injection and electroporation apparatus for drug and gene delivery
|
|
US5240885A
(en)
|
1992-09-21 |
1993-08-31 |
Corning Incorporated |
Rare earth-doped, stabilized cadmium halide glasses
|
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
|
US5334144A
(en)
|
1992-10-30 |
1994-08-02 |
Becton, Dickinson And Company |
Single use disposable needleless injector
|
|
AU5665694A
(en)
|
1992-11-04 |
1994-05-24 |
Denver Biomaterials Inc. |
Apparatus for removal of pleural effusion fluid
|
|
US5736137A
(en)
|
1992-11-13 |
1998-04-07 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
|
ATE196606T1
(de)
|
1992-11-13 |
2000-10-15 |
Idec Pharma Corp |
Therapeutische verwendung von chimerischen und markierten antikörpern, die gegen ein differenzierung-antigen gerichtet sind, dessen expression auf menschliche b lymphozyt beschränkt ist, für die behandlung von b-zell-lymphoma
|
|
US5574142A
(en)
|
1992-12-15 |
1996-11-12 |
Microprobe Corporation |
Peptide linkers for improved oligonucleotide delivery
|
|
NZ261259A
(en)
|
1993-01-12 |
1996-12-20 |
Biogen Inc |
Humanised recombinant anti-vla4 antibody and diagnostic compositions and medicaments
|
|
FR2703253B1
(fr)
|
1993-03-30 |
1995-06-23 |
Centre Nat Rech Scient |
Applicateur d'impulsions electriques pour traitement de tissus biologiques.
|
|
WO1994022864A1
(en)
|
1993-03-30 |
1994-10-13 |
Sterling Winthrop Inc. |
Acyclic nucleoside analogs and oligonucleotide sequences containing them
|
|
DE4311944A1
(de)
|
1993-04-10 |
1994-10-13 |
Degussa |
Umhüllte Natriumpercarbonatpartikel, Verfahren zu deren Herstellung und sie enthaltende Wasch-, Reinigungs- und Bleichmittelzusammensetzungen
|
|
US7135312B2
(en)
|
1993-04-15 |
2006-11-14 |
University Of Rochester |
Circular DNA vectors for synthesis of RNA and DNA
|
|
US5773244A
(en)
|
1993-05-19 |
1998-06-30 |
Regents Of The University Of California |
Methods of making circular RNA
|
|
US6541498B2
(en)
|
1993-05-20 |
2003-04-01 |
Texas Biotechnology |
Benzenesulfonamides and the use thereof to modulate the activity of endothelin
|
|
US5851829A
(en)
|
1993-07-16 |
1998-12-22 |
Dana-Farber Cancer Institute |
Method of intracellular binding of target molecules
|
|
US6294664B1
(en)
|
1993-07-29 |
2001-09-25 |
Isis Pharmaceuticals, Inc. |
Synthesis of oligonucleotides
|
|
US5672491A
(en)
|
1993-09-20 |
1997-09-30 |
The Leland Stanford Junior University |
Recombinant production of novel polyketides
|
|
US6432711B1
(en)
|
1993-11-03 |
2002-08-13 |
Diacrin, Inc. |
Embryonic stem cells capable of differentiating into desired cell lines
|
|
US6096503A
(en)
|
1993-11-12 |
2000-08-01 |
The Scripps Research Institute |
Method for simultaneous identification of differentially expresses mRNAs and measurement of relative concentrations
|
|
US5446137B1
(en)
|
1993-12-09 |
1998-10-06 |
Behringwerke Ag |
Oligonucleotides containing 4'-substituted nucleotides
|
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
|
US7435802B2
(en)
|
1994-01-25 |
2008-10-14 |
Elan Pharaceuticals, Inc. |
Humanized anti-VLA4 immunoglobulins
|
|
US5840299A
(en)
|
1994-01-25 |
1998-11-24 |
Athena Neurosciences, Inc. |
Humanized antibodies against leukocyte adhesion molecule VLA-4
|
|
DE69533295T3
(de)
|
1994-02-16 |
2009-07-16 |
The Government Of The United States Of America, As Represented By The Secretary, The Department Of Health And Human Services |
Melanoma-assoziierte Antigene, Epitope davon und Impstoffe gegen Melanoma
|
|
WO1995024176A1
(en)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Ampule filling device
|
|
IL112820A0
(en)
|
1994-03-07 |
1995-05-26 |
Merck & Co Inc |
Coordinate in vivo gene expression
|
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
|
HUT76094A
(en)
|
1994-03-18 |
1997-06-30 |
Lynx Therapeutics |
Oligonucleotide n3'-p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties
|
|
US5457041A
(en)
|
1994-03-25 |
1995-10-10 |
Science Applications International Corporation |
Needle array and method of introducing biological substances into living cells using the needle array
|
|
WO1995026204A1
(en)
|
1994-03-25 |
1995-10-05 |
Isis Pharmaceuticals, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
|
US5627053A
(en)
|
1994-03-29 |
1997-05-06 |
Ribozyme Pharmaceuticals, Inc. |
2'deoxy-2'-alkylnucleotide containing nucleic acid
|
|
US5464395A
(en)
|
1994-04-05 |
1995-11-07 |
Faxon; David P. |
Catheter for delivering therapeutic and/or diagnostic agents to the tissue surrounding a bodily passageway
|
|
US6074642A
(en)
|
1994-05-02 |
2000-06-13 |
Alexion Pharmaceuticals, Inc. |
Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis
|
|
ATE368118T1
(de)
|
1994-05-18 |
2007-08-15 |
Bayer Bioscience Gmbh |
Für enzyme, die die fähigkeit besitzen lineare alpha 1,4-glucane in pflanzen, pilzen und mikroorganismen zu synthesieren, kodierende dna sequenzen
|
|
CA2191362A1
(en)
|
1994-06-02 |
1995-12-14 |
Mark Selby |
Nucleic acid immunization using a virus-based infection/transfection system
|
|
GB9412230D0
(en)
|
1994-06-17 |
1994-08-10 |
Celltech Ltd |
Interleukin-5 specific recombiant antibodies
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US5597696A
(en)
|
1994-07-18 |
1997-01-28 |
Becton Dickinson And Company |
Covalent cyanine dye oligonucleotide conjugates
|
|
WO1996004925A1
(en)
|
1994-08-12 |
1996-02-22 |
Immunomedics, Inc. |
Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells
|
|
US5580731A
(en)
|
1994-08-25 |
1996-12-03 |
Chiron Corporation |
N-4 modified pyrimidine deoxynucleotides and oligonucleotide probes synthesized therewith
|
|
US5597909A
(en)
|
1994-08-25 |
1997-01-28 |
Chiron Corporation |
Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use
|
|
US5665545A
(en)
|
1994-11-28 |
1997-09-09 |
Akzo Nobel N.V. |
Terminal repeat amplification method
|
|
US5641665A
(en)
|
1994-11-28 |
1997-06-24 |
Vical Incorporated |
Plasmids suitable for IL-2 expression
|
|
US5588960A
(en)
|
1994-12-01 |
1996-12-31 |
Vidamed, Inc. |
Transurethral needle delivery device with cystoscope and method for treatment of urinary incontinence
|
|
US5807718A
(en)
|
1994-12-02 |
1998-09-15 |
The Scripps Research Institute |
Enzymatic DNA molecules
|
|
WO1996021023A1
(en)
|
1995-01-06 |
1996-07-11 |
Centrum Voor Plantenveredelings- En Reproduktieonderzoek (Cpro - Dlo) |
Dna sequences encoding carbohydrate polymer synthesizing enzymes and method for producing transgenic plants
|
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
US5824497A
(en)
|
1995-02-10 |
1998-10-20 |
Mcmaster University |
High efficiency translation of mRNA molecules
|
|
EP0727187B1
(en)
|
1995-02-15 |
2003-08-06 |
Joseph Eldor |
Multiple hole spinal needle
|
|
US5707807A
(en)
|
1995-03-28 |
1998-01-13 |
Research Development Corporation Of Japan |
Molecular indexing for expressed gene analysis
|
|
US5869230A
(en)
|
1995-03-30 |
1999-02-09 |
Beth Israel Hospital Association |
Gene transfer into the kidney
|
|
US5986054A
(en)
|
1995-04-28 |
1999-11-16 |
The Hospital For Sick Children, Hsc Research And Development Limited Partnership |
Genetic sequences and proteins related to alzheimer's disease
|
|
FR2733762B1
(fr)
|
1995-05-02 |
1997-08-01 |
Genset Sa |
Methode de couplage specifique de la coiffe de l'extremite 5' d'un fragment d'arnm et preparation d'arnm et d'adnc complet
|
|
US5700642A
(en)
|
1995-05-22 |
1997-12-23 |
Sri International |
Oligonucleotide sizing using immobilized cleavable primers
|
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
US6051429A
(en)
|
1995-06-07 |
2000-04-18 |
Life Technologies, Inc. |
Peptide-enhanced cationic lipid transfections
|
|
US6111095A
(en)
|
1995-06-07 |
2000-08-29 |
Merck & Co., Inc. |
Capped synthetic RNA, analogs, and aptamers
|
|
US5889136A
(en)
|
1995-06-09 |
1999-03-30 |
The Regents Of The University Of Colorado |
Orthoester protecting groups in RNA synthesis
|
|
US5713863A
(en)
|
1996-01-11 |
1998-02-03 |
Interventional Technologies Inc. |
Catheter with fluid medication injectors
|
|
US5766903A
(en)
|
1995-08-23 |
1998-06-16 |
University Technology Corporation |
Circular RNA and uses thereof
|
|
US6265389B1
(en)
|
1995-08-31 |
2001-07-24 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of oligonucleotides
|
|
WO1997011085A1
(en)
|
1995-09-19 |
1997-03-27 |
University Of Massachusetts |
Inhibited biological degradation of oligodeoxynucleotides
|
|
US5830879A
(en)
|
1995-10-02 |
1998-11-03 |
St. Elizabeth's Medical Center Of Boston, Inc. |
Treatment of vascular injury using vascular endothelial growth factor
|
|
US6265387B1
(en)
|
1995-10-11 |
2001-07-24 |
Mirus, Inc. |
Process of delivering naked DNA into a hepatocyte via bile duct
|
|
US6132988A
(en)
|
1995-10-27 |
2000-10-17 |
Takeda Chemical Industries, Ltd. |
DNA encoding a neuronal cell-specific receptor protein
|
|
CU22584A1
(es)
|
1995-11-17 |
1999-11-03 |
Centro Inmunologia Molecular |
Composiciones farmacéuticas que contienen un anticuerpo monoclonal que reconoce el antígeno de diferenciación leucocitario humano cd6 y sus usos para el diagnóstico y tratamiento de la psoriasis
|
|
US6090382A
(en)
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
|
US5962271A
(en)
|
1996-01-03 |
1999-10-05 |
Cloutech Laboratories, Inc. |
Methods and compositions for generating full-length cDNA having arbitrary nucleotide sequence at the 3'-end
|
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
|
US6395292B2
(en)
|
1996-02-02 |
2002-05-28 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
|
US6261584B1
(en)
|
1996-02-02 |
2001-07-17 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
|
AU1874397A
(en)
|
1996-02-16 |
1997-09-02 |
Stichting Rega Vzw |
Hexitol containing oligonucleotides and their use in antisense strategies
|
|
US6534312B1
(en)
|
1996-02-22 |
2003-03-18 |
Merck & Co., Inc. |
Vaccines comprising synthetic genes
|
|
US6090391A
(en)
|
1996-02-23 |
2000-07-18 |
Aviron |
Recombinant tryptophan mutants of influenza
|
|
US6300487B1
(en)
|
1996-03-19 |
2001-10-09 |
Cell Therapuetics, Inc. |
Mammalian lysophosphatidic acid acyltransferase
|
|
TW517061B
(en)
|
1996-03-29 |
2003-01-11 |
Pharmacia & Amp Upjohn Ab |
Modified/chimeric superantigens and their use
|
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
|
US20030073908A1
(en)
|
1996-04-26 |
2003-04-17 |
2000 Injectx, Inc. |
Method and apparatus for delivery of genes, enzymes and biological agents to tissue cells
|
|
US5712127A
(en)
|
1996-04-29 |
1998-01-27 |
Genescape Inc. |
Subtractive amplification
|
|
US5853719A
(en)
|
1996-04-30 |
1998-12-29 |
Duke University |
Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
|
|
US7329741B2
(en)
|
1996-06-05 |
2008-02-12 |
Chiron Corporation |
Polynucleotides that hybridize to DP-75 and their use
|
|
AU3230797A
(en)
|
1996-06-05 |
1998-01-05 |
Chiron Corporation |
Dna encoding dp. 75 and a process for its use
|
|
EP0912607A2
(en)
|
1996-06-21 |
1999-05-06 |
Merck & Co., Inc. |
Vaccines comprising synthetic genes
|
|
EP0925088A2
(en)
|
1996-06-28 |
1999-06-30 |
Sontra Medical, L.P. |
Ultrasound enhancement of transdermal transport
|
|
US5939262A
(en)
|
1996-07-03 |
1999-08-17 |
Ambion, Inc. |
Ribonuclease resistant RNA preparation and utilization
|
|
US5677124A
(en)
|
1996-07-03 |
1997-10-14 |
Ambion, Inc. |
Ribonuclease resistant viral RNA standards
|
|
US7288266B2
(en)
|
1996-08-19 |
2007-10-30 |
United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Liposome complexes for increased systemic delivery
|
|
US5849546A
(en)
|
1996-09-13 |
1998-12-15 |
Epicentre Technologies Corporation |
Methods for using mutant RNA polymerases with reduced discrimination between non-canonical and canonical nucleoside triphosphates
|
|
US6114148C1
(en)
|
1996-09-20 |
2012-05-01 |
Gen Hospital Corp |
High level expression of proteins
|
|
JP4299886B2
(ja)
|
1996-09-24 |
2009-07-22 |
タノックス インコーポレイテッド |
アポトーシス関連ペプチドをコードする遺伝子ファミリー、それによってコードされるペプチド、およびそれらの使用方法
|
|
US6214966B1
(en)
|
1996-09-26 |
2001-04-10 |
Shearwater Corporation |
Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
|
|
ATE292980T1
(de)
|
1996-10-11 |
2005-04-15 |
Univ California |
Immunostimulierende oligonucleotidekonjugate
|
|
EP0839912A1
(en)
|
1996-10-30 |
1998-05-06 |
Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) |
Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
|
|
GB9623051D0
(en)
|
1996-11-06 |
1997-01-08 |
Schacht Etienne H |
Delivery of DNA to target cells in biological systems
|
|
US5980887A
(en)
|
1996-11-08 |
1999-11-09 |
St. Elizabeth's Medical Center Of Boston |
Methods for enhancing angiogenesis with endothelial progenitor cells
|
|
US5759179A
(en)
|
1996-12-31 |
1998-06-02 |
Johnson & Johnson Medical, Inc. |
Needle and valve assembly for use with a catheter
|
|
WO1998031700A1
(en)
|
1997-01-21 |
1998-07-23 |
The General Hospital Corporation |
Selection of proteins using rna-protein fusions
|
|
EP0855184A1
(en)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
|
US6228640B1
(en)
|
1997-02-07 |
2001-05-08 |
Cem Cezayirli |
Programmable antigen presenting cell of CD34 lineage
|
|
CA2280195A1
(en)
|
1997-02-07 |
1998-08-13 |
Merck & Co., Inc. |
Synthetic hiv gag genes
|
|
US6251665B1
(en)
|
1997-02-07 |
2001-06-26 |
Cem Cezayirli |
Directed maturation of stem cells and production of programmable antigen presenting dentritic cells therefrom
|
|
US6696291B2
(en)
|
1997-02-07 |
2004-02-24 |
Merck & Co., Inc. |
Synthetic HIV gag genes
|
|
US6576752B1
(en)
|
1997-02-14 |
2003-06-10 |
Isis Pharmaceuticals, Inc. |
Aminooxy functionalized oligomers
|
|
JP3756313B2
(ja)
|
1997-03-07 |
2006-03-15 |
武 今西 |
新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
US6306393B1
(en)
|
1997-03-24 |
2001-10-23 |
Immunomedics, Inc. |
Immunotherapy of B-cell malignancies using anti-CD22 antibodies
|
|
US6261281B1
(en)
|
1997-04-03 |
2001-07-17 |
Electrofect As |
Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
|
|
US5914269A
(en)
|
1997-04-04 |
1999-06-22 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide inhibition of epidermal growth factor receptor expression
|
|
WO1998047913A2
(en)
|
1997-04-18 |
1998-10-29 |
The University Of Medicine And Dentistry Of New Jersey |
Inhibition of hiv-1 replication by a tat rna-binding domain peptide analog
|
|
US5958688A
(en)
|
1997-04-28 |
1999-09-28 |
The Trustees Of The University Of Pennsylvania |
Characterization of mRNA patterns in neurites and single cells for medical diagnosis and therapeutics
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
US5989911A
(en)
|
1997-05-09 |
1999-11-23 |
University Of Massachusetts |
Site-specific synthesis of pseudouridine in RNA
|
|
US6761726B1
(en)
|
1998-05-15 |
2004-07-13 |
Pyng Medical Corp. |
Method and apparatus for the intraosseous introduction of a device such as an infusion tube
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
US6124091A
(en)
|
1997-05-30 |
2000-09-26 |
Research Corporation Technologies, Inc. |
Cell growth-controlling oligonucleotides
|
|
EP2085090A3
(en)
|
1997-06-06 |
2012-05-02 |
The Regents of the University of California |
Inhibitors of DNA immunostimulatory sequence activity
|
|
US6589940B1
(en)
|
1997-06-06 |
2003-07-08 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
|
FI105309B
(fi)
|
1997-06-24 |
2000-07-14 |
Nokia Mobile Phones Ltd |
Matkaviestinjärjestelmät
|
|
JP2002510319A
(ja)
|
1997-07-01 |
2002-04-02 |
アイシス・ファーマシューティカルス・インコーポレーテッド |
オリゴヌクレオチドの消化管を介したデリバリーのための組成物及び方法
|
|
US5994511A
(en)
|
1997-07-02 |
1999-11-30 |
Genentech, Inc. |
Anti-IgE antibodies and methods of improving polypeptides
|
|
EP0998305B1
(en)
|
1997-07-21 |
2007-05-02 |
Active Biotech AB |
Cytolysis of target cells by superantigen conjugates inducing t-cell activation
|
|
US20030073640A1
(en)
|
1997-07-23 |
2003-04-17 |
Ribozyme Pharmaceuticals, Inc. |
Novel compositions for the delivery of negatively charged molecules
|
|
EP1009441A1
(en)
|
1997-07-31 |
2000-06-21 |
St. Elizabeth's Medical Center of Boston, Inc. |
Method for the treatment of grafts
|
|
US6794499B2
(en)
|
1997-09-12 |
2004-09-21 |
Exiqon A/S |
Oligonucleotide analogues
|
|
PT2044950E
(pt)
|
1997-09-18 |
2012-09-18 |
Univ Pennsylvania |
Cassetes de imunização adn de vif atenuadas para vacinas genéticas
|
|
EP2292771A3
(en)
|
1997-09-19 |
2011-07-27 |
Life Technologies Corporation |
Sense mRNA therapy
|
|
US6004573A
(en)
|
1997-10-03 |
1999-12-21 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
|
WO1999018221A1
(en)
|
1997-10-07 |
1999-04-15 |
University Of Maryland Biotechnology Institute |
Method for introducing and expressing rna in animal cells
|
|
WO1999020766A2
(en)
|
1997-10-20 |
1999-04-29 |
Genzyme Transgenics Corporation |
NOVEL MODIFIED NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS
|
|
US6019747A
(en)
|
1997-10-21 |
2000-02-01 |
I-Flow Corporation |
Spring-actuated infusion syringe
|
|
JP2001520889A
(ja)
|
1997-10-24 |
2001-11-06 |
バレンティス，インコーポレイティド |
ポリヌクレオチドトランスフェクション複合体を調製する方法
|
|
US6077251A
(en)
|
1997-10-30 |
2000-06-20 |
Ting; Windsor |
Medicinal agent administration system
|
|
US6310197B1
(en)
|
1997-11-12 |
2001-10-30 |
The Brigham And Women's Hospital, Inc. |
Translation enhancer element of the human amyloid precursor protein gene
|
|
US6548633B1
(en)
|
1998-12-22 |
2003-04-15 |
Genset, S.A. |
Complementary DNA's encoding proteins with signal peptides
|
|
EP1987845B1
(en)
|
1997-11-20 |
2012-03-21 |
Vical Incorporated |
Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor.
|
|
US7655777B2
(en)
|
1997-11-24 |
2010-02-02 |
Monsanto Technology Llc |
Nucleic acid molecules associated with the tocopherol pathway
|
|
US6267987B1
(en)
|
1997-12-12 |
2001-07-31 |
Samyang Corporation |
Positively charged poly[alpha-(omega-aminoalkyl) glycolic acid] for the delivery of a bioactive agent via tissue and cellular uptake
|
|
US6517869B1
(en)
|
1997-12-12 |
2003-02-11 |
Expression Genetics, Inc. |
Positively charged poly(alpha-(omega-aminoalkyl)lycolic acid) for the delivery of a bioactive agent via tissue and cellular uptake
|
|
US6320017B1
(en)
|
1997-12-23 |
2001-11-20 |
Inex Pharmaceuticals Corp. |
Polyamide oligomers
|
|
JP2002500010A
(ja)
|
1997-12-23 |
2002-01-08 |
カイロン コーポレイション |
ヒト遺伝子および遺伝子発現産物ｉ
|
|
US6383811B2
(en)
|
1997-12-30 |
2002-05-07 |
Mirus Corporation |
Polyampholytes for delivering polyions to a cell
|
|
DE69941447D1
(de)
|
1998-01-05 |
2009-11-05 |
Univ Washington |
Erhöhter transport unter benutzung membranzerstörender stoffe
|
|
US8287483B2
(en)
|
1998-01-08 |
2012-10-16 |
Echo Therapeutics, Inc. |
Method and apparatus for enhancement of transdermal transport
|
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
|
CA2317777C
(en)
|
1998-01-08 |
2005-05-03 |
Sontra Medical, Inc. |
Sonophoretic enhanced transdermal transport
|
|
US6365346B1
(en)
|
1998-02-18 |
2002-04-02 |
Dade Behring Inc. |
Quantitative determination of nucleic acid amplification products
|
|
US5955310A
(en)
|
1998-02-26 |
1999-09-21 |
Novo Nordisk Biotech, Inc. |
Methods for producing a polypeptide in a bacillus cell
|
|
US6432925B1
(en)
|
1998-04-16 |
2002-08-13 |
John Wayne Cancer Institute |
RNA cancer vaccine and methods for its use
|
|
US6429301B1
(en)
|
1998-04-17 |
2002-08-06 |
Whitehead Institute For Biomedical Research |
Use of a ribozyme to join nucleic acids and peptides
|
|
GB9808327D0
(en)
|
1998-04-20 |
1998-06-17 |
Chiron Spa |
Antidiotypic compounds
|
|
US6395253B2
(en)
|
1998-04-23 |
2002-05-28 |
The Regents Of The University Of Michigan |
Microspheres containing condensed polyanionic bioactive agents and methods for their production
|
|
EP1816197B1
(en)
|
1998-04-23 |
2009-09-16 |
Takara Bio Inc. |
Method for synthesizing DNA
|
|
US20020064517A1
(en)
|
1998-04-30 |
2002-05-30 |
Stewart A. Cederholm-Williams |
Fibrin sealant as a transfection/transformation vehicle for gene therapy
|
|
US20090208418A1
(en)
|
2005-04-29 |
2009-08-20 |
Innexus Biotechnology Internaltional Ltd. |
Superantibody synthesis and use in detection, prevention and treatment of disease
|
|
TR200003441T2
(tr)
|
1998-05-20 |
2001-04-20 |
Expression Genetics, Inc. |
Hepatositi hedefleyen polietilen gliko-ekli poli-l-lisin polimerik bir gen taşıyıcı
|
|
US6503231B1
(en)
|
1998-06-10 |
2003-01-07 |
Georgia Tech Research Corporation |
Microneedle device for transport of molecules across tissue
|
|
US7091192B1
(en)
|
1998-07-01 |
2006-08-15 |
California Institute Of Technology |
Linear cyclodextrin copolymers
|
|
WO2000002950A1
(en)
|
1998-07-13 |
2000-01-20 |
Expression Genetics, Inc. |
Polyester analogue of poly-l-lysine as a soluble, biodegradable gene delivery carrier
|
|
US6222030B1
(en)
|
1998-08-03 |
2001-04-24 |
Agilent Technologies, Inc. |
Solid phase synthesis of oligonucleotides using carbonate protecting groups and alpha-effect nucleophile deprotection
|
|
DE69939939D1
(de)
|
1998-08-11 |
2009-01-02 |
Idec Pharma Corp |
Kombinationstherapien gegen b-zell-lymphome beinhaltend die verabreichung von anti-cd20-antikörpern
|
|
GB9817662D0
(en)
|
1998-08-13 |
1998-10-07 |
Crocker Peter J |
Substance delivery
|
|
US6924365B1
(en)
|
1998-09-29 |
2005-08-02 |
Transkaryotic Therapies, Inc. |
Optimized messenger RNA
|
|
US20090017533A1
(en)
|
1998-09-29 |
2009-01-15 |
Shire Human Genetic Therapies, Inc., A Delaware Corporation |
Optimized messenger rna
|
|
AU772881B2
(en)
|
1998-11-03 |
2004-05-13 |
Yale University |
Multidomain polynucleotide molecular sensors
|
|
KR20010103655A
(ko)
|
1998-11-09 |
2001-11-23 |
케네쓰 제이. 울코트 |
키메라 항-ｃｄ２０항체를 이용한 순환성 종양세포와관련된 혈액학적 악성종양의 치료법
|
|
DE69941903D1
(de)
|
1998-11-09 |
2010-02-25 |
Biogen Idec Inc |
Behandlung von patienten die eine knochenmarktransplantation oder eine transplantation peripherer blutstammzellen erhalten mit anti-cd20 antikörpern
|
|
WO2000027340A2
(en)
|
1998-11-12 |
2000-05-18 |
The Children's Medical Center Corporation |
USE OF t-RNA AND FRAGMENTS FOR INHIBITING ANGIOGENESIS AND COMPOSITIONS THEREOF
|
|
US6210931B1
(en)
|
1998-11-30 |
2001-04-03 |
The United States Of America As Represented By The Secretary Of Agriculture |
Ribozyme-mediated synthesis of circular RNA
|
|
US20040171980A1
(en)
|
1998-12-18 |
2004-09-02 |
Sontra Medical, Inc. |
Method and apparatus for enhancement of transdermal transport
|
|
WO2000039327A1
(en)
|
1998-12-23 |
2000-07-06 |
Human Genome Sciences, Inc. |
Peptidoglycan recognition proteins
|
|
US6255476B1
(en)
|
1999-02-22 |
2001-07-03 |
Pe Corporation (Ny) |
Methods and compositions for synthesis of labelled oligonucleotides and analogs on solid-supports
|
|
EP1155124A2
(en)
|
1999-02-22 |
2001-11-21 |
European Molecular Biology Laboratory |
In vitro translation system
|
|
US7629311B2
(en)
|
1999-02-24 |
2009-12-08 |
Edward Lewis Tobinick |
Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers
|
|
JP2002537102A
(ja)
|
1999-02-26 |
2002-11-05 |
カイロン コーポレイション |
吸着された高分子および微粒子を有するミクロエマルジョン
|
|
AU763173B2
(en)
|
1999-03-01 |
2003-07-17 |
Atossa Genetics, Inc. |
Apparatus, methods and kits for simultaneous delivery of a substance to multiple breast milk ducts
|
|
US7084125B2
(en)
|
1999-03-18 |
2006-08-01 |
Exiqon A/S |
Xylo-LNA analogues
|
|
EP1165798A2
(en)
|
1999-03-29 |
2002-01-02 |
Statens Serum Institut |
Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope
|
|
CA2369293C
(en)
|
1999-04-09 |
2010-06-08 |
Dynal Particles As |
Process for the preparation of monodisperse polymer particles
|
|
US7053207B2
(en)
|
1999-05-04 |
2006-05-30 |
Exiqon A/S |
L-ribo-LNA analogues
|
|
US8663692B1
(en)
|
1999-05-07 |
2014-03-04 |
Pharmasol Gmbh |
Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
|
|
JP2002544174A
(ja)
|
1999-05-07 |
2002-12-24 |
ジェネンテック・インコーポレーテッド |
Ｂ細胞表面マーカーに結合するアンタゴニストを用いた自己免疫疾患の治療
|
|
US7171264B1
(en)
|
1999-05-10 |
2007-01-30 |
Genetronics, Inc. |
Intradermal delivery of active agents by needle-free injection and electroporation
|
|
US6346382B1
(en)
|
1999-06-01 |
2002-02-12 |
Vanderbilt University |
Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto
|
|
US6743211B1
(en)
|
1999-11-23 |
2004-06-01 |
Georgia Tech Research Corporation |
Devices and methods for enhanced microneedle penetration of biological barriers
|
|
US6611707B1
(en)
|
1999-06-04 |
2003-08-26 |
Georgia Tech Research Corporation |
Microneedle drug delivery device
|
|
WO2000075356A1
(en)
|
1999-06-04 |
2000-12-14 |
Lin Shi Lung |
Rna polymerase chain reaction
|
|
US6303573B1
(en)
|
1999-06-07 |
2001-10-16 |
The Burnham Institute |
Heart homing peptides and methods of using same
|
|
EP1196558A1
(fr)
|
1999-06-08 |
2002-04-17 |
Aventis Pasteur |
Oligonucleotide immunostimulant
|
|
ES2331644T3
(es)
|
1999-06-09 |
2010-01-12 |
Immunomedics, Inc. |
Inmunoterapia de trastornos autoinmunes usando anticuerpos cuya diana son celulas b.
|
|
US6949245B1
(en)
|
1999-06-25 |
2005-09-27 |
Genentech, Inc. |
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
|
|
WO2001000650A1
(en)
|
1999-06-30 |
2001-01-04 |
Advanced Cell Technology, Inc. |
Cytoplasmic transfer to de-differentiate recipient cells
|
|
US6514948B1
(en)
|
1999-07-02 |
2003-02-04 |
The Regents Of The University Of California |
Method for enhancing an immune response
|
|
IL147026A0
(en)
|
1999-07-09 |
2002-08-14 |
American Home Prod |
Method and compositions for preventing the formation of aberrant rna during transcripting of a plasmid sequence
|
|
CA2311201A1
(en)
|
1999-08-05 |
2001-02-05 |
Genset S.A. |
Ests and encoded human proteins
|
|
US8557244B1
(en)
|
1999-08-11 |
2013-10-15 |
Biogen Idec Inc. |
Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody
|
|
US6984720B1
(en)
|
1999-08-24 |
2006-01-10 |
Medarex, Inc. |
Human CTLA-4 antibodies
|
|
US20050112141A1
(en)
|
2000-08-30 |
2005-05-26 |
Terman David S. |
Compositions and methods for treatment of neoplastic disease
|
|
US6551338B1
(en)
|
1999-09-01 |
2003-04-22 |
Mcgill University |
Method and device for myogenesis and angiogenesis of the heart
|
|
US20040106567A1
(en)
|
1999-09-07 |
2004-06-03 |
Hagstrom James E. |
Intravascular delivery of non-viral nucleic acid
|
|
EP1083232B1
(en)
|
1999-09-09 |
2005-02-23 |
CureVac GmbH |
Transfer of mRNA using polycationic compounds
|
|
AU7398200A
(en)
|
1999-09-17 |
2001-04-24 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
|
US6623457B1
(en)
|
1999-09-22 |
2003-09-23 |
Becton, Dickinson And Company |
Method and apparatus for the transdermal administration of a substance
|
|
WO2002064799A2
(en)
|
1999-09-28 |
2002-08-22 |
Transkaryotic Therapies, Inc. |
Optimized messenger rna
|
|
US6528262B1
(en)
|
1999-10-06 |
2003-03-04 |
Quark Biotech, Inc. |
Method for enrichment of natural antisense messenger RNA
|
|
US7060291B1
(en)
|
1999-11-24 |
2006-06-13 |
Transave, Inc. |
Modular targeted liposomal delivery system
|
|
US6613026B1
(en)
|
1999-12-08 |
2003-09-02 |
Scimed Life Systems, Inc. |
Lateral needle-less injection apparatus and method
|
|
US6277974B1
(en)
|
1999-12-14 |
2001-08-21 |
Cogent Neuroscience, Inc. |
Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
|
|
US6245929B1
(en)
|
1999-12-20 |
2001-06-12 |
General Electric Company |
Catalyst composition and method for producing diaryl carbonates, using bisphosphines
|
|
WO2001046272A1
(en)
|
1999-12-22 |
2001-06-28 |
Basell Technology Company B.V. |
Alpha-olefin polymerization catalyst system which contains an aromatic silane compound
|
|
SE515932C2
(sv)
|
1999-12-23 |
2001-10-29 |
Prostalund Operations Ab |
Sätt och anordning vid behandling av prostata
|
|
US7737108B1
(en)
|
2000-01-07 |
2010-06-15 |
University Of Washington |
Enhanced transport using membrane disruptive agents
|
|
WO2001051661A2
(en)
|
2000-01-13 |
2001-07-19 |
Amsterdam Support Diagnostics B.V. |
A universal nucleic acid amplification system for nucleic acids in a sample
|
|
US7468275B2
(en)
|
2000-01-28 |
2008-12-23 |
The Scripps Research Institute |
Synthetic internal ribosome entry sites and methods of identifying same
|
|
EP1259602A1
(en)
|
2000-01-28 |
2002-11-27 |
The Scripps Research Institute |
Methods of identifying synthetic transcriptional and translational regulatory elements, and compositions relating to same
|
|
AU2001231245A1
(en)
|
2000-01-31 |
2001-08-07 |
The Regents Of The University Of California |
Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen
|
|
CA2395811A1
(en)
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
|
US7833992B2
(en)
|
2001-05-18 |
2010-11-16 |
Merck Sharpe & Dohme |
Conjugates and compositions for cellular delivery
|
|
US7491805B2
(en)
|
2001-05-18 |
2009-02-17 |
Sirna Therapeutics, Inc. |
Conjugates and compositions for cellular delivery
|
|
US6602498B2
(en)
|
2000-02-22 |
2003-08-05 |
Shearwater Corporation |
N-maleimidyl polymer derivatives
|
|
WO2001062801A2
(en)
|
2000-02-24 |
2001-08-30 |
Washington University |
Humanized antibodies that sequester amyloid beta peptide
|
|
AU2001245427A1
(en)
|
2000-03-03 |
2001-09-17 |
Valentis, Inc. |
Nucleic acid formulations for gene delivery and methods of use
|
|
CN1441677A
(zh)
|
2000-03-31 |
2003-09-10 |
Idec药物公司 |
抗细胞因子抗体或拮抗剂与抗－cd20在b细胞淋巴瘤治疗中的联合应用
|
|
AU2001249727A1
(en)
|
2000-03-31 |
2001-10-15 |
Genentech, Inc. |
Compositions and methods for detecting and quantifying gene expression
|
|
US6565572B2
(en)
|
2000-04-10 |
2003-05-20 |
Sdgi Holdings, Inc. |
Fenestrated surgical screw and method
|
|
CA2405557C
(en)
|
2000-04-12 |
2013-09-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
US6368801B1
(en)
|
2000-04-12 |
2002-04-09 |
Molecular Staging, Inc. |
Detection and amplification of RNA using target-mediated ligation of DNA by RNA ligase
|
|
US20010046496A1
(en)
|
2000-04-14 |
2001-11-29 |
Brettman Lee R. |
Method of administering an antibody
|
|
US6468247B1
(en)
|
2000-04-21 |
2002-10-22 |
Mark Zamoyski |
Perfusion device for localized drug delivery
|
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
|
US20040229271A1
(en)
|
2000-05-19 |
2004-11-18 |
Williams Richard B. |
Compositions and methods for the identification and selection of nucleic acids and polypeptides
|
|
WO2001092523A2
(en)
|
2000-05-30 |
2001-12-06 |
Curagen Corporation |
Human polynucleotides and polypeptides encoded thereby
|
|
US6537242B1
(en)
|
2000-06-06 |
2003-03-25 |
Becton, Dickinson And Company |
Method and apparatus for enhancing penetration of a member for the intradermal sampling or administration of a substance
|
|
WO2001093902A2
(en)
|
2000-06-07 |
2001-12-13 |
Biosynexus Incorporated |
Immunostimulatory rna/dna hybrid molecules
|
|
US6607513B1
(en)
|
2000-06-08 |
2003-08-19 |
Becton, Dickinson And Company |
Device for withdrawing or administering a substance and method of manufacturing a device
|
|
WO2002000694A2
(en)
|
2000-06-23 |
2002-01-03 |
American Cyanamid Company |
Modified morbillivirus v proteins
|
|
US20050181033A1
(en)
|
2000-06-29 |
2005-08-18 |
Dekker John P.Iii |
Method for delivering interferons to the intradermal compartment
|
|
WO2002002606A2
(en)
|
2000-07-03 |
2002-01-10 |
Chiron S.P.A. |
Immunisation against chlamydia pneumoniae
|
|
US6440096B1
(en)
|
2000-07-14 |
2002-08-27 |
Becton, Dickinson And Co. |
Microdevice and method of manufacturing a microdevice
|
|
DK1301614T3
(da)
|
2000-07-21 |
2007-04-02 |
Glaxo Group Ltd |
Codon-optimerede papillomavirus-sekvenser
|
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
|
US6696038B1
(en)
|
2000-09-14 |
2004-02-24 |
Expression Genetics, Inc. |
Cationic lipopolymer as biocompatible gene delivery agent
|
|
US20040142474A1
(en)
|
2000-09-14 |
2004-07-22 |
Expression Genetics, Inc. |
Novel cationic lipopolymer as a biocompatible gene delivery agent
|
|
WO2002024873A1
(en)
|
2000-09-20 |
2002-03-28 |
Christopher Ralph Franks |
Stem cell therapy
|
|
AU2002211524B2
(en)
|
2000-10-04 |
2007-03-22 |
The Trustees Of The University Of Pennsylvania |
Highly expressible genes
|
|
JP4413493B2
(ja)
|
2000-10-04 |
2010-02-10 |
サンタリス ファーマ アー／エス |
プリンｌｎａ類似体の改善された合成方法
|
|
US6998115B2
(en)
|
2000-10-10 |
2006-02-14 |
Massachusetts Institute Of Technology |
Biodegradable poly(β-amino esters) and uses thereof
|
|
US7202226B2
(en)
|
2000-10-23 |
2007-04-10 |
Detroit R & D |
Augmentation of wound healing by elF-4E mRNA and EGF mRNA
|
|
US20030077604A1
(en)
|
2000-10-27 |
2003-04-24 |
Yongming Sun |
Compositions and methods relating to breast specific genes and proteins
|
|
US20020132788A1
(en)
|
2000-11-06 |
2002-09-19 |
David Lewis |
Inhibition of gene expression by delivery of small interfering RNA to post-embryonic animal cells in vivo
|
|
AU2002226930A1
(en)
|
2000-11-17 |
2002-05-27 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the fv to lower the isoelectric point
|
|
EP2339035A1
(en)
|
2000-12-07 |
2011-06-29 |
Novartis Vaccines and Diagnostics, Inc. |
Endogenous retroviruses up-regulated in prostate cancer
|
|
US7708915B2
(en)
|
2004-05-06 |
2010-05-04 |
Castor Trevor P |
Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein
|
|
US20020130430A1
(en)
|
2000-12-29 |
2002-09-19 |
Castor Trevor Percival |
Methods for making polymer microspheres/nanospheres and encapsulating therapeutic proteins and other products
|
|
US7628780B2
(en)
|
2001-01-13 |
2009-12-08 |
Medtronic, Inc. |
Devices and methods for interstitial injection of biologic agents into tissue
|
|
CA2435180C
(en)
|
2001-01-19 |
2019-04-09 |
Vironovative B.V. |
A virus causing respiratory tract illness in susceptible mammals
|
|
EP1224943A1
(en)
|
2001-01-19 |
2002-07-24 |
Crucell Holland B.V. |
Fibronectin as a tumor marker detected by phage antibodies
|
|
US20040110191A1
(en)
|
2001-01-31 |
2004-06-10 |
Winkler Matthew M. |
Comparative analysis of nucleic acids using population tagging
|
|
EP1366196A4
(en)
|
2001-02-14 |
2004-07-07 |
Baylor College Medicine |
METHOD AND COMPOSITIONS FOR AMPLIFICATING RNA
|
|
US6652886B2
(en)
|
2001-02-16 |
2003-11-25 |
Expression Genetics |
Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
|
|
DE10109897A1
(de)
|
2001-02-21 |
2002-11-07 |
Novosom Ag |
Fakultativ kationische Liposomen und Verwendung dieser
|
|
US7232425B2
(en)
|
2001-03-02 |
2007-06-19 |
Sorenson Development, Inc. |
Apparatus and method for specific interstitial or subcutaneous diffusion and dispersion of medication
|
|
CN100471956C
(zh)
|
2001-03-09 |
2009-03-25 |
基因流股份有限公司 |
新型表达载体
|
|
JP2002262882A
(ja)
|
2001-03-12 |
2002-09-17 |
Nisshinbo Ind Inc |
Ｒｎａの増幅法
|
|
FR2822164B1
(fr)
|
2001-03-19 |
2004-06-18 |
Centre Nat Rech Scient |
Polypeptides derives des arn polymerases, et leurs utilisations
|
|
US6520949B2
(en)
|
2001-04-02 |
2003-02-18 |
Martin St. Germain |
Method and apparatus for administering fluid to animals subcutaneously
|
|
US6625486B2
(en)
|
2001-04-11 |
2003-09-23 |
Advanced Cardiovascular Systems, Inc. |
Method and apparatus for intracellular delivery of an agent
|
|
DE10119005A1
(de)
|
2001-04-18 |
2002-10-24 |
Roche Diagnostics Gmbh |
Verfahren zur Proteinexpression ausgehend von stabilisierter linearer kurzer DNA in zellfreien in vitro-Transkription/Translations-Systemen mit Exonuklease-haltigen Lysaten oder in einem zellulären System enthaltend Exonukleasen
|
|
US20030171253A1
(en)
|
2001-04-19 |
2003-09-11 |
Averil Ma |
Methods and compositions relating to modulation of A20
|
|
DE10291734D2
(de)
|
2001-04-23 |
2004-05-27 |
Lorbach Elke |
Pufferlösung für die Elektroporation und Verfahren umfassend die Verwendung derselben
|
|
US7560424B2
(en)
|
2001-04-30 |
2009-07-14 |
Zystor Therapeutics, Inc. |
Targeted therapeutic proteins
|
|
US6777187B2
(en)
|
2001-05-02 |
2004-08-17 |
Rubicon Genomics, Inc. |
Genome walking by selective amplification of nick-translate DNA library and amplification from complex mixtures of templates
|
|
AU2002308623A1
(en)
|
2001-05-08 |
2002-11-18 |
Magnatech International, L.P. |
Electronic length control wire pay-off system and method
|
|
US20050137155A1
(en)
|
2001-05-18 |
2005-06-23 |
Sirna Therapeutics, Inc. |
RNA interference mediated treatment of Parkinson disease using short interfering nucleic acid (siNA)
|
|
US8137911B2
(en)
|
2001-05-22 |
2012-03-20 |
Cellscript, Inc. |
Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences
|
|
US7514098B2
(en)
|
2001-05-30 |
2009-04-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Use of targeted cross-linked nanoparticles for in vivo gene delivery
|
|
EP2305699B1
(de)
|
2001-06-05 |
2014-08-13 |
CureVac GmbH |
Stabilisierte mRNA mit erhöhtem G/C-Gehalt und optimierter Codon Usage für die Impfung gegen Schlafkrankheit, Leishmaniose und Toxoplasmose
|
|
EP1402035A2
(en)
|
2001-06-18 |
2004-03-31 |
Novartis AG |
G-protein coupled receptors and dna sequences thereof
|
|
US7785610B2
(en)
|
2001-06-21 |
2010-08-31 |
Dynavax Technologies Corporation |
Chimeric immunomodulatory compounds and methods of using the same—III
|
|
US7547551B2
(en)
|
2001-06-21 |
2009-06-16 |
University Of Antwerp. |
Transfection of eukaryontic cells with linear polynucleotides by electroporation
|
|
WO2003002604A2
(en)
|
2001-06-26 |
2003-01-09 |
Novartis Ag |
G protein coupled receptors and dna sequences thereof
|
|
SE0102327D0
(sv)
|
2001-06-28 |
2001-06-28 |
Active Biotech Ab |
A novel engineered superantigen for human therapy
|
|
WO2003002069A2
(en)
|
2001-06-29 |
2003-01-09 |
Becton, Dickinson And Company |
Intradermal delivery of vaccines and gene therapeutic agents via microcannula
|
|
US20040236092A1
(en)
|
2001-07-13 |
2004-11-25 |
Roman Dziarski |
Peptidologlycan recognition protein encoding nucleic acids and methods of use thereof
|
|
US6586524B2
(en)
|
2001-07-19 |
2003-07-01 |
Expression Genetics, Inc. |
Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier
|
|
AU2002312543A1
(en)
|
2001-08-01 |
2003-02-17 |
University Of Utah, Technology Transfer Office |
Isoform-selective inhibitors and activators of pde3 cyclic
|
|
WO2003018798A2
(en)
|
2001-08-27 |
2003-03-06 |
Novartis Ag |
G-protein coupled receptor and dna sequences thereof
|
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
|
EP2428571B1
(en)
|
2001-09-28 |
2018-07-18 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
MicroRNA molecules
|
|
AR045702A1
(es)
|
2001-10-03 |
2005-11-09 |
Chiron Corp |
Composiciones de adyuvantes.
|
|
DE10148886A1
(de)
|
2001-10-04 |
2003-04-30 |
Avontec Gmbh |
Inhibition von STAT-1
|
|
US7276489B2
(en)
|
2002-10-24 |
2007-10-02 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
|
|
US7429258B2
(en)
|
2001-10-26 |
2008-09-30 |
Massachusetts Institute Of Technology |
Microneedle transport device
|
|
US7384739B2
(en)
|
2001-11-14 |
2008-06-10 |
Toyo Boseki Kabushiki Kaisha |
Compositions for enhancing DNA synthesis, DNA polymerase-related factors and utilization thereof
|
|
WO2003044482A2
(en)
|
2001-11-16 |
2003-05-30 |
The University Of Tennessee Research Corporation |
Recombinant antibody fusion proteins and methods for detection of apoptotic cells
|
|
JP2005510251A
(ja)
|
2001-11-29 |
2005-04-21 |
ノバルティス アクチエンゲゼルシャフト |
サルコイドーシスの評価法と予後判定法
|
|
CA2409775C
(en)
|
2001-12-03 |
2010-07-13 |
F. Hoffmann-La Roche Ag |
Reversibly modified thermostable enzymes for dna synthesis and amplification in vitro
|
|
EP1521594B1
(en)
|
2001-12-07 |
2013-10-02 |
Novartis Vaccines and Diagnostics, Inc. |
Endogenous retrovirus polypeptides linked to oncogenic transformation
|
|
ATE458003T1
(de)
|
2001-12-07 |
2010-03-15 |
Novartis Vaccines & Diagnostic |
Bei prostatakrebs hochreguliertes endogenes retrovirus
|
|
US20060275747A1
(en)
|
2001-12-07 |
2006-12-07 |
Hardy Stephen F |
Endogenous retrovirus up-regulated in prostate cancer
|
|
JP2005520498A
(ja)
|
2001-12-17 |
2005-07-14 |
ノバルティス アクチエンゲゼルシャフト |
新規ｇタンパク質共役受容体およびそのｄｎａ配列
|
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
|
DK1474109T3
(da)
|
2001-12-21 |
2010-10-25 |
Alcon Inc |
Anvendelse af syntetiske uorganiske nanopartikler som bærere af ophthalmiske lægemidler
|
|
AU2003235707A1
(en)
|
2002-01-18 |
2003-07-30 |
Curevac Gmbh |
Immunogenic preparations and vaccines on the basis of mrna
|
|
WO2003066649A1
(en)
|
2002-02-04 |
2003-08-14 |
Biomira Inc. |
Immunostimulatory, covalently lipidated oligonucleotides
|
|
AU2003210802B2
(en)
|
2002-02-05 |
2009-09-10 |
Genentech Inc. |
Protein purification
|
|
FR2835749B1
(fr)
|
2002-02-08 |
2006-04-14 |
Inst Nat Sante Rech Med |
Composition pharmaceutique ameliorant le transfert de gene in vivo
|
|
DE10207178A1
(de)
|
2002-02-19 |
2003-09-04 |
Novosom Ag |
Komponenten für die Herstellung amphoterer Liposomen
|
|
AR038568A1
(es)
|
2002-02-20 |
2005-01-19 |
Hoffmann La Roche |
Anticuerpos anti-a beta y su uso
|
|
US20050222064A1
(en)
|
2002-02-20 |
2005-10-06 |
Sirna Therapeutics, Inc. |
Polycationic compositions for cellular delivery of polynucleotides
|
|
US7354742B2
(en)
|
2002-02-22 |
2008-04-08 |
Ortho-Mcneil Pharmaceutical, Inc. |
Method for generating amplified RNA
|
|
EP1572941A4
(en)
|
2002-02-26 |
2009-03-18 |
Maxygen Inc |
NEW FLAVIVIRUS ANTIGENES
|
|
SI1487856T1
(sl)
|
2002-03-04 |
2010-12-31 |
Imclone Llc |
Äśloveĺ ka protitelesa specifiäśna za kdr (receptor z domeno kinaznega vkljuäśka) in njihove uporabe
|
|
WO2003075892A1
(en)
|
2002-03-13 |
2003-09-18 |
Novartis Ag |
Pharmaceutical microparticles
|
|
US7074596B2
(en)
|
2002-03-25 |
2006-07-11 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Synthesis and use of anti-reverse mRNA cap analogues
|
|
NZ573064A
(en)
|
2002-04-04 |
2011-02-25 |
Coley Pharm Gmbh |
Immunostimulatory G,U-containing oligoribonucleotides
|
|
WO2003087815A2
(en)
|
2002-04-17 |
2003-10-23 |
Novartis Ag |
Method for the identification of inhibitors of the binding of are-containing mrn a and an hur protein
|
|
GB0209539D0
(en)
|
2002-04-26 |
2002-06-05 |
Avecia Ltd |
Monomer Polymer and process
|
|
EP1361277A1
(en)
|
2002-04-30 |
2003-11-12 |
Centre National De La Recherche Scientifique (Cnrs) |
Optimization of transgene expression in mammalian cells
|
|
DK1507556T3
(en)
|
2002-05-02 |
2016-09-12 |
Wyeth Holdings Llc |
Calicheamicin derivative-carrier conjugates
|
|
BR0311443A
(pt)
|
2002-05-06 |
2005-03-22 |
Becton Dickinson Co |
Método e dispositivo para controlar farmacocinética de droga
|
|
EP1503716A4
(en)
|
2002-05-08 |
2007-07-04 |
Univ California |
SYSTEM AND METHOD FOR TREATMENT OF CARDIAC ARRHYTHMIAS USING FIBROBLAST CELLS
|
|
US7374930B2
(en)
|
2002-05-21 |
2008-05-20 |
Expression Genetics, Inc. |
GLP-1 gene delivery for the treatment of type 2 diabetes
|
|
US20040018525A1
(en)
|
2002-05-21 |
2004-01-29 |
Bayer Aktiengesellschaft |
Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasma
|
|
DE10224200C1
(de)
|
2002-05-31 |
2003-08-21 |
Artus Ges Fuer Molekularbiolog |
Vermehrung von Ribonukleinsäuren
|
|
WO2003101401A2
(en)
|
2002-06-03 |
2003-12-11 |
Chiron Corporation |
Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
|
|
SE0201907D0
(sv)
|
2002-06-19 |
2002-06-19 |
Atos Medical Ab |
Plaster for tracheostoma valves
|
|
DK1519714T3
(da)
|
2002-06-28 |
2011-01-31 |
Protiva Biotherapeutics Inc |
Fremgangsmåde og apparat til fremstilling af liposomer
|
|
PL374580A1
(en)
|
2002-07-01 |
2005-10-31 |
The Kenneth S.Warren Institute, Inc. |
Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs
|
|
DE10229872A1
(de)
|
2002-07-03 |
2004-01-29 |
Curevac Gmbh |
Immunstimulation durch chemisch modifizierte RNA
|
|
GB0215509D0
(en)
|
2002-07-04 |
2002-08-14 |
Novartis Ag |
Marker genes
|
|
US20040009180A1
(en)
|
2002-07-11 |
2004-01-15 |
Allergan, Inc. |
Transdermal botulinum toxin compositions
|
|
AU2003249208B2
(en)
|
2002-07-16 |
2010-03-04 |
Vgx Pharmaceuticals, Llc |
Codon optimized synthetic plasmids
|
|
CA2493808A1
(en)
|
2002-07-24 |
2004-01-29 |
Ptc Therapeutics, Inc. |
Methods for identifying small molecules that modulate premature translation termination and nonsense mediated mrna decay
|
|
EP1393745A1
(en)
|
2002-07-29 |
2004-03-03 |
Hybridon, Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5'ends
|
|
US6653468B1
(en)
|
2002-07-31 |
2003-11-25 |
Isis Pharmaceuticals, Inc. |
Universal support media for synthesis of oligomeric compounds
|
|
EP1386925A1
(en)
|
2002-07-31 |
2004-02-04 |
Girindus AG |
Method for preparing oligonucleotides
|
|
WO2004012605A1
(en)
|
2002-08-01 |
2004-02-12 |
Abbott Laboratories Vascular Enterprises, Limited |
Apparatus for sealing a puncture by causing a reduction in the circumference of the puncture
|
|
EP1873180B1
(en)
|
2002-08-14 |
2014-05-07 |
Novartis AG |
Ophthalmic device made from a radiation-curable prepolymer
|
|
JP2005537054A
(ja)
|
2002-08-30 |
2005-12-08 |
ベクトン・ディキンソン・アンド・カンパニー |
免疫調節化合物の薬物動態を制御する方法
|
|
CN102516417B
(zh)
|
2002-09-06 |
2014-12-10 |
天蓝制药公司 |
用于传递治疗剂的以环糊精为基础的聚合物
|
|
ATE412684T1
(de)
|
2002-09-09 |
2008-11-15 |
Nektar Therapeutics Al Corp |
Verfahren zur herstellung von wasserlöslichen polymerderivaten mit terminalen carboxylgruppen
|
|
US7534872B2
(en)
|
2002-09-27 |
2009-05-19 |
Syngen, Inc. |
Compositions and methods for the use of FMOC derivatives in DNA/RNA synthesis
|
|
PL218660B1
(pl)
|
2002-10-17 |
2015-01-30 |
Genmab As |
Izolowane ludzkie przeciwciało monoklonalne wiążące ludzki CD20, związane z tym przeciwciałem transfektoma, komórka gospodarza, transgeniczne zwierzę lub roślina, kompozycja, immunokoniugat, cząsteczka bispecyficzna, wektor ekspresyjny, kompozycja farmaceutyczna, zastosowanie medyczne, zestaw oraz przeciwciało antyidiotypowe i jego zastosowanie
|
|
CN1891826B
(zh)
|
2002-10-22 |
2011-09-14 |
卫材R&D管理有限公司 |
在分裂停止后的产多巴胺型神经元前体细胞中特异性表达的基因
|
|
US6896666B2
(en)
|
2002-11-08 |
2005-05-24 |
Kochamba Family Trust |
Cutaneous injection delivery under suction
|
|
AU2003294440A1
(en)
|
2002-11-21 |
2004-06-18 |
Epicentre Technologies |
Methods for using riboprimers for strand displacement replication of target sequences
|
|
US7491234B2
(en)
|
2002-12-03 |
2009-02-17 |
Boston Scientific Scimed, Inc. |
Medical devices for delivery of therapeutic agents
|
|
JP4959136B2
(ja)
|
2002-12-13 |
2012-06-20 |
イミューノメディクス、インコーポレイテッド |
細胞内で開裂可能な結合を有する免疫接合体
|
|
EP2301966A1
(en)
|
2002-12-16 |
2011-03-30 |
Genentech, Inc. |
Immunoglobulin variants and uses thereof
|
|
WO2004058159A2
(en)
|
2002-12-23 |
2004-07-15 |
Dynavax Technologies Corporation |
Branched immunomodulatory compounds and methods of using the same
|
|
US7169892B2
(en)
|
2003-01-10 |
2007-01-30 |
Astellas Pharma Inc. |
Lipid-peptide-polymer conjugates for long blood circulation and tumor specific drug delivery systems
|
|
WO2004067728A2
(en)
|
2003-01-17 |
2004-08-12 |
Ptc Therapeutics |
Methods and systems for the identification of rna regulatory sequences and compounds that modulate their function
|
|
EP1604011A4
(en)
|
2003-01-21 |
2009-12-09 |
Ptc Therapeutics Inc |
METHODS FOR IDENTIFYING COMPOUNDS THAT MODULATE THE EXPRESSION OF DEPENDENT GENES FROM A NON-TRANSLATED REGION, AND METHODS OF USING SAME
|
|
US8426194B2
(en)
|
2003-01-21 |
2013-04-23 |
Ptc Therapeutics, Inc. |
Methods and agents for screening for compounds capable of modulating VEGF expression
|
|
US9068234B2
(en)
|
2003-01-21 |
2015-06-30 |
Ptc Therapeutics, Inc. |
Methods and agents for screening for compounds capable of modulating gene expression
|
|
US20040147027A1
(en)
|
2003-01-28 |
2004-07-29 |
Troy Carol M. |
Complex for facilitating delivery of dsRNA into a cell and uses thereof
|
|
WO2004076622A2
(en)
|
2003-02-10 |
2004-09-10 |
National Institute Of Advanced Industrial Science And Technology |
Regulation of gene expression by dna interference
|
|
AU2004210679A1
(en)
|
2003-02-10 |
2004-08-26 |
Elan Pharmaceuticals, Inc. |
Immunoglobulin formulation and method of preparation thereof
|
|
US20040167090A1
(en)
|
2003-02-21 |
2004-08-26 |
Monahan Sean D. |
Covalent modification of RNA for in vitro and in vivo delivery
|
|
CA2450289A1
(en)
|
2003-03-20 |
2005-05-19 |
Imclone Systems Incorporated |
Method of producing an antibody to epidermal growth factor receptor
|
|
US7320961B2
(en)
|
2003-03-24 |
2008-01-22 |
Abbott Laboratories |
Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate
|
|
CA2519309A1
(en)
|
2003-03-25 |
2004-10-14 |
Stratagene California |
Dna polymerase fusions and uses thereof
|
|
WO2004092329A2
(en)
|
2003-04-08 |
2004-10-28 |
Galenica Pharmaceuticals, Inc. |
Semi-synthetic saponin analogs with carrier and immune stimulatory activities for dna and rna vaccines
|
|
JP2006522811A
(ja)
|
2003-04-09 |
2006-10-05 |
ジェネンテック・インコーポレーテッド |
ＴＮＦαインヒビターに対して不十分な反応を示す患者の自己免疫疾患治療法
|
|
EP2314327B2
(en)
|
2003-05-05 |
2017-09-20 |
Ben-Gurion University Of The Negev Research And Development Authority |
Injectable cross-linked polymeric preparations and uses thereof
|
|
ATE497783T1
(de)
|
2003-05-06 |
2011-02-15 |
Syntonix Pharmaceuticals Inc |
Gerinnungsfaktor vii-fc chimäre proteine zur behandlung von hämostatischen krankheiten
|
|
US7348004B2
(en)
|
2003-05-06 |
2008-03-25 |
Syntonix Pharmaceuticals, Inc. |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
US20040226556A1
(en)
|
2003-05-13 |
2004-11-18 |
Deem Mark E. |
Apparatus for treating asthma using neurotoxin
|
|
US9567591B2
(en)
|
2003-05-15 |
2017-02-14 |
Mello Biotechnology, Inc. |
Generation of human embryonic stem-like cells using intronic RNA
|
|
GB0313132D0
(en)
|
2003-06-06 |
2003-07-09 |
Ich Productions Ltd |
Peptide ligands
|
|
WO2005009346A2
(en)
|
2003-06-24 |
2005-02-03 |
Mirus Corporation |
Inhibition of gene function by delivery of polynucleotide-based gene expression inhibitors to mammalian cells in vivo
|
|
GB0316089D0
(en)
|
2003-07-09 |
2003-08-13 |
Xo Bioscience Ltd |
Differentiation method
|
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
US7575572B2
(en)
|
2003-07-15 |
2009-08-18 |
Spinal Generations, Llc |
Method and device for delivering medicine to bone
|
|
US20050013870A1
(en)
|
2003-07-17 |
2005-01-20 |
Toby Freyman |
Decellularized extracellular matrix of conditioned body tissues and uses thereof
|
|
TWI476206B
(zh)
|
2003-07-18 |
2015-03-11 |
Amgen Inc |
對肝細胞生長因子具專一性之結合劑
|
|
US7683036B2
(en)
|
2003-07-31 |
2010-03-23 |
Regulus Therapeutics Inc. |
Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
|
|
DE10335833A1
(de)
*
|
2003-08-05 |
2005-03-03 |
Curevac Gmbh |
Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie
|
|
US8668926B1
(en)
|
2003-09-15 |
2014-03-11 |
Shaker A. Mousa |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
|
|
US7135010B2
(en)
|
2003-09-30 |
2006-11-14 |
Damage Control Surgical Technologies, Inc. |
Method and apparatus for rapid deployment chest drainage
|
|
ATE515577T1
(de)
|
2003-10-06 |
2011-07-15 |
Novartis Pharma Gmbh |
Verwendung von mit der wirksamkeit der behandlung einer entzündungskrankheit assoziierten genetischen polymorphismen
|
|
DE10347710B4
(de)
|
2003-10-14 |
2006-03-30 |
Johannes-Gutenberg-Universität Mainz |
Rekombinante Impfstoffe und deren Verwendung
|
|
US20050130201A1
(en)
|
2003-10-14 |
2005-06-16 |
Dharmacon, Inc. |
Splint-assisted enzymatic synthesis of polyribounucleotides
|
|
LT2348051T
(lt)
|
2003-11-05 |
2019-02-25 |
Roche Glycart Ag |
Cd20 antikūnai su padidintu fc receptoriaus prisijungimo giminingumu ir efektorine funkcija
|
|
WO2005047536A2
(en)
|
2003-11-13 |
2005-05-26 |
Novartis Ag |
Detection of genomic amplification and deletion in cancer
|
|
US7998119B2
(en)
|
2003-11-18 |
2011-08-16 |
Nano Pass Technologies Ltd. |
System and method for delivering fluid into flexible biological barrier
|
|
US20070054278A1
(en)
|
2003-11-18 |
2007-03-08 |
Applera Corporation |
Polymorphisms in nucleic acid molecules encoding human enzyme proteins, methods of detection and uses thereof
|
|
US7699852B2
(en)
|
2003-11-19 |
2010-04-20 |
Zimmer Spine, Inc. |
Fenestrated bone tap and method
|
|
US20050153333A1
(en)
|
2003-12-02 |
2005-07-14 |
Sooknanan Roy R. |
Selective terminal tagging of nucleic acids
|
|
US8304183B2
(en)
|
2005-11-30 |
2012-11-06 |
Cellscript, Inc. |
Selective terminal tagging of nucleic acids
|
|
EP1691746B1
(en)
|
2003-12-08 |
2015-05-27 |
Gel-Del Technologies, Inc. |
Mucoadhesive drug delivery devices and methods of making and using thereof
|
|
US7674884B2
(en)
|
2003-12-10 |
2010-03-09 |
Novimmune S.A. |
Neutralizing antibodies and methods of use thereof
|
|
US7927873B2
(en)
|
2003-12-19 |
2011-04-19 |
University Of Cincinnati |
Polyamides for nucleic acid delivery
|
|
HUE064610T2
(hu)
|
2003-12-23 |
2024-04-28 |
Genentech Inc |
Új anti-IL 13 antitestek és alkalmazásaik
|
|
US7150726B2
(en)
|
2004-01-23 |
2006-12-19 |
Norfolk Medical |
Device for subcutaneous infusion of fluids
|
|
US8957034B2
(en)
|
2004-01-28 |
2015-02-17 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
|
WO2005073375A1
(en)
|
2004-01-30 |
2005-08-11 |
Maxygen Holdings Ltd. |
Regulated stop codon readthrough
|
|
US7309487B2
(en)
|
2004-02-09 |
2007-12-18 |
George Inana |
Methods and compositions for detecting and treating retinal diseases
|
|
EP1716179A2
(en)
|
2004-02-12 |
2006-11-02 |
Morphotek, Inc. |
Monoclonal antibodies that specifically bind to folate receptor alpha
|
|
US20070265220A1
(en)
|
2004-03-15 |
2007-11-15 |
City Of Hope |
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
|
|
EP3269738A1
(en)
|
2004-03-24 |
2018-01-17 |
Chugai Seiyaku Kabushiki Kaisha |
Subtypes of humanized antibody against interleukin-6 receptor
|
|
WO2005098433A2
(en)
|
2004-04-01 |
2005-10-20 |
Novartis Ag |
Diagnostic assays for alzheimer’s disease
|
|
US8882717B2
(en)
|
2004-04-12 |
2014-11-11 |
Allergan, Inc. |
Multi-site injection system
|
|
US7850962B2
(en)
|
2004-04-20 |
2010-12-14 |
Genmab A/S |
Human monoclonal antibodies against CD20
|
|
ES2246694B1
(es)
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
Nanoparticulas pegiladas.
|
|
WO2005108411A2
(en)
|
2004-05-05 |
2005-11-17 |
Isis Pharmaceuticals, Inc. |
Substituted pixyl protecting groups for oligonucleotide synthesis
|
|
AU2005244842B2
(en)
|
2004-05-12 |
2010-09-23 |
Baxter Healthcare S.A. |
Nucleic acid microspheres, production and delivery thereof
|
|
US20080103053A1
(en)
|
2005-11-22 |
2008-05-01 |
Helicos Biosciences Corporation |
Methods and compositions for sequencing a nucleic acid
|
|
WO2005117557A2
(en)
|
2004-06-01 |
2005-12-15 |
San Diego State University Foundation |
Expression system
|
|
AU2005252273B2
(en)
|
2004-06-07 |
2011-04-28 |
Arbutus Biopharma Corporation |
Lipid encapsulated interfering RNA
|
|
ATE537263T1
(de)
|
2004-06-07 |
2011-12-15 |
Protiva Biotherapeutics Inc |
Kationische lipide und verwendungsverfahren
|
|
US8178656B2
(en)
|
2004-06-11 |
2012-05-15 |
Trustees Of Tufts College |
Silk-based drug delivery system
|
|
US8338648B2
(en)
|
2004-06-12 |
2012-12-25 |
Signum Biosciences, Inc. |
Topical compositions and methods for epithelial-related conditions
|
|
US7527947B2
(en)
|
2004-06-14 |
2009-05-05 |
Novozymes A/S |
Signal peptide for producing a polypeptide
|
|
WO2006046978A2
(en)
|
2004-06-28 |
2006-05-04 |
Argos Therapeutics, Inc. |
Cationic peptide-mediated transformation
|
|
ES2390082T5
(es)
|
2004-06-30 |
2018-01-19 |
Nektar Therapeutics |
Conjugados de resto de Factor IX y polímeros
|
|
JP2008505685A
(ja)
|
2004-07-06 |
2008-02-28 |
トランスファーマ メディカル リミテッド |
経皮免疫処置用送達システム
|
|
DE102004035227A1
(de)
|
2004-07-21 |
2006-02-16 |
Curevac Gmbh |
mRNA-Gemisch zur Vakzinierung gegen Tumorerkrankungen
|
|
WO2006093526A2
(en)
|
2004-07-21 |
2006-09-08 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising a modified or non-natural nucleobase
|
|
US7603349B1
(en)
|
2004-07-29 |
2009-10-13 |
Yahoo! Inc. |
User interfaces for search systems using in-line contextual queries
|
|
GB0417487D0
(en)
|
2004-08-05 |
2004-09-08 |
Novartis Ag |
Organic compound
|
|
EP2990410A1
(en)
|
2004-08-10 |
2016-03-02 |
Alnylam Pharmaceuticals Inc. |
Chemically modified oligonucleotides
|
|
SE0402025D0
(sv)
|
2004-08-13 |
2004-08-13 |
Active Biotech Ab |
Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent
|
|
CA2478458A1
(en)
|
2004-08-20 |
2006-02-20 |
Michael Panzara |
Treatment of pediatric multiple sclerosis
|
|
SI2386640T1
(sl)
|
2004-08-26 |
2015-06-30 |
Engeneic Molecular Delivery Pty Ltd |
Dostava funkcionalnih nukleinskih kislin celicam sesalcev preko bakterijsko izvirajočih, intaktnih minicelic
|
|
DE102004042546A1
(de)
|
2004-09-02 |
2006-03-09 |
Curevac Gmbh |
Kombinationstherapie zur Immunstimulation
|
|
US7501486B2
(en)
|
2004-09-07 |
2009-03-10 |
Burnham Institute For Medical Research |
Peptides that selectively home to heart vasculature and related conjugates and methods
|
|
US8663599B1
(en)
|
2004-10-05 |
2014-03-04 |
Gp Medical, Inc. |
Pharmaceutical composition of nanoparticles
|
|
US20080075698A1
(en)
|
2004-10-12 |
2008-03-27 |
Tissue Targeting Japan Inc. |
Brain-Localizing Bone Marrow Progenitor cells
|
|
EP3067053A1
(en)
|
2004-10-13 |
2016-09-14 |
PTC Therapeutics, Inc. |
Compounds for nonsense suppression, and methods for their use
|
|
US8057821B2
(en)
|
2004-11-03 |
2011-11-15 |
Egen, Inc. |
Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
|
|
EP1812569A2
(en)
|
2004-11-08 |
2007-08-01 |
K.U. Leuven Research and Development |
Modified nucleosides for rna interference
|
|
WO2006054280A2
(en)
|
2004-11-18 |
2006-05-26 |
Nanopass Technologies Ltd. |
System and method for delivering fluid into flexible biological barrier
|
|
US8143257B2
(en)
|
2004-11-23 |
2012-03-27 |
Ptc Therapeutics, Inc. |
Substituted phenols as active agents inhibiting VEGF production
|
|
US7964571B2
(en)
|
2004-12-09 |
2011-06-21 |
Egen, Inc. |
Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
|
|
ES2407979T3
(es)
|
2004-12-10 |
2013-06-17 |
Kala Pharmaceuticals, Inc. |
Copolímeros de bloques de poli(éter-anhídrido) funcionalizados
|
|
WO2006071903A2
(en)
|
2004-12-28 |
2006-07-06 |
Ptc Therapeutics, Inc. |
Cell based methods and systems for the identification of rna regulatory sequences and compounds that modulate their functions
|
|
US8535702B2
(en)
|
2005-02-01 |
2013-09-17 |
Boston Scientific Scimed, Inc. |
Medical devices having porous polymeric regions for controlled drug delivery and regulated biocompatibility
|
|
US7404969B2
(en)
|
2005-02-14 |
2008-07-29 |
Sirna Therapeutics, Inc. |
Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
|
|
JP5042863B2
(ja)
|
2005-02-14 |
2012-10-03 |
サーナ・セラピューティクス・インコーポレイテッド |
生物学的に活性な分子をデリバリーするための脂質ナノ粒子系組成物および方法
|
|
US20060263338A1
(en)
|
2005-03-04 |
2006-11-23 |
Jacoby Douglas B |
Catheter-based delivery of Skeletal Myoblasts to the Myocardium of Damaged Hearts
|
|
EP1910825B1
(en)
|
2005-03-11 |
2012-08-08 |
Firalis SAS |
Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds
|
|
JP4793806B2
(ja)
|
2005-03-22 |
2011-10-12 |
Ｔｔｉ・エルビュー株式会社 |
イオントフォレーシス装置
|
|
US8415325B2
(en)
|
2005-03-31 |
2013-04-09 |
University Of Delaware |
Cell-mediated delivery and targeted erosion of noncovalently crosslinked hydrogels
|
|
US20090214536A1
(en)
|
2005-04-07 |
2009-08-27 |
Guoying Yu |
CACNA1E in Cancer Diagnosis, Detection and Treatment
|
|
EP1910557A2
(en)
|
2005-04-07 |
2008-04-16 |
Chiron Corporation |
Cancer-related genes
|
|
WO2006110776A2
(en)
|
2005-04-12 |
2006-10-19 |
Nektar Therapeutics Al, Corporation |
Polyethylene glycol cojugates of antimicrobial agents
|
|
AU2006237317B8
(en)
|
2005-04-19 |
2011-05-12 |
Basf Plant Science Gmbh |
Improved methods controlling gene expression
|
|
WO2006116458A2
(en)
|
2005-04-26 |
2006-11-02 |
Coley Pharmaceutical Gmbh |
Modified oligoribonucleotide analogs with enhances immunostimulatory activity
|
|
US7850656B2
(en)
|
2005-04-29 |
2010-12-14 |
Warsaw Orthopedic, Inc. |
Devices and methods for delivering medical agents
|
|
CN117534755A
(zh)
|
2005-05-09 |
2024-02-09 |
小野药品工业株式会社 |
程序性死亡-1(pd-1)的人单克隆抗体及使用抗pd-1抗体来治疗癌症的方法
|
|
US20070072175A1
(en)
|
2005-05-13 |
2007-03-29 |
Biogen Idec Ma Inc. |
Nucleotide array containing polynucleotide probes complementary to, or fragments of, cynomolgus monkey genes and the use thereof
|
|
US20060265771A1
(en)
|
2005-05-17 |
2006-11-23 |
Lewis David L |
Monitoring microrna expression and function
|
|
DE102005023170A1
(de)
|
2005-05-19 |
2006-11-23 |
Curevac Gmbh |
Optimierte Formulierung für mRNA
|
|
US10000757B2
(en)
|
2005-05-27 |
2018-06-19 |
Ospedale San Raffaele S.R.L. |
Gene vector
|
|
JP2008541737A
(ja)
|
2005-06-03 |
2008-11-27 |
サウザーン アデレード ヘルス サービス−ファインダーズ メディカル センター |
マイクロｒｎａ発現の変化した細胞を標的とすること
|
|
EP1888638A2
(en)
|
2005-06-03 |
2008-02-20 |
Genentech, Inc. |
Method of producing antibodies with modified fucosylation level
|
|
US7550264B2
(en)
|
2005-06-10 |
2009-06-23 |
Datascope Investment Corporation |
Methods and kits for sense RNA synthesis
|
|
US7691086B2
(en)
|
2005-06-14 |
2010-04-06 |
Tengiz Tkebuchava |
Catheter for introduction of medications to the tissues of a heart or other organ
|
|
PT2279758E
(pt)
|
2005-06-16 |
2015-05-27 |
Nektar Therapeutics |
Conjugados possuindo uma ligação degradável e reagentes poliméricos úteis na preparação de tais conjugados
|
|
US8202835B2
(en)
|
2005-06-17 |
2012-06-19 |
Yitzchak Hillman |
Disease treatment via antimicrobial peptides or their inhibitors
|
|
AU2006282042B2
(en)
|
2005-06-17 |
2011-12-22 |
The University Of North Carolina At Chapel Hill |
Nanoparticle fabrication methods, systems, and materials
|
|
CA2613442C
(en)
|
2005-06-30 |
2016-08-23 |
Archemix Corp. |
Materials and methods for the generation of fully 2'-modified nucleic acid transcripts
|
|
US8101385B2
(en)
|
2005-06-30 |
2012-01-24 |
Archemix Corp. |
Materials and methods for the generation of transcripts comprising modified nucleotides
|
|
WO2007014363A2
(en)
|
2005-07-27 |
2007-02-01 |
Genentech, Inc. |
Vectors for inducible expression of hairpin rna and use thereof
|
|
US9012219B2
(en)
|
2005-08-23 |
2015-04-21 |
The Trustees Of The University Of Pennsylvania |
RNA preparations comprising purified modified RNA for reprogramming cells
|
|
SI3611266T1
(sl)
|
2005-08-23 |
2023-02-28 |
The Trustees Of The University Of Pennsylvania |
Modificirani nukleozidi, ki vsebujejo RNA, in postopki za njihovo uporabo
|
|
AU2006283077B2
(en)
|
2005-08-24 |
2012-06-28 |
The Scripps Research Institute |
Translation Enhancer-Element dependent vector systems
|
|
US20070048741A1
(en)
|
2005-08-24 |
2007-03-01 |
Getts Robert C |
Methods and kits for sense RNA synthesis
|
|
EP1967204B1
(en)
|
2005-09-01 |
2013-10-30 |
Novartis Vaccines and Diagnostics GmbH |
Multiple vaccination including serogroup c meningococcus
|
|
CA2621136C
(en)
|
2005-09-01 |
2014-10-14 |
Celgene Corporation |
Immunological uses of immunomodulatory compounds for vaccine and anti-infectious disease therapy
|
|
US8420605B2
(en)
|
2005-09-07 |
2013-04-16 |
The University Of Strathclyde |
Hydrogel compositions
|
|
US20120021042A1
(en)
|
2005-09-15 |
2012-01-26 |
Steffen Panzner |
Efficient Method For Loading Amphoteric Liposomes With Nucleic Acid Active Substances
|
|
US20070185432A1
(en)
|
2005-09-19 |
2007-08-09 |
Transport Pharmaceuticals, Inc. |
Electrokinetic system and method for delivering methotrexate
|
|
DE102005046490A1
(de)
|
2005-09-28 |
2007-03-29 |
Johannes-Gutenberg-Universität Mainz |
Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen
|
|
US20070087437A1
(en)
|
2005-10-14 |
2007-04-19 |
Jifan Hu |
Methods for rejuvenating cells in vitro and in vivo
|
|
US8012096B2
(en)
|
2005-10-17 |
2011-09-06 |
Cardiogenesis Corporation |
Surgical device and method for performing combination revascularization and therapeutic substance delivery to tissue
|
|
NZ568211A
(en)
|
2005-11-04 |
2011-11-25 |
Novartis Vaccines & Diagnostic |
Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
|
|
US20070105124A1
(en)
|
2005-11-08 |
2007-05-10 |
Getts Robert C |
Methods and kits for nucleic acid amplification
|
|
JP2009515539A
(ja)
|
2005-11-18 |
2009-04-16 |
バイオライン・リミテッド |
酵素的ｄｎａポリメラーゼ反応を増強するための方法
|
|
CA2631184A1
(en)
|
2005-11-28 |
2007-05-31 |
Genmab A/S |
Recombinant monovalent antibodies and methods for production thereof
|
|
TWI389709B
(zh)
|
2005-12-01 |
2013-03-21 |
Novartis Ag |
經皮治療系統
|
|
US8603457B2
(en)
|
2005-12-02 |
2013-12-10 |
University Of Rochester |
Nonsense suppression and genetic codon alteration by targeted modification
|
|
JP5806444B2
(ja)
|
2005-12-02 |
2015-11-10 |
ノバルティス アーゲー |
免疫原性組成物で使用するためのナノ粒子
|
|
US7579318B2
(en)
|
2005-12-06 |
2009-08-25 |
Centre De La Recherche De La Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
|
CA2632451C
(en)
|
2005-12-06 |
2015-11-03 |
Centre National De La Recherche Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
|
EP1960547A2
(en)
|
2005-12-08 |
2008-08-27 |
Novartis AG |
Effects of inhibitors of fgfr3 on gene transcription
|
|
EP3418297B1
(en)
|
2005-12-13 |
2023-04-05 |
Kyoto University |
Nuclear reprogramming factor
|
|
EP1968643A2
(en)
|
2005-12-16 |
2008-09-17 |
Diatos |
Cell penetrating peptide conjugates for delivering of nucleic acids into a cell
|
|
CA2635616A1
(en)
|
2006-01-05 |
2007-07-19 |
Carlo M. Croce |
Microrna expression abnormalities in pancreatic endocrine and acinar tumors
|
|
EP2487258B1
(en)
|
2006-01-05 |
2014-10-01 |
The Ohio State University Research Foundation |
MicroRNA-based methods for the diagnosis of colon, pancreas and stomach cancer
|
|
CA2636867C
(en)
|
2006-01-13 |
2015-12-01 |
The Trustees Of The University Of Pennsylvania |
Vaccines and immunotherapeutics using codon optimized il-15 and methods for using the same
|
|
EP2314594B1
(en)
|
2006-01-27 |
2014-07-23 |
Isis Pharmaceuticals, Inc. |
6-modified bicyclic nucleic acid analogs
|
|
US20070178103A1
(en)
|
2006-01-30 |
2007-08-02 |
Fey Georg H |
CD19-specific immunotoxin and treatment method
|
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
|
DE102006007433A1
(de)
|
2006-02-17 |
2007-08-23 |
Curevac Gmbh |
Adjuvanz in Form einer Lipid-modifizierten Nukleinsäure
|
|
JP5295785B2
(ja)
|
2006-02-20 |
2013-09-18 |
エファ・ユニバーシティ・インダストリー・コラボレイション・ファウンデイション |
細胞膜透過性ペプチド
|
|
CN101420984B
(zh)
|
2006-02-21 |
2013-01-02 |
尼克塔治疗公司 |
嵌段可降解聚合物及由其制备的轭合物
|
|
WO2007100789A2
(en)
|
2006-02-24 |
2007-09-07 |
Wyeth |
Gpat3 encodes a mammalian, microsomal acyl-coa:glycerol 3-phosphate acyltransferase
|
|
US8431160B2
(en)
|
2006-02-24 |
2013-04-30 |
Novartis Ag |
Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions
|
|
LT2676967T
(lt)
|
2006-02-28 |
2019-09-10 |
Biogen Ma Inc. |
Uždegiminių ir autoimuninių ligų gydymo būdai su natalizumabu
|
|
US7910152B2
(en)
|
2006-02-28 |
2011-03-22 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide)-based drug delivery systems with controlled release rate and morphology
|
|
WO2007103808A2
(en)
|
2006-03-02 |
2007-09-13 |
The Ohio State University |
Microrna expression profile associated with pancreatic cancer
|
|
GB0605217D0
(en)
|
2006-03-15 |
2006-04-26 |
Novartis Ag |
Method and compositions for assessing acute rejection
|
|
EP2012751A4
(en)
|
2006-03-21 |
2010-11-24 |
Morehouse School Of Medicine |
NEW NANOPARTICLES FOR THE DELIVERY OF ACTIVE AGENTS
|
|
JP2009534309A
(ja)
|
2006-03-31 |
2009-09-24 |
マサチューセッツ インスティテュート オブ テクノロジー |
治療剤の標的化送達のためのシステム
|
|
AU2007240986A1
(en)
|
2006-04-04 |
2007-11-01 |
Stc.Unm |
Swellable particles for drug delivery
|
|
AU2007238624B2
(en)
|
2006-04-14 |
2012-05-31 |
Cellscript, Llc |
Kits and methods for generating 5' capped RNA
|
|
EP1852127A1
(en)
|
2006-05-02 |
2007-11-07 |
Charité - Universitätsmedizin Berlin |
Use of a B-cell-depleting antibody for treatment of polyoma virus infections
|
|
JP5630998B2
(ja)
|
2006-05-15 |
2014-11-26 |
マサチューセッツ インスティテュート オブ テクノロジー |
機能的粒子のためのポリマー
|
|
AU2007253254B2
(en)
|
2006-05-24 |
2013-01-17 |
Merck Serono Sa |
Cladribine regimen for treating multiple sclerosis
|
|
AU2007256780B2
(en)
|
2006-06-02 |
2013-08-29 |
President And Fellows Of Harvard College |
Protein surface remodeling
|
|
US20090018566A1
(en)
|
2006-06-30 |
2009-01-15 |
Artheromed, Inc. |
Atherectomy devices, systems, and methods
|
|
CA2656620C
(en)
|
2006-07-04 |
2018-03-13 |
Genmab A/S |
Cd20 binding molecules for the treatment of copd
|
|
DK2037899T3
(da)
|
2006-07-07 |
2011-05-09 |
Univ Aarhus |
Nanopartikler til nukleinsyreafgivelse
|
|
AU2007272558B2
(en)
|
2006-07-12 |
2010-12-09 |
Novartis Ag |
Actinically crosslinkable copolymers for manufacturing contact lenses
|
|
KR20090039748A
(ko)
|
2006-07-20 |
2009-04-22 |
노파르티스 아게 |
암의 치료, 진단 또는 검출을 위한 ａｍｉｇｏ-2 억제제
|
|
EP2054036B1
(en)
|
2006-07-24 |
2019-12-18 |
Singh-Broemer and Company, Inc. |
Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
|
|
EP2049665A2
(en)
|
2006-07-28 |
2009-04-22 |
Applera Corporation |
Dinucleotide mrna cap analogs
|
|
DE102006035618A1
(de)
|
2006-07-31 |
2008-02-07 |
Curevac Gmbh |
Nukleinsäure der Formel (I): GlXmGn, insbesondere als immunstimulierendes Adjuvanz
|
|
EP2046954A2
(en)
|
2006-07-31 |
2009-04-15 |
Curevac GmbH |
NUCLEIC ACID OF FORMULA (I): GIXmGn, OR (II): CIXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT
|
|
AR062271A1
(es)
|
2006-08-07 |
2008-10-29 |
Genzyme Corp |
Uso de una cantidad efectiva de al menos un inhibidor de cxcr4, al menos un agonista de cxcr2 y g-csf para movilizar las celulas progenitoras y/o celulas madre
|
|
US20080076701A1
(en)
|
2006-08-18 |
2008-03-27 |
Nastech Pharmaceutical Company Inc. |
Dicer substrate rna peptide conjugates and methods for rna therapeutics
|
|
US8658211B2
(en)
|
2006-08-18 |
2014-02-25 |
Arrowhead Madison Inc. |
Polyconjugates for in vivo delivery of polynucleotides
|
|
WO2008030988A2
(en)
|
2006-09-06 |
2008-03-13 |
The Regents Of The University Of California |
Selectively targeted antimicrobial peptides and the use thereof
|
|
EP2450377A1
(en)
|
2006-09-07 |
2012-05-09 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
|
|
US20080140061A1
(en)
|
2006-09-08 |
2008-06-12 |
Arbel Medical Ltd. |
Method And Device For Combined Treatment
|
|
DE602007012559D1
(de)
|
2006-09-08 |
2011-03-31 |
Univ Johns Hopkins |
H die schleimhaut
|
|
US8454948B2
(en)
|
2006-09-14 |
2013-06-04 |
Medgenics Medical Israel Ltd. |
Long lasting drug formulations
|
|
US20090131348A1
(en)
|
2006-09-19 |
2009-05-21 |
Emmanuel Labourier |
Micrornas differentially expressed in pancreatic diseases and uses thereof
|
|
GB0619182D0
(en)
|
2006-09-29 |
2006-11-08 |
Leuven K U Res & Dev |
Oligonucleotide arrays
|
|
KR101129509B1
(ko)
|
2006-10-03 |
2012-04-13 |
알닐람 파마슈티칼스 인코포레이티드 |
지질 함유 조성물
|
|
MX2009003680A
(es)
|
2006-10-05 |
2009-07-17 |
Univ Johns Hopkins |
Formulaciones orales, parenterales y topicas dispersables en agua para farmacos deficientemente solubles en agua con el uso de nanoparticulas polimericas inteligentes.
|
|
DE102006051516A1
(de)
|
2006-10-31 |
2008-05-08 |
Curevac Gmbh |
(Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins
|
|
US8252538B2
(en)
|
2006-11-01 |
2012-08-28 |
The Ohio State University |
MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma
|
|
US8414927B2
(en)
|
2006-11-03 |
2013-04-09 |
Boston Scientific Scimed, Inc. |
Cross-linked polymer particles
|
|
US7999087B2
(en)
|
2006-11-15 |
2011-08-16 |
Agilent Technologies, Inc. |
2′-silyl containing thiocarbonate protecting groups for RNA synthesis
|
|
US8242258B2
(en)
|
2006-12-03 |
2012-08-14 |
Agilent Technologies, Inc. |
Protecting groups for RNA synthesis
|
|
US8399007B2
(en)
|
2006-12-05 |
2013-03-19 |
Landec Corporation |
Method for formulating a controlled-release pharmaceutical formulation
|
|
PL2121011T3
(pl)
|
2006-12-06 |
2014-10-31 |
Novartis Ag |
Szczepionki zawierające antygeny czterech szczepów wirusa grypy
|
|
CN101627121A
(zh)
|
2006-12-08 |
2010-01-13 |
奥斯瑞根公司 |
作为治疗干预的靶标的miRNA调控基因和路径
|
|
US9034348B2
(en)
|
2006-12-11 |
2015-05-19 |
Chi2Gel Ltd. |
Injectable chitosan mixtures forming hydrogels
|
|
WO2008076437A2
(en)
|
2006-12-18 |
2008-06-26 |
Acceleron Pharma Inc. |
Activin-actrii antagonists and uses for increasing red blood cell levels
|
|
WO2008140615A2
(en)
|
2006-12-21 |
2008-11-20 |
Novozymes, Inc. |
Modified messenger rna stabilizing sequences for expressing genes in bacterial cells
|
|
AU2007339280B2
(en)
|
2006-12-21 |
2013-12-05 |
Stryker Corporation |
Sustained-release formulations comprising crystals, macromolecular gels, and particulate suspensions of biologic agents
|
|
EP2207891B1
(en)
|
2006-12-22 |
2012-07-25 |
Archemix LLC |
Materials and methods for the generation of transcripts comprising modified nucleotides
|
|
DE102006061015A1
(de)
|
2006-12-22 |
2008-06-26 |
Curevac Gmbh |
Verfahren zur Reinigung von RNA im präparativen Maßstab mittels HPLC
|
|
US7699803B2
(en)
|
2007-01-03 |
2010-04-20 |
Medtronic Vascular, Inc. |
Devices and methods for injection of multiple-component therapies
|
|
US8338166B2
(en)
|
2007-01-04 |
2012-12-25 |
Lawrence Livermore National Security, Llc |
Sorting, amplification, detection, and identification of nucleic acid subsequences in a complex mixture
|
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
|
WO2008091799A2
(en)
|
2007-01-22 |
2008-07-31 |
The Trustees Of Columbia University In The City Of New York |
Cell-based methods for identifying inhibitors of parkinson's disease-associated lrrk2 mutants
|
|
KR101722305B1
(ko)
|
2007-01-30 |
2017-03-31 |
에피백스, 인크. |
조절 ｔ 세포 에피토프, 그의 조성물 및 용도
|
|
US8859229B2
(en)
|
2007-02-02 |
2014-10-14 |
Yale University |
Transient transfection with RNA
|
|
TW201627320A
(zh)
|
2007-02-02 |
2016-08-01 |
艾瑟勒朗法瑪公司 |
衍生自ＡｃｔＲＩＩＢ的變體與其用途
|
|
WO2008096370A2
(en)
|
2007-02-05 |
2008-08-14 |
Natco Pharma Limited |
An efficient and novel purification method of recombinant hg-csf
|
|
US8333799B2
(en)
|
2007-02-12 |
2012-12-18 |
C. R. Bard, Inc. |
Highly flexible stent and method of manufacture
|
|
EP2131848A4
(en)
|
2007-02-16 |
2012-06-27 |
Merck Sharp & Dohme |
COMPOSITIONS AND METHODS FOR POTENTIATING THE ACTIVITY OF BIOLOGICALLY ACTIVE MOLECULES
|
|
US8242087B2
(en)
|
2007-02-27 |
2012-08-14 |
K.U.Leuven Research & Development |
Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
|
|
EA018190B1
(ru)
|
2007-03-02 |
2013-06-28 |
Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг |
Улучшение производства белков
|
|
EP1964922A1
(en)
|
2007-03-02 |
2008-09-03 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Improvement of protein production
|
|
US8029496B2
(en)
|
2007-03-05 |
2011-10-04 |
Ebrahim Versi |
Method and device for delivering drug to the trigone of the bladder
|
|
WO2008109712A2
(en)
|
2007-03-05 |
2008-09-12 |
Washington University |
Nanoparticle delivery systems for membrane-integrating peptides
|
|
EP2125892A2
(en)
|
2007-03-20 |
2009-12-02 |
Millennium Pharmaceuticals, Inc. |
Nucleic acids encoding humanized immunoglobulin that binds a4b7 integrin
|
|
NZ580997A
(en)
|
2007-04-27 |
2011-08-26 |
Echo Therapeutics Inc |
Dermal abrasion device with feedback electrode to deliver data on skin thickness and removable abrasion heads
|
|
US20100086554A1
(en)
|
2007-04-30 |
2010-04-08 |
Smithkline Beecham Corporation |
Methods for administering anti-il-5 antibodies
|
|
US8703204B2
(en)
|
2007-05-03 |
2014-04-22 |
Bend Research, Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
|
|
CN101674853B
(zh)
|
2007-05-04 |
2013-03-27 |
玛瑞纳生物技术有限公司 |
氨基酸脂质及其用途
|
|
US7682789B2
(en)
|
2007-05-04 |
2010-03-23 |
Ventana Medical Systems, Inc. |
Method for quantifying biomolecules conjugated to a nanoparticle
|
|
WO2009023311A2
(en)
|
2007-05-07 |
2009-02-19 |
Alba Therapeutics Corporation |
Transcutaneous delivery of therapeutic agents
|
|
JP5296328B2
(ja)
|
2007-05-09 |
2013-09-25 |
独立行政法人理化学研究所 |
１本鎖環状ｒｎａおよびその製造方法
|
|
EP2476689B1
(en)
|
2007-05-10 |
2015-10-21 |
Agilent Technologies, Inc. |
Thiocarbon-protecting groups for RNA synthesis
|
|
SI3072525T1
(en)
|
2007-05-14 |
2018-06-29 |
Astrazeneca Ab |
Procedures for lowering the levels of basophiles
|
|
WO2008144365A2
(en)
|
2007-05-17 |
2008-11-27 |
Novartis Ag |
Method for making dry powder compositions containing ds-rna based on supercritical fluid technology
|
|
EA200901550A1
(ru)
|
2007-05-22 |
2010-10-29 |
Новартис Аг |
Способы лечения, диагностирования и выявления ассоциированных с fgf21 нарушений
|
|
US8415096B2
(en)
|
2007-05-23 |
2013-04-09 |
University Of South Florida |
Micro-RNAs modulating immunity and inflammation
|
|
EP2164951A2
(en)
|
2007-05-30 |
2010-03-24 |
The General Hospital Corporation |
Methods of generating pluripotent cells from somatic cells
|
|
AU2008259907B2
(en)
|
2007-05-30 |
2014-12-04 |
Northwestern University |
Nucleic acid functionalized nanoparticles for therapeutic applications
|
|
WO2008154098A2
(en)
|
2007-06-07 |
2008-12-18 |
Wisconsin Alumni Research Foundation |
Reagents and methods for mirna expression analysis and identification of cancer biomarkers
|
|
WO2008157688A2
(en)
|
2007-06-19 |
2008-12-24 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Synthesis and use of anti-reverse phosphorothioate analogs of the messenger rna cap
|
|
US8039214B2
(en)
|
2007-06-29 |
2011-10-18 |
Cellscript, Inc. |
Synthesis of tagged nucleic acids
|
|
US8367318B2
(en)
|
2007-07-23 |
2013-02-05 |
Dharmacon, Inc. |
Screening of micro-RNA cluster inhibitor pools
|
|
US20090042825A1
(en)
|
2007-08-06 |
2009-02-12 |
Majed Matar |
Composition, method of preparation & application of concentrated formulations of condensed nucleic acids with a cationic lipopolymer
|
|
US9144546B2
(en)
|
2007-08-06 |
2015-09-29 |
Clsn Laboratories, Inc. |
Nucleic acid-lipopolymer compositions
|
|
CN101801445B
(zh)
|
2007-08-14 |
2013-04-17 |
弗雷德哈钦森癌症研究中心 |
用于递送治疗药物的针阵列组件
|
|
KR20100063079A
(ko)
|
2007-08-23 |
2010-06-10 |
노파르티스 아게 |
올리고뉴클레오티드의 탐지 방법
|
|
WO2009030254A1
(en)
|
2007-09-04 |
2009-03-12 |
Curevac Gmbh |
Complexes of rna and cationic peptides for transfection and for immunostimulation
|
|
KR101234436B1
(ko)
|
2007-09-05 |
2013-02-18 |
로슈 글리카트 아게 |
유형 ⅰ 및 유형 ⅱ 항-ｃｄ２０ 항체를 사용하는 병용 치료요법
|
|
US8506928B2
(en)
|
2007-09-07 |
2013-08-13 |
The Regents Of The University Of California |
Methods and compounds for targeting tissues
|
|
US20130108663A1
(en)
|
2007-09-14 |
2013-05-02 |
Vrije Universiteit Brussel |
Enhancing the t-cell stimulatory capacity of human antigen presenting cells in vitro and in vivo and their use in vaccination
|
|
US20110086904A1
(en)
|
2007-09-17 |
2011-04-14 |
The Trustees Of The University Of Pennsylvania |
GENERATION OF HYPERSTABLE mRNAs
|
|
NZ584356A
(en)
|
2007-09-26 |
2011-10-28 |
Univ Oregon Health & Science |
Cyclic undecapeptides and derivatives as multiple sclerosis therapies
|
|
HUE031422T2
(en)
|
2007-09-26 |
2017-07-28 |
Intrexon Corp |
Artificial 5'UTRs, expression vectors, and methods for increasing transgene expression
|
|
EP2644594B1
(en)
|
2007-09-28 |
2017-08-23 |
Pfizer Inc |
Cancer Cell Targeting Using Nanoparticles
|
|
EP2042193A1
(en)
|
2007-09-28 |
2009-04-01 |
Biomay AG |
RNA Vaccines
|
|
US8470560B2
(en)
|
2007-10-03 |
2013-06-25 |
The United States Of America As Represented By The Secretary Of The Army |
CR-2 binding peptide P28 as molecular adjuvant for DNA vaccines
|
|
WO2009046739A1
(en)
|
2007-10-09 |
2009-04-16 |
Curevac Gmbh |
Composition for treating prostate cancer (pca)
|
|
WO2009046738A1
(en)
|
2007-10-09 |
2009-04-16 |
Curevac Gmbh |
Composition for treating lung cancer, particularly of non-small lung cancers (nsclc)
|
|
AU2008314647B2
(en)
|
2007-10-12 |
2013-03-21 |
Massachusetts Institute Of Technology |
Vaccine nanotechnology
|
|
US20090098118A1
(en)
|
2007-10-15 |
2009-04-16 |
Thomas Friess |
Combination therapy of a type ii anti-cd20 antibody with an anti-bcl-2 active agent
|
|
EP2205277B1
(en)
|
2007-10-22 |
2017-07-26 |
Genmab A/S |
Novel antibody therapies
|
|
CA2703948A1
(en)
|
2007-11-01 |
2009-05-07 |
University Of Rochester |
Recombinant factor viii having increased stability
|
|
AU2008323815B2
(en)
|
2007-11-09 |
2013-09-19 |
Novartis Ag |
Uses of anti-CD40 antibodies
|
|
US8470771B2
(en)
|
2007-11-14 |
2013-06-25 |
Institute Of Microbiology, Chinese Academy Of Sciences |
Method and medicament for inhibiting the infection of influenza virus
|
|
US20090137945A1
(en)
|
2007-11-28 |
2009-05-28 |
Claire Marquez |
Electro Collagen Induction Therapy Device
|
|
CN104650235A
(zh)
|
2007-11-30 |
2015-05-27 |
葛兰素集团有限公司 |
抗原结合构建体
|
|
AU2008329755A1
(en)
|
2007-11-30 |
2009-06-04 |
The Ohio State University Research Foundation |
MicroRNA expression profiling and targeting in peripheral blood in lung cancer
|
|
AU2008335202A1
(en)
|
2007-12-10 |
2009-06-18 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of Factor VII gene
|
|
CA2904904A1
(en)
|
2007-12-11 |
2009-06-18 |
The Scripps Research Institute |
Compositions and methods related to mrna translational enhancer elements
|
|
US20090238772A1
(en)
|
2007-12-13 |
2009-09-24 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for prevention or treatment of rsv infection
|
|
EP2072618A1
(en)
|
2007-12-14 |
2009-06-24 |
Johannes Gutenberg-Universität Mainz |
Use of RNA for reprogramming somatic cells
|
|
EP2231183A2
(en)
|
2007-12-21 |
2010-09-29 |
Genentech, Inc. |
Therapy of rituximab-refractory rheumatoid arthritis patients
|
|
EP2248906A4
(en)
|
2008-01-23 |
2012-07-11 |
Ajinomoto Kk |
PROCESS FOR THE PREPARATION OF L-AMINO ACID
|
|
WO2009093384A1
(ja)
|
2008-01-24 |
2009-07-30 |
National Institute Of Advanced Industrial Science And Technology |
ポリヌクレオチド及びポリヌクレオチド類似体並びにこれらを用いた遺伝子発現制御方法
|
|
AU2009210266B2
(en)
|
2008-01-31 |
2015-01-29 |
CureVac SE |
Nucleic acids comprising formula (NuGlXmGmGnNv)a and derivatives thereof as an immunostimulating agents/adjuvants
|
|
US20090263803A1
(en)
|
2008-02-08 |
2009-10-22 |
Sylvie Beaudenon |
Mirnas differentially expressed in lymph nodes from cancer patients
|
|
EP2250252A2
(en)
|
2008-02-11 |
2010-11-17 |
Cambridge Enterprise Limited |
Improved reprogramming of mammalian cells, and the cells obtained
|
|
EP2240155B1
(en)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
DE102008009920A1
(de)
|
2008-02-15 |
2009-08-20 |
Aj Innuscreen Gmbh |
Mobiles Gerät für die Nukleinsäureisolierung
|
|
US20120027813A1
(en)
|
2008-02-22 |
2012-02-02 |
Novartis Vaccines And Diagnostics Srl |
Adjuvanted influenza vaccines for pediatric use
|
|
US8506966B2
(en)
|
2008-02-22 |
2013-08-13 |
Novartis Ag |
Adjuvanted influenza vaccines for pediatric use
|
|
AU2009219193A1
(en)
|
2008-02-28 |
2009-09-03 |
The Ohio State University Research Foundation |
MicroRNA signatures associated with human chronic lymphocytic leukemia (CCL) and uses thereof
|
|
US20100004313A1
(en)
|
2008-02-29 |
2010-01-07 |
Tbd |
Modified Poloxamers for Gene Expression and Associated Methods
|
|
AU2009223313A1
(en)
|
2008-03-14 |
2009-09-17 |
Egen, Inc. |
Biodegradable cross-linked branched poly (alkylene imines)
|
|
WO2009113083A1
(en)
|
2008-03-14 |
2009-09-17 |
Biocon Limited |
A monoclonal antibody and a method thereof
|
|
AU2009228163B2
(en)
|
2008-03-28 |
2012-08-30 |
Glaxosmithkline Llc |
Methods of treatment
|
|
HUE034483T2
(en)
|
2008-04-15 |
2018-02-28 |
Protiva Biotherapeutics Inc |
New lipid preparations for introducing a nucleic acid
|
|
WO2009127230A1
(en)
|
2008-04-16 |
2009-10-22 |
Curevac Gmbh |
MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION
|
|
EP2112235A1
(en)
|
2008-04-24 |
2009-10-28 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Compositions and methods for microRNA expression profiling of nasopharyngeal carcinoma
|
|
AU2009238607B2
(en)
|
2008-04-25 |
2015-08-06 |
Northwestern University |
Nanostructures suitable for sequestering cholesterol
|
|
CA2725601A1
(en)
|
2008-04-28 |
2009-11-05 |
President And Fellows Of Harvard College |
Supercharged proteins for cell penetration
|
|
WO2009134717A1
(en)
|
2008-04-30 |
2009-11-05 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Chimeric west nile/dengue viruses
|
|
US9394538B2
(en)
|
2008-05-07 |
2016-07-19 |
Shi-Lung Lin |
Development of universal cancer drugs and vaccines
|
|
US8231609B2
(en)
|
2008-05-08 |
2012-07-31 |
Minipumps, Llc |
Drug-delivery pumps and methods of manufacture
|
|
US8697098B2
(en)
|
2011-02-25 |
2014-04-15 |
South Dakota State University |
Polymer conjugated protein micelles
|
|
EP2281011B1
(en)
|
2008-05-13 |
2013-02-27 |
University Of Washington |
Diblock copolymers and polynucleotide complexes thereof for delivery into cells
|
|
WO2009141146A1
(en)
|
2008-05-21 |
2009-11-26 |
Gunther Hartmann |
5' triphosphate oligonucleotide with blunt end and uses thereof
|
|
US20120264686A9
(en)
|
2008-05-29 |
2012-10-18 |
Hanall Biopharma Co. Ltd |
Modified erythropoietin (epo) polypeptides that exhibit increased protease resistance and pharmaceutical compositions thereof
|
|
FR2931824B1
(fr)
|
2008-05-29 |
2014-11-28 |
Centre Nat Rech Scient |
Procede de synthese d'arn par voie chimique.
|
|
US20100086922A1
(en)
|
2008-05-30 |
2010-04-08 |
Millennium Pharmaceuticals, Inc. |
Assessment of chromosomal alterations to predict clinical outcome of bortezomib treatment
|
|
PL215513B1
(pl)
|
2008-06-06 |
2013-12-31 |
Univ Warszawski |
Nowe boranofosforanowe analogi dinukleotydów, ich zastosowanie, czasteczka RNA, sposób otrzymywania RNA oraz sposób otrzymywania peptydów lub bialka
|
|
WO2009147641A2
(en)
|
2008-06-06 |
2009-12-10 |
Wockhardt Research Centre |
A device and a system for delivery of biological material
|
|
TWI451876B
(zh)
|
2008-06-13 |
2014-09-11 |
Lilly Co Eli |
聚乙二醇化之離脯胰島素化合物
|
|
JP2011525180A
(ja)
|
2008-06-16 |
2011-09-15 |
バインド バイオサイエンシズ インコーポレイテッド |
治療的標的化ナノ粒子の製作に用いるためのジブロックコポリマーで官能化された標的薬の製造方法
|
|
ES2462090T5
(es)
|
2008-06-16 |
2017-07-12 |
Pfizer Inc. |
Nanopartículas poliméricas cargadas de fármaco y procedimientos de fabricación y uso de las mismas
|
|
WO2010005726A2
(en)
|
2008-06-16 |
2010-01-14 |
Bind Biosciences Inc. |
Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
|
|
EP2309991B1
(en)
|
2008-06-16 |
2019-03-06 |
Pfizer Inc |
Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same
|
|
US7799016B2
(en)
|
2008-06-20 |
2010-09-21 |
Pharmaco-Kinesis Corporation |
Magnetic breather pump and a method for treating a brain tumor using the same
|
|
US9913806B2
(en)
|
2008-06-25 |
2018-03-13 |
Fe3 Medical, Inc. |
Patches and methods for the transdermal delivery of a therapeutically effective amount of iron
|
|
US20100009424A1
(en)
|
2008-07-14 |
2010-01-14 |
Natasha Forde |
Sonoporation systems and methods
|
|
CA2730737A1
(en)
|
2008-07-15 |
2010-01-21 |
Novartis Ag |
Immunogenic amphipathic peptide compositions
|
|
WO2010009065A2
(en)
|
2008-07-15 |
2010-01-21 |
Novartis Ag |
Amphipathic peptide compositions
|
|
WO2010018563A2
(en)
|
2008-08-12 |
2010-02-18 |
Rosetta Genomics Ltd. |
Compositions and methods for the prognosis of lymphoma
|
|
WO2010021865A1
(en)
|
2008-08-18 |
2010-02-25 |
Merck Sharp & Dohme Corp. |
Novel lipid nanoparticles and novel components for delivery of nucleic acids
|
|
US8357118B2
(en)
|
2008-08-26 |
2013-01-22 |
Cook Medical Technologies Llc |
Balloon catheters having a plurality of needles for the injection of one or more therapeutic agents
|
|
WO2010025510A1
(en)
|
2008-09-03 |
2010-03-11 |
Xenome Ltd |
Libraries of peptide conjugates and methods for making them
|
|
CA2735251C
(en)
|
2008-09-06 |
2017-07-11 |
Chemgenes Corporation |
Rna synthesis - phosphoramidites for synthetic rna in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic rna at the 3' - end
|
|
US20120100558A1
(en)
|
2008-09-08 |
2012-04-26 |
Hanash Samir M |
Lung cancer diagnosis
|
|
US20100087337A1
(en)
|
2008-09-10 |
2010-04-08 |
Bind Biosciences, Inc. |
High Throughput Fabrication of Nanoparticles
|
|
TW201014605A
(en)
|
2008-09-16 |
2010-04-16 |
Genentech Inc |
Methods for treating progressive multiple sclerosis
|
|
WO2010033906A2
(en)
|
2008-09-19 |
2010-03-25 |
President And Fellows Of Harvard College |
Efficient induction of pluripotent stem cells using small molecule compounds
|
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
|
WO2010042490A1
(en)
|
2008-10-06 |
2010-04-15 |
Boston Medical Center Corporation |
A single lentiviral vector system for induced pluripotent (ips) stem cells derivation
|
|
EP2350043B9
(en)
|
2008-10-09 |
2014-08-20 |
TEKMIRA Pharmaceuticals Corporation |
Improved amino lipids and methods for the delivery of nucleic acids
|
|
RU2011114561A
(ru)
|
2008-10-10 |
2012-11-20 |
Милакс Холдинг Са (Lu) |
Ввод лекарственных препаратов
|
|
US8535655B2
(en)
|
2008-10-10 |
2013-09-17 |
Polyactiva Pty Ltd. |
Biodegradable polymer—bioactive moiety conjugates
|
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
|
ITVI20080239A1
(it)
|
2008-10-14 |
2010-04-15 |
Antoine Assaf |
Apparato medicale per iniezioni multiple.
|
|
SI2344639T1
(sl)
|
2008-10-20 |
2015-09-30 |
Alnylam Pharmaceuticals, Inc. |
Sestavki in postopki inhibicije izražanja transtiretina
|
|
WO2010047765A2
(en)
|
2008-10-20 |
2010-04-29 |
Massachussetts Institute Of Technology |
Nanostructures for drug delivery
|
|
US20120015899A1
(en)
|
2008-10-25 |
2012-01-19 |
Plant Bioscience, Limited |
Modified plant virus particles and uses therefor
|
|
CA2742954C
(en)
|
2008-11-07 |
2018-07-10 |
Massachusetts Institute Of Technology |
Aminoalcohol lipidoids and uses thereof
|
|
SG10201901089TA
(en)
|
2008-11-10 |
2019-03-28 |
Arbutus Biopharma Corp |
Novel lipids and compositions for the delivery of therapeutics
|
|
WO2010055413A1
(en)
|
2008-11-12 |
2010-05-20 |
Fondazione Centro San Raffaele Del Monte Tabor |
Gene vector for inducing transgene-specific immune tolerance
|
|
CN102439169B
(zh)
|
2008-11-13 |
2014-11-19 |
复旦大学 |
用于结肠直肠癌的微rna表达谱分析的组合物和方法
|
|
CA2780482A1
(en)
|
2008-11-17 |
2010-05-10 |
Anil K. Sood |
Hdl particles for delivery of nucleic acids
|
|
EP2191840A1
(en)
|
2008-11-28 |
2010-06-02 |
Sanofi-Aventis |
Antitumor combinations containing antibodies recognizing specifically CD38 and melphalan
|
|
US20120053224A1
(en)
|
2008-12-10 |
2012-03-01 |
Universitat Regensburg |
Compositions and methods for micro-rna expression profiling of cancer stem cells
|
|
EP2196476A1
(en)
|
2008-12-10 |
2010-06-16 |
Novartis Ag |
Antibody formulation
|
|
US8563041B2
(en)
|
2008-12-12 |
2013-10-22 |
Bind Therapeutics, Inc. |
Therapeutic particles suitable for parenteral administration and methods of making and using same
|
|
EP2376091A4
(en)
|
2008-12-12 |
2012-08-01 |
Univ California |
NEW TARGETS FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
|
|
JP2012512175A
(ja)
|
2008-12-15 |
2012-05-31 |
バインド バイオサイエンシズ インコーポレイテッド |
治療薬を徐放するための長時間循環性ナノ粒子
|
|
WO2010080724A1
(en)
|
2009-01-12 |
2010-07-15 |
Merck Sharp & Dohme Corp. |
Novel lipid nanoparticles and novel components for delivery of nucleic acids
|
|
JP2012515217A
(ja)
|
2009-01-16 |
2012-07-05 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー |
ベンダムスチンおよび抗−ｃｄ２０抗体の組合せを用いた癌治療
|
|
WO2010084371A1
(en)
|
2009-01-26 |
2010-07-29 |
Mitoprod |
Novel circular interfering rna molecules
|
|
EP3243504A1
(en)
|
2009-01-29 |
2017-11-15 |
Arbutus Biopharma Corporation |
Improved lipid formulation
|
|
US8669085B2
(en)
|
2009-02-05 |
2014-03-11 |
Ut-Battelle, Llc |
Transformation of gram positive bacteria by sonoporation
|
|
WO2010088927A1
(en)
|
2009-02-09 |
2010-08-12 |
Curevac Gmbh |
Use of pei for the improvement of endosomal release and expression of transfected nucleic acids, complexed with cationic or polycationic compounds
|
|
US20140141089A1
(en)
|
2009-02-11 |
2014-05-22 |
Colorado School Of Mines |
Nanoparticles, Compositions Thereof, and Methods of Use, and Methods of Making the Same
|
|
US8853179B2
(en)
|
2009-02-24 |
2014-10-07 |
The Scripps Research Institute |
Reengineering mRNA primary structure for enhanced protein production
|
|
WO2010141135A2
(en)
|
2009-03-05 |
2010-12-09 |
Trustees Of Boston University |
Bacteriophages expressing antimicrobial peptides and uses thereof
|
|
WO2010102066A1
(en)
|
2009-03-05 |
2010-09-10 |
Bend Research, Inc. |
Dextran polymer powder for inhalation administration of pharmaceuticals
|
|
AU2010223888A1
(en)
|
2009-03-13 |
2011-10-06 |
Egen, Inc. |
Compositions and methods for the delivery of biologically active RNAs
|
|
AU2010226434A1
(en)
|
2009-03-20 |
2011-10-13 |
Egen, Inc. |
Polyamine derivatives
|
|
WO2010111290A1
(en)
|
2009-03-23 |
2010-09-30 |
University Of Utah Research Foundation |
Methods and compositions related to modified guanine bases for controlling off-target effects in rna interference
|
|
JP5622254B2
(ja)
|
2009-03-31 |
2014-11-12 |
国立大学法人東京大学 |
二本鎖リボ核酸ポリイオンコンプレックス
|
|
WO2011005341A2
(en)
|
2009-04-03 |
2011-01-13 |
University Of Chicago |
Compositions and methods related to protein a (spa) variants
|
|
EP3427755B1
(en)
|
2009-04-13 |
2020-10-21 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Hpv particles and uses thereof
|
|
CA2758548A1
(en)
|
2009-04-17 |
2010-10-21 |
Biogen Idec Ma Inc. |
Compositions and methods to treat acute myelogenous leukemia
|
|
EP2421561A2
(en)
|
2009-04-21 |
2012-02-29 |
Selecta Biosciences, Inc. |
Immunonanotherapeutics providing a th1-biased response
|
|
US10837020B2
(en)
*
|
2009-04-22 |
2020-11-17 |
Massachusetts Institute Of Technology |
Innate immune suppression enables repeated delivery of long RNA molecules
|
|
EP2421563B1
(en)
|
2009-04-22 |
2017-04-12 |
Massachusetts Institute of Technology |
Innate immune suppression enables repeated delivery of long rna molecules
|
|
MY153078A
(en)
|
2009-04-27 |
2014-12-31 |
Novartis Ag |
Compositions and methods for increasing muscle growth
|
|
US8287910B2
(en)
|
2009-04-30 |
2012-10-16 |
Intezyne Technologies, Inc. |
Polymeric micelles for polynucleotide encapsulation
|
|
US8715736B2
(en)
|
2009-04-30 |
2014-05-06 |
Florida Agricultural And Mechanical University |
Nanoparticle formulations for skin delivery
|
|
SG10201402054UA
(en)
|
2009-05-05 |
2014-09-26 |
Muthiah Manoharan |
Lipid compositions
|
|
CA2761411A1
(en)
|
2009-05-08 |
2010-11-11 |
The Ohio State University Research Foundation |
Microrna expression profiling and targeting in chronic obstructive pulmonary disease (copd) lung tissue and methods of use thereof
|
|
DE202009007116U1
(de)
|
2009-05-18 |
2010-10-14 |
Amoena Medizin-Orthopädie-Technik GmbH |
Antidekubituskissen
|
|
US8629151B2
(en)
|
2009-05-27 |
2014-01-14 |
Selecta Biosciences, Inc. |
Immunomodulatory agent-polymeric compounds
|
|
US8574835B2
(en)
|
2009-05-29 |
2013-11-05 |
Life Technologies Corporation |
Scaffolded nucleic acid polymer particles and methods of making and using
|
|
HUE056773T2
(hu)
|
2009-06-10 |
2022-03-28 |
Arbutus Biopharma Corp |
Továbbfejlesztett lipid készítmény
|
|
EP2440556A1
(en)
|
2009-06-10 |
2012-04-18 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of phosphatidylinositol 3-kinase
|
|
US8273869B2
(en)
|
2009-06-15 |
2012-09-25 |
Alnylam Pharmaceuticals, Inc. |
Lipid formulated dsRNA targeting the PCSK9 gene
|
|
US20110097329A1
(en)
|
2009-06-26 |
2011-04-28 |
Massachusetts Institute Of Technology |
Compositions and methods for treating cancer and modulating stress granule formation
|
|
US8569256B2
(en)
|
2009-07-01 |
2013-10-29 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
|
WO2011000107A1
(en)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for delivery of therapeutic agents to solid tumors
|
|
EP2451823A4
(en)
*
|
2009-07-06 |
2013-07-03 |
Alnylam Pharmaceuticals Inc |
COMPOSITIONS AND METHODS FOR ENHANCING THE PRODUCTION OF A BIOLOGICAL PRODUCT
|
|
EP2451475A2
(en)
|
2009-07-06 |
2012-05-16 |
Novartis AG |
Self replicating rna molecules and uses thereof
|
|
EP3581197A1
(de)
*
|
2009-07-31 |
2019-12-18 |
ethris GmbH |
Rna mit einer kombination aus unmodifizierten und modifizierten nucleotiden zur proteinexpression
|
|
EP2281579A1
(en)
|
2009-08-05 |
2011-02-09 |
BioNTech AG |
Vaccine composition comprising 5'-Cap modified RNA
|
|
EP2467357B1
(en)
|
2009-08-20 |
2016-03-30 |
Sirna Therapeutics, Inc. |
Novel cationic lipids with various head groups for oligonucleotide delivery
|
|
WO2011028175A1
(en)
|
2009-09-01 |
2011-03-10 |
Agency For Science, Technology And Research |
Terminal device and method for processing an encrypted bit stream
|
|
US20110053829A1
(en)
|
2009-09-03 |
2011-03-03 |
Curevac Gmbh |
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
|
|
US20110070227A1
(en)
|
2009-09-18 |
2011-03-24 |
Anna-Marie Novotney-Barry |
Treatment of Autoimmune and Inflammatory Diseases
|
|
EP2485770A4
(en)
|
2009-10-08 |
2013-04-10 |
Merck Sharp & Dohme |
NEW CATIONIC LIPIDS WITH SHORT LIPID CHAINS FOR ADMINISTRATION OF OLIGONUCLEOTIDES
|
|
US8859284B2
(en)
|
2009-10-22 |
2014-10-14 |
The United States Of America, As Represented By The Secretary Of The Navy |
Delivery of nanoparticles to neurons
|
|
US8449916B1
(en)
|
2009-11-06 |
2013-05-28 |
Iowa State University Research Foundation, Inc. |
Antimicrobial compositions and methods
|
|
WO2011060250A1
(en)
|
2009-11-13 |
2011-05-19 |
Bend Research, Inc. |
Cationic dextran polymer derivatives
|
|
WO2011062965A2
(en)
|
2009-11-18 |
2011-05-26 |
University Of Washington Through Its Center For Commercialization |
Targeting monomers and polymers having targeting blocks
|
|
US8530429B2
(en)
|
2009-11-24 |
2013-09-10 |
Arch Cancer Therapeutics, Inc. |
Brain tumor targeting peptides and methods
|
|
PL3338765T3
(pl)
|
2009-12-01 |
2019-06-28 |
Translate Bio, Inc. |
Pochodna steroidowa dla dostarczania mrna w ludzkich chorobach genetycznych
|
|
US20110245756A1
(en)
|
2009-12-03 |
2011-10-06 |
Rishi Arora |
Devices for material delivery, electroporation, sonoporation, and/or monitoring electrophysiological activity
|
|
DE102009056884B4
(de)
|
2009-12-03 |
2021-03-18 |
Novartis Ag |
Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
|
|
AU2010325787B2
(en)
|
2009-12-06 |
2016-05-12 |
Bioverativ Therapeutics Inc. |
Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereof
|
|
WO2011071860A2
(en)
|
2009-12-07 |
2011-06-16 |
Alnylam Pharmaceuticals, Inc. |
Compositions for nucleic acid delivery
|
|
US20130189741A1
(en)
|
2009-12-07 |
2013-07-25 |
Cellscript, Inc. |
Compositions and methods for reprogramming mammalian cells
|
|
SI3112467T1
(en)
|
2009-12-07 |
2018-06-29 |
The Trustees Of The University Of Pennsylvania |
RNA preparations comprising purified modified RNA for reprogramming cells
|
|
WO2011069529A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids
|
|
WO2011069528A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Lyophilization of nucleic acids in lactate-containing solutions
|
|
ES2721898T3
(es)
|
2009-12-11 |
2019-08-06 |
Pfizer |
Formulaciones estables para liofilizar partículas terapéuticas
|
|
EA201290499A1
(ru)
|
2009-12-15 |
2013-01-30 |
Байнд Байосайенсиз, Инк. |
Композиции терапевтических полимерных наночастиц с высокой температурой стеклования и высокомолекулярными сополимерами
|
|
JP5898627B2
(ja)
|
2009-12-15 |
2016-04-06 |
バインド セラピューティックス インコーポレイテッド |
エポチロンを含む治療用ポリマーナノ粒子ならびにそれを製造および使用する方法
|
|
EA201290497A1
(ru)
|
2009-12-15 |
2013-01-30 |
Байнд Байосайенсиз, Инк. |
Терапевтические полимерные наночастицы, включающие кортикостероиды, и способы получения таковых
|
|
EA201290506A1
(ru)
|
2009-12-16 |
2013-03-29 |
Брихэм Энд Уимен'З Хоспитал, Инк. |
Частицы для доставки множества агентов
|
|
DE102009058769A1
(de)
|
2009-12-16 |
2011-06-22 |
MagForce Nanotechnologies AG, 10589 |
Temperaturabhängige Aktivierung von katalytischen Nukleinsäuren zur kontrollierten Wirkstofffreisetzung
|
|
AU2010330814B2
(en)
|
2009-12-18 |
2017-01-12 |
Acuitas Therapeutics Inc. |
Methods and compositions for delivery of nucleic acids
|
|
EP2338520A1
(de)
|
2009-12-21 |
2011-06-29 |
Ludwig Maximilians Universität |
Konjugat mit Zielfindungsligand und dessen Verwendung
|
|
BR112012015755B1
(pt)
|
2009-12-23 |
2021-06-22 |
Novartis Ag |
Lipídeo furtivo, e composição
|
|
WO2011076142A1
(en)
|
2009-12-24 |
2011-06-30 |
Fudan University |
Compositions and methods for microrna expession profiling in plasma of colorectal cancer
|
|
WO2011076143A1
(en)
|
2009-12-24 |
2011-06-30 |
Fudan University |
Compositions and methods for microrna expression profiling of lung cancer
|
|
EP2341145A1
(en)
|
2009-12-30 |
2011-07-06 |
febit holding GmbH |
miRNA fingerprint in the diagnosis of diseases
|
|
WO2011085231A2
(en)
|
2010-01-08 |
2011-07-14 |
Selecta Biosciences, Inc. |
Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines
|
|
WO2011088309A1
(en)
|
2010-01-14 |
2011-07-21 |
Regulus Therapeutics Inc. |
Microrna compositions and methods
|
|
US20130116419A1
(en)
|
2010-01-22 |
2013-05-09 |
Daniel Zewge |
Post-synthetic chemical modification of rna at the 2'-position of the ribose ring via "click" chemistry
|
|
WO2011094683A2
(en)
|
2010-01-29 |
2011-08-04 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Method of identifying myelodysplastic syndromes
|
|
EP2354246A1
(en)
|
2010-02-05 |
2011-08-10 |
febit holding GmbH |
miRNA in the diagnosis of ovarian cancer
|
|
PT2539451E
(pt)
|
2010-02-24 |
2016-03-28 |
Arrowhead Res Corp |
Composições para entrega de arnsi dirigida ao alvo
|
|
EP2538929A4
(en)
|
2010-02-25 |
2014-07-09 |
Univ Johns Hopkins |
PROLONGED DELIVERY OF THERAPEUTIC AGENTS TO AN OCULAR COMPARTMENT
|
|
WO2011112608A1
(en)
|
2010-03-08 |
2011-09-15 |
University Of Rochester |
Synthesis of nanoparticles using reducing gases
|
|
WO2011113030A2
(en)
|
2010-03-11 |
2011-09-15 |
H.Lee Moffitt Cancer Center & Research Institute |
Human cancer micro-rna expression profiles predictive of chemo-response
|
|
EP2547715A4
(en)
|
2010-03-16 |
2013-10-30 |
Univ Utah Res Found |
SPLICABLE MODIFICATIONS FOR REDUCABLE POLY (AMID ETHYLENIMINE) FOR REINFORCED NUCLEOTIDE DELIVERY
|
|
WO2011116072A1
(en)
|
2010-03-16 |
2011-09-22 |
Escape Therapeutics, Inc. |
Hybrid hydrogel scaffold compositions and methods of use
|
|
WO2011115862A1
(en)
|
2010-03-18 |
2011-09-22 |
Merck Sharp & Dohme Corp. |
Endosomolytic poly(amidoamine) disulfide polymers for the delivery of oligonucleotides
|
|
US20110230816A1
(en)
|
2010-03-18 |
2011-09-22 |
Tyco Healthcare Group Lp |
Gels for Transdermal Delivery
|
|
US9149432B2
(en)
|
2010-03-19 |
2015-10-06 |
Massachusetts Institute Of Technology |
Lipid vesicle compositions and methods of use
|
|
GB201005005D0
(en)
|
2010-03-25 |
2010-05-12 |
Angeletti P Ist Richerche Bio |
New vaccine
|
|
US8349308B2
(en)
|
2010-03-26 |
2013-01-08 |
Mersana Therapeutics, Inc. |
Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof
|
|
WO2011119262A1
(en)
|
2010-03-26 |
2011-09-29 |
Cerulean Pharma Inc. |
Methods and systems for generating nanoparticles
|
|
US20110247090A1
(en)
|
2010-04-02 |
2011-10-06 |
Intrexon Corporation |
Synthetic 5'UTRs, Expression Vectors, and Methods for Increasing Transgene Expression
|
|
JP2013523818A
(ja)
|
2010-04-05 |
2013-06-17 |
ザ・ユニバーシティー・オブ・シカゴ |
免疫反応のエンハンサーとしてのプロテインＡ（ＳｐＡ）抗体に関連する組成物および方法
|
|
US9744228B2
(en)
|
2010-04-07 |
2017-08-29 |
Norvartis Ag |
Method for generating a parvovirus B19 virus-like particle
|
|
WO2011127255A1
(en)
|
2010-04-08 |
2011-10-13 |
Merck Sharp & Dohme Corp. |
Preparation of lipid nanoparticles
|
|
JP5652830B2
(ja)
|
2010-04-09 |
2015-01-14 |
国立大学法人 東京大学 |
マイクロｒｎａ制御組換えワクシニアウイルス及びその使用
|
|
WO2011127456A2
(en)
|
2010-04-09 |
2011-10-13 |
Pacira Pharmaceuticals, Inc. |
Method for formulating large diameter synthetic membrane vesicles
|
|
US20110262491A1
(en)
|
2010-04-12 |
2011-10-27 |
Selecta Biosciences, Inc. |
Emulsions and methods of making nanocarriers
|
|
KR101196667B1
(ko)
|
2010-04-15 |
2012-11-02 |
포항공과대학교 산학협력단 |
피에이치 민감성 금속 나노 입자를 이용한 항암제 전달 시스템
|
|
EP2377938A1
(en)
|
2010-04-16 |
2011-10-19 |
Eukarys |
Capping-prone RNA polymerase enzymes and their applications
|
|
WO2011130624A2
(en)
|
2010-04-16 |
2011-10-20 |
Immune Disease Institute, Inc. |
Sustained polypeptide expression from synthetic, modified rnas and uses thereof
|
|
LT2558577T
(lt)
|
2010-04-16 |
2019-03-12 |
Nuevolution A/S |
Bifunkciniai kompleksai ir tokių kompleksų gamybos ir naudojimo būdai
|
|
US20130260460A1
(en)
|
2010-04-22 |
2013-10-03 |
Isis Pharmaceuticals Inc |
Conformationally restricted dinucleotide monomers and oligonucleotides
|
|
CA3049237C
(en)
|
2010-04-23 |
2024-06-11 |
University Of Massachusetts |
Cns targeting aav vectors and methods of use thereof
|
|
EP2563455A4
(en)
|
2010-04-28 |
2014-02-19 |
Kimberly Clark Co |
METHOD FOR INCREASING THE PERMEABILITY OF AN EPITHELIAL BARRIER
|
|
US9629979B2
(en)
|
2010-04-28 |
2017-04-25 |
Sanovas, Inc. |
Pressure/Vacuum actuated catheter drug delivery probe
|
|
US20130156845A1
(en)
|
2010-04-29 |
2013-06-20 |
Alnylam Pharmaceuticals, Inc. |
Lipid formulated single stranded rna
|
|
MA34263B1
(fr)
|
2010-04-30 |
2013-05-02 |
Novartis Ag |
Marqueurs de prédiction utiles dans traitement du syndrome de l'x fragile (fxs)
|
|
US9254327B2
(en)
|
2010-05-10 |
2016-02-09 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
|
US20130123338A1
(en)
|
2010-05-12 |
2013-05-16 |
Protiva Biotherapeutics, Inc. |
Novel cationic lipids and methods of use thereof
|
|
WO2011141704A1
(en)
|
2010-05-12 |
2011-11-17 |
Protiva Biotherapeutics, Inc |
Novel cyclic cationic lipids and methods of use
|
|
EP2387999A1
(en)
|
2010-05-21 |
2011-11-23 |
CureVac GmbH |
Histidine-containing solution for transfection and/or injection of nucleic acids and uses thereof
|
|
JP2013531634A
(ja)
|
2010-05-24 |
2013-08-08 |
メルク・シャープ・エンド・ドーム・コーポレイション |
オリゴヌクレオチド送達のための新規なアミノアルコールカチオン性脂質
|
|
EP2575773A4
(en)
|
2010-05-26 |
2014-06-25 |
Selecta Biosciences Inc |
SYNTHETIC NANOTRÄGERKOMBINATIONSIMPFSTOFFE
|
|
JP5957646B2
(ja)
|
2010-06-04 |
2016-07-27 |
サーナ・セラピューティクス・インコーポレイテッドＳｉｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
オリゴヌクレオチド送達のための新規な低分子量カチオン性脂質
|
|
NZ603732A
(en)
|
2010-06-14 |
2015-02-27 |
Hoffmann La Roche |
Cell-penetrating peptides and uses therof
|
|
WO2011157294A1
(en)
|
2010-06-16 |
2011-12-22 |
Universita' Degli Studi Di Padova |
Compositions for use in treating or preventing cancer, breast cancer, lung cancer, ovarian cancer, metastasis, heart failure, cardiac remodelling, dilated cardiomyopathy, autoimmune diseases, or diseases or disorders related thereto
|
|
WO2011163264A2
(en)
|
2010-06-21 |
2011-12-29 |
Candela Corporation |
Driving microneedle arrays into skin and delivering rf energy
|
|
US20130236968A1
(en)
|
2010-06-21 |
2013-09-12 |
Alnylam Pharmaceuticals, Inc. |
Multifunctional copolymers for nucleic acid delivery
|
|
CA2803239A1
(en)
|
2010-06-25 |
2011-12-29 |
Novartis Ag |
Combinations of meningococcal factor h binding proteins
|
|
WO2012002760A2
(ko)
|
2010-07-01 |
2012-01-05 |
포항공과대학교 산학협력단 |
세균유래 마이크로베시클을 이용한 암치료 및 암진단 방법
|
|
KR101130137B1
(ko)
|
2010-07-02 |
2012-03-28 |
연세대학교 산학협력단 |
발광다이오드 모듈
|
|
CA2803298C
(en)
|
2010-07-02 |
2020-07-14 |
The University Of Chicago |
Compositions and methods related to protein a (spa) variants
|
|
US8353871B2
(en)
|
2010-07-05 |
2013-01-15 |
Roller Jet Ltd. |
Drug delivery device with needles and roller
|
|
ES2649896T3
(es)
|
2010-07-06 |
2018-01-16 |
Glaxosmithkline Biologicals Sa |
Emulsiones catiónicas de aceite en agua
|
|
US9192661B2
(en)
|
2010-07-06 |
2015-11-24 |
Novartis Ag |
Delivery of self-replicating RNA using biodegradable polymer particles
|
|
LT3243526T
(lt)
|
2010-07-06 |
2020-02-10 |
Glaxosmithkline Biologicals S.A. |
Rnr pristatymas, skirtas keleto imuninio atsako paleidimui
|
|
US9770463B2
(en)
|
2010-07-06 |
2017-09-26 |
Glaxosmithkline Biologicals Sa |
Delivery of RNA to different cell types
|
|
WO2012006378A1
(en)
|
2010-07-06 |
2012-01-12 |
Novartis Ag |
Liposomes with lipids having an advantageous pka- value for rna delivery
|
|
DK2591114T3
(en)
|
2010-07-06 |
2016-08-29 |
Glaxosmithkline Biologicals Sa |
Immunization of large mammals with low doses of RNA
|
|
SI4005592T1
(sl)
|
2010-07-06 |
2023-03-31 |
Glaxosmithkline Biologicals S.A. |
Virionom podobni dostavni delci za samopodvojene molekule RNA
|
|
NZ605348A
(en)
|
2010-07-09 |
2015-01-30 |
Biogen Idec Hemophilia Inc |
Factor ix polypeptides and methods of use thereof
|
|
EP3508573A1
(en)
|
2010-07-09 |
2019-07-10 |
Bioverativ Therapeutics Inc. |
Systems for factor viii processing and methods thereof
|
|
WO2012009406A2
(en)
|
2010-07-13 |
2012-01-19 |
University Of Utah Research Foundation |
Gold particles and methods of making and using the same in cancer treatment
|
|
WO2012009644A2
(en)
|
2010-07-16 |
2012-01-19 |
Arizona Board Of Regents |
Methods to identify synthetic and natural rna elements that enhance protein translation
|
|
GB201012410D0
(en)
|
2010-07-23 |
2010-09-08 |
Medical Res Council |
Intracellular immunity
|
|
DK2449113T3
(en)
|
2010-07-30 |
2016-01-11 |
Curevac Ag |
Complex formation of nucleic acids with the disulfide cross-linked cationic components for transfection and immunostimulation
|
|
WO2012019168A2
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
US9121065B2
(en)
|
2010-08-09 |
2015-09-01 |
The Trustees Of The University Of Pennsylvania |
Nanoparticle-oligonucleotide hybrid structures and methods of use thereof
|
|
WO2012019630A1
(en)
|
2010-08-13 |
2012-02-16 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein
|
|
US20120058153A1
(en)
|
2010-08-20 |
2012-03-08 |
Selecta Biosciences, Inc. |
Synthetic nanocarrier vaccines comprising proteins obtained or derived from human influenza a virus hemagglutinin
|
|
WO2012024595A2
(en)
|
2010-08-20 |
2012-02-23 |
University Of Washington |
Circumferential aerosol device for delivering drugs to olfactory epithelium and brain
|
|
CA2808965C
(en)
|
2010-08-20 |
2020-01-07 |
Novartis Ag |
Soluble needle arrays for delivery of influenza vaccines
|
|
EA201390145A1
(ru)
|
2010-08-20 |
2013-11-29 |
Серулин Фарма Инк. |
Конъюгаты, частицы, композиции и связанные с ними способы
|
|
ES2939732T3
(es)
|
2010-08-31 |
2023-04-26 |
Glaxosmithkline Biologicals Sa |
Liposomas pequeños para la administración de ARN que codifica para inmunógeno
|
|
KR20130100278A
(ko)
|
2010-08-31 |
2013-09-10 |
머크 샤프 앤드 돔 코포레이션 |
올리고뉴클레오티드의 전달을 위한 신규 단일 화학 존재물 및 방법
|
|
ES2774369T3
(es)
|
2010-08-31 |
2020-07-20 |
Theraclone Science Int |
Anticuerpo de neutralización del virus de la inmunodeficiencia humana
|
|
AU2011295938B2
(en)
|
2010-08-31 |
2016-01-14 |
Glaxosmithkline Biologicals S.A. |
Lipids suitable for liposomal delivery of protein-coding RNA
|
|
DK2611461T3
(da)
|
2010-08-31 |
2022-05-16 |
Glaxosmithkline Biologicals Sa |
Pegylerede liposomer til afgivelse af RNA, der koder immunogen
|
|
WO2012031205A2
(en)
|
2010-09-03 |
2012-03-08 |
The Brigham And Women's Hospital, Inc. |
Lipid-polymer hybrid particles
|
|
WO2012034077A2
(en)
|
2010-09-09 |
2012-03-15 |
The University Of Chicago |
Compositions and methods related to attenuated staphylococcal strains
|
|
US9095540B2
(en)
|
2010-09-09 |
2015-08-04 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens
|
|
WO2012039979A2
(en)
|
2010-09-10 |
2012-03-29 |
The Johns Hopkins University |
Rapid diffusion of large polymeric nanoparticles in the mammalian brain
|
|
US8466122B2
(en)
|
2010-09-17 |
2013-06-18 |
Protiva Biotherapeutics, Inc. |
Trialkyl cationic lipids and methods of use thereof
|
|
US9669097B2
(en)
|
2010-09-20 |
2017-06-06 |
Sirna Therapeutics, Inc. |
Low molecular weight cationic lipids for oligonucleotide delivery
|
|
EP2619307A1
(en)
|
2010-09-21 |
2013-07-31 |
RiboxX GmbH |
Method for synthesizing rna using dna template
|
|
EP2618821A4
(en)
|
2010-09-24 |
2014-08-13 |
Brigham & Womens Hospital |
NANOSTRUCTURED GELS FOR CONTROLLED RELEASE OF CAPSUED MEDIUM
|
|
WO2012050975A2
(en)
|
2010-09-29 |
2012-04-19 |
The University Of North Carolina At Chapel Hill |
Novel circular mammalian rna molecules and uses thereof
|
|
CN103260611A
(zh)
|
2010-09-30 |
2013-08-21 |
默沙东公司 |
用于寡核苷酸递送的低分子量阳离子脂质
|
|
CA2821992A1
(en)
|
2010-10-01 |
2012-04-05 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
US10078075B2
(en)
|
2011-12-09 |
2018-09-18 |
Vanderbilt University |
Integrated organ-on-chip systems and applications of the same
|
|
WO2012051211A2
(en)
|
2010-10-11 |
2012-04-19 |
Novartis Ag |
Antigen delivery platforms
|
|
JP2013545727A
(ja)
|
2010-10-21 |
2013-12-26 |
メルク・シャープ・アンド・ドーム・コーポレーション |
オリゴヌクレオチド送達用の新規低分子量カチオン性脂質
|
|
EP2629760A4
(en)
|
2010-10-22 |
2014-04-02 |
Bind Therapeutics Inc |
THERAPEUTIC NANOPARTICLES CONTAINING COPOLYMERS OF HIGH MOLECULAR WEIGHT
|
|
EP2632485A4
(en)
|
2010-10-29 |
2014-05-28 |
Merck Sharp & Dohme |
RECOMBINANT SUBUNIT VACCINE AGAINST DENGUE VIRUS
|
|
WO2012061259A2
(en)
|
2010-11-05 |
2012-05-10 |
Merck Sharp & Dohme Corp. |
Novel low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery
|
|
AU2011323250B2
(en)
|
2010-11-05 |
2015-11-19 |
The Johns Hopkins University |
Compositions and methods relating to reduced mucoadhesion
|
|
AU2011326732B2
(en)
|
2010-11-09 |
2016-07-21 |
The Regents Of The University Of California |
Skin permeating and cell entering (space) peptides and methods of use thereof
|
|
ES2718846T3
(es)
|
2010-11-12 |
2019-07-04 |
Univ Pennsylvania |
Antígenos de próstata consenso, molécula de ácido nucleico que los codifica y la vacuna y usos que los comprenden
|
|
JP5933577B2
(ja)
|
2010-11-16 |
2016-06-15 |
セレクタ バイオサイエンシーズ インコーポレーテッドＳｅｌｅｃｔａ Ｂｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ． |
免疫刺激オリゴヌクレオチド
|
|
ES2684684T3
(es)
|
2010-11-17 |
2018-10-04 |
Aduro Biotech, Inc. |
Métodos y composiciones para inducir una respuesta inmune al EGFRVIII
|
|
US8987377B2
(en)
|
2010-11-19 |
2015-03-24 |
Alnylam Pharmaceuticals, Inc. |
Poly(amide) polymers for the delivery of oligonucleotides
|
|
EP3213770B1
(en)
|
2010-11-19 |
2021-02-24 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
|
|
US8853377B2
(en)
|
2010-11-30 |
2014-10-07 |
Shire Human Genetic Therapies, Inc. |
mRNA for use in treatment of human genetic diseases
|
|
WO2012072096A1
(en)
|
2010-12-03 |
2012-06-07 |
Biontech Ag |
Method for cellular rna expression
|
|
CA2821622C
(en)
|
2010-12-16 |
2019-09-03 |
Sprna Gmbh |
Pharmaceutical composition consisting of rna having alkali metal as counter ion and formulated with dications
|
|
US8501930B2
(en)
|
2010-12-17 |
2013-08-06 |
Arrowhead Madison Inc. |
Peptide-based in vivo siRNA delivery system
|
|
WO2012082574A1
(en)
|
2010-12-17 |
2012-06-21 |
Merck Sharp & Dohme Corp. |
Membrane lytic poly(amido amine) polymers for the delivery of oligonucleotides
|
|
US9394537B2
(en)
|
2010-12-22 |
2016-07-19 |
President And Fellows Of Harvard College |
Continuous directed evolution
|
|
WO2012089225A1
(en)
|
2010-12-29 |
2012-07-05 |
Curevac Gmbh |
Combination of vaccination and inhibition of mhc class i restricted antigen presentation
|
|
EP3147367A1
(en)
|
2010-12-29 |
2017-03-29 |
F. Hoffmann-La Roche AG |
Small molecule conjugates for intracellular delivery of nucleic acids
|
|
WO2012092552A1
(en)
|
2010-12-30 |
2012-07-05 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers with reactive groups that release biologically active agents
|
|
US10364440B2
(en)
|
2011-01-04 |
2019-07-30 |
Brown University |
Nanotubes as carriers of nucleic acids into cells
|
|
WO2012094574A2
(en)
|
2011-01-06 |
2012-07-12 |
The Johns Hopkins University |
Stabilized polyribonucleotide nanoparticles
|
|
WO2012094653A2
(en)
|
2011-01-07 |
2012-07-12 |
Massachusetts Institute Of Technology |
Compositions and methods for macromolecular drug delivery
|
|
EP3202760B1
(en)
|
2011-01-11 |
2019-08-21 |
Alnylam Pharmaceuticals, Inc. |
Pegylated lipids and their use for drug delivery
|
|
DE102011082231A1
(de)
|
2011-01-12 |
2012-07-12 |
Robert Bosch Gmbh |
Zündspule, insbesondere für kleinbauende Motoren
|
|
US20120189700A1
(en)
|
2011-01-19 |
2012-07-26 |
Zoraida Aguilar |
Nanoparticle Based Immunological Stimulation
|
|
WO2012101235A1
(en)
|
2011-01-26 |
2012-08-02 |
Cenix Bioscience Gmbh |
Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes
|
|
US10363309B2
(en)
|
2011-02-04 |
2019-07-30 |
Case Western Reserve University |
Targeted nanoparticle conjugates
|
|
US20140066363A1
(en)
|
2011-02-07 |
2014-03-06 |
Arun K. Bhunia |
Carbohydrate nanoparticles for prolonged efficacy of antimicrobial peptide
|
|
WO2012116715A1
(en)
|
2011-03-02 |
2012-09-07 |
Curevac Gmbh |
Vaccination in newborns and infants
|
|
US20120207840A1
(en)
|
2011-02-10 |
2012-08-16 |
Aura Biosciences, Inc. |
Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment Of Non-Melanoma Skin Cancer
|
|
JP2014507149A
(ja)
|
2011-02-14 |
2014-03-27 |
スウィフト バイオサイエンシーズ， インコーポレイテッド |
ポリヌクレオチドプライマーおよびプローブ
|
|
US20140081012A1
(en)
|
2011-02-15 |
2014-03-20 |
The University Of North Carolina At Chapel Hill |
Nanoparticle, liposomes, polymers, agents and proteins modified with reversible linkers
|
|
AU2012217685B2
(en)
|
2011-02-15 |
2017-05-18 |
Merrimack Pharmaceuticals, Inc. |
Compositions and methods for delivering nucleic acid to a cell
|
|
EP2489371A1
(en)
|
2011-02-18 |
2012-08-22 |
Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria |
Carrier peptides for drug delivery
|
|
WO2012113413A1
(en)
|
2011-02-21 |
2012-08-30 |
Curevac Gmbh |
Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged with disulfide-linked polyethyleneglycol/peptide conjugates
|
|
WO2012115980A1
(en)
|
2011-02-22 |
2012-08-30 |
California Institute Of Technology |
Delivery of proteins using adeno-associated virus (aav) vectors
|
|
US8696637B2
(en)
|
2011-02-28 |
2014-04-15 |
Kimberly-Clark Worldwide |
Transdermal patch containing microneedles
|
|
WO2012116714A1
(en)
|
2011-03-02 |
2012-09-07 |
Curevac Gmbh |
Vaccination in elderly patients
|
|
KR20140026392A
(ko)
|
2011-03-02 |
2014-03-05 |
노파르티스 아게 |
저용량의 항원 및/또는 보조제를 갖는 조합 백신
|
|
WO2012122318A2
(en)
|
2011-03-07 |
2012-09-13 |
Massachusetts Institute Of Technology |
Methods for transfecting cells with nucleic acids
|
|
WO2012125680A1
(en)
|
2011-03-16 |
2012-09-20 |
Novartis Ag |
Methods of treating vasculitis using an il-17 binding molecule
|
|
WO2012125987A2
(en)
|
2011-03-17 |
2012-09-20 |
Massachusetts Institute Of Technology |
Delivery system
|
|
US20130345234A1
(en)
|
2011-03-17 |
2013-12-26 |
Humphrey Athelstan Roy Gardner |
Fgfr and ligands thereof as biomarkers for breast cancer in hr positive subjects
|
|
WO2012129483A1
(en)
|
2011-03-24 |
2012-09-27 |
Novartis Ag |
Adjuvant nanoemulsions with phospholipids
|
|
PL2691443T3
(pl)
|
2011-03-28 |
2021-08-30 |
Massachusetts Institute Of Technology |
Sprzężone lipomery i ich zastosowania
|
|
EP2691538A1
(en)
|
2011-03-28 |
2014-02-05 |
Novartis AG |
Markers associated with cyclin-dependent kinase inhibitors
|
|
DE12722942T1
(de)
|
2011-03-31 |
2021-09-30 |
Modernatx, Inc. |
Freisetzung und formulierung von manipulierten nukleinsäuren
|
|
US10086043B2
(en)
*
|
2011-04-03 |
2018-10-02 |
The General Hospital Corporation |
Efficient protein expression in vivo using modified RNA (MOD-RNA)
|
|
WO2012138530A1
(en)
|
2011-04-04 |
2012-10-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
2'-o-aminooxymethyl nucleoside derivatives for use in the synthesis and modification of nucleosides, nucleotides and oligonucleotides
|
|
WO2012142132A1
(en)
|
2011-04-11 |
2012-10-18 |
Life Technologies Corporation |
Polymer particles and methods of making and using same
|
|
EP2696855B1
(en)
|
2011-04-13 |
2021-06-02 |
The Trustees Of The University Of Pennsylvania |
Coated mesoporous nanoparticles
|
|
WO2013158127A1
(en)
|
2012-04-16 |
2013-10-24 |
Molecular Transfer, Inc. |
Agents for improved delivery of nucleic acids to eukaryotic cells
|
|
US20140178894A1
(en)
|
2011-04-20 |
2014-06-26 |
Novartis Forschungsstiftung, Zweigniederlassung |
Culture medium suitable for the culture of undifferentiated cells
|
|
CA2834349A1
(en)
|
2011-04-26 |
2012-11-01 |
Molecular Express, Inc. |
Liposomal formulations
|
|
US20160272697A2
(en)
|
2011-04-28 |
2016-09-22 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Neutralizing Antibodies to Nipah and Hendra Virus
|
|
JP2014512409A
(ja)
|
2011-04-28 |
2014-05-22 |
エスティーシー． ユーエヌエム |
標的送達用の多孔性ナノ粒子に担持された脂質二重層（プロトセル）及びその使用方法
|
|
WO2012149393A2
(en)
|
2011-04-29 |
2012-11-01 |
Selecta Biosciences, Inc. |
Tolerogenic synthetic nanocarriers for antigen-specific deletion of t effector cells
|
|
EP2702408A1
(en)
|
2011-04-29 |
2014-03-05 |
Novartis AG |
Methods of treating squamous cell carcinoma related applications
|
|
WO2012151212A1
(en)
|
2011-05-01 |
2012-11-08 |
University Of Rochester |
Multifocal hepatocellular carcinoma microrna expression patterns and uses thereof
|
|
ES2957478T3
(es)
|
2011-05-02 |
2024-01-19 |
Univ Wayne State |
Una tecnología de células madre pluripotentes inducidas por proteínas y usos de las mismas
|
|
UA116189C2
(uk)
|
2011-05-02 |
2018-02-26 |
Мілленніум Фармасьютікалз, Інк. |
КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА
|
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
|
WO2012153187A2
(en)
|
2011-05-06 |
2012-11-15 |
Xentech |
Markers for cancer prognosis and therapy and methods of use
|
|
WO2012152810A1
(de)
|
2011-05-10 |
2012-11-15 |
Basf Se |
Öl-in-wasser-emulsionen
|
|
WO2012153297A1
(en)
|
2011-05-11 |
2012-11-15 |
Ramot At Tel-Aviv University Ltd. |
Targeted polymeric conjugates and uses thereof
|
|
WO2012152910A1
(en)
|
2011-05-12 |
2012-11-15 |
Helmut Vockner |
Novel pharmaceutical formulation
|
|
DK2706988T3
(da)
|
2011-05-12 |
2020-01-20 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Liposomer omfattende polymer konjugerede lipider og relateret brug
|
|
JP2014519819A
(ja)
|
2011-05-13 |
2014-08-21 |
ノバルティス アーゲー |
融合前ｒｓｖｆ抗原
|
|
US8691750B2
(en)
|
2011-05-17 |
2014-04-08 |
Axolabs Gmbh |
Lipids and compositions for intracellular delivery of biologically active compounds
|
|
AU2012255913A1
(en)
|
2011-05-17 |
2013-11-21 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof for non-human vertebrates
|
|
CN103052757B
(zh)
|
2011-05-20 |
2015-02-25 |
科勒公司 |
马桶安装系统和方法
|
|
NZ730355A
(en)
|
2011-05-24 |
2022-10-28 |
Tron Translationale Onkologie An Der Univ Der Johannes Gutenberg Univ Mainz Gemeinnuetzige Gmbh |
Individualized vaccines for cancer
|
|
EP2714926B1
(en)
|
2011-05-25 |
2015-07-22 |
Novartis AG |
Biomarkers for lung cancer
|
|
WO2012166923A2
(en)
|
2011-05-31 |
2012-12-06 |
Bind Biosciences |
Drug loaded polymeric nanoparticles and methods of making and using same
|
|
JP2014516549A
(ja)
|
2011-06-02 |
2014-07-17 |
ノバルティス アーゲー |
ヘッジホッグ阻害剤療法のためのバイオマーカー
|
|
JP6100762B2
(ja)
|
2011-06-02 |
2017-03-22 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
膜で被包されたナノ粒子および使用方法
|
|
EP2717911A1
(en)
|
2011-06-06 |
2014-04-16 |
Novartis Forschungsstiftung, Zweigniederlassung |
Protein tyrosine phosphatase, non-receptor type 11 (ptpn11) and triple-negative breast cancer
|
|
EP3336082B1
(en)
|
2011-06-08 |
2020-04-15 |
Translate Bio, Inc. |
Cleavable lipids
|
|
CN111671918A
(zh)
|
2011-06-08 |
2020-09-18 |
川斯勒佰尔公司 |
Mrna递送的脂质纳米颗粒组合物和方法
|
|
US9364527B2
(en)
|
2011-06-10 |
2016-06-14 |
Novartis Tiergesundheit Ag |
Bovine vaccines and methods
|
|
US8636696B2
(en)
|
2011-06-10 |
2014-01-28 |
Kimberly-Clark Worldwide, Inc. |
Transdermal device containing microneedles
|
|
WO2012168491A1
(en)
|
2011-06-10 |
2012-12-13 |
Novartis Ag |
Pharmaceutical formulations of pcsk9 antagonists
|
|
WO2012170607A2
(en)
|
2011-06-10 |
2012-12-13 |
Novartis Ag |
Use of pcsk9 antagonists
|
|
US8916696B2
(en)
|
2011-06-12 |
2014-12-23 |
City Of Hope |
Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their use
|
|
WO2012172495A1
(en)
|
2011-06-14 |
2012-12-20 |
Novartis Ag |
Compositions and methods for antibodies targeting tem8
|
|
US9457183B2
(en)
|
2011-06-15 |
2016-10-04 |
Tripep Ab |
Injection needle and device
|
|
MX2013014789A
(es)
|
2011-06-16 |
2014-01-20 |
Novartis Ag |
Proteinas solubles para utilizarse como productos terapeuticos.
|
|
KR20140047069A
(ko)
|
2011-06-20 |
2014-04-21 |
유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 |
계산에 최적화된 광범위 반응을 나타내는 ｈ１ｎ１ 인플루엔자를 위한 항원
|
|
WO2013003475A1
(en)
|
2011-06-27 |
2013-01-03 |
Cellscript, Inc. |
Inhibition of innate immune response
|
|
KR102436439B1
(ko)
|
2011-06-28 |
2022-08-25 |
이노비오 파마수티컬즈, 인크. |
최소 침습 피부 전기천공 장치
|
|
PL2726099T3
(pl)
|
2011-07-01 |
2018-12-31 |
Novartis Ag |
Sposób leczenia zaburzeń metabolicznych
|
|
WO2013003887A1
(en)
|
2011-07-04 |
2013-01-10 |
Commonwealth Scientific And Industrial Research Organisation |
Nucleic acid complex
|
|
CA2840965C
(en)
|
2011-07-06 |
2021-03-02 |
Novartis Ag |
Cationic oil-in-water emulsions
|
|
EP2729125B1
(en)
|
2011-07-06 |
2017-12-13 |
GlaxoSmithKline Biologicals SA |
Oil-in-water emulsions that contain nucleic acids
|
|
ES2656050T3
(es)
|
2011-07-06 |
2018-02-22 |
Glaxosmithkline Biologicals Sa |
Composiciones de combinación inmunogénica y usos de las mismas
|
|
EP4014966A1
(en)
|
2011-07-06 |
2022-06-22 |
GlaxoSmithKline Biologicals S.A. |
Liposomes having useful n:p ratio for delivery of rna molecules
|
|
EP3508219A1
(en)
|
2011-07-06 |
2019-07-10 |
GlaxoSmithKline Biologicals S.A. |
Self-replicating rna prime - protein boost vaccines
|
|
WO2013006824A2
(en)
|
2011-07-07 |
2013-01-10 |
Life Technologies Corporation |
Polymer particles, nucleic acid polymer particles and methods of making and using the same
|
|
WO2013009717A1
(en)
|
2011-07-10 |
2013-01-17 |
Elisabet De Los Pinos |
Virion derived protein nanoparticles for delivering diagnostic or therapeutic agents for the treatment of skin-related diseases
|
|
US20130012566A1
(en)
|
2011-07-10 |
2013-01-10 |
Aura Biosciences, Inc. |
Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment of Alopecia
|
|
WO2013009736A2
(en)
|
2011-07-10 |
2013-01-17 |
President And Fellows Of Harvard College |
Compositions and methods for self-assembly of polymers with complementary macroscopic and microscopic scale units
|
|
DK2732052T3
(en)
|
2011-07-15 |
2017-02-20 |
Leo Pharma As |
Diagnostic microRNA profiling in cutaneous T cell lymphoma (CTCL)
|
|
GB2492999A
(en)
|
2011-07-20 |
2013-01-23 |
Univ Central Lancashire |
Neutron detector
|
|
US20140148503A1
(en)
|
2011-07-20 |
2014-05-29 |
University Of Iowa Research Foundation |
Nucleic acid aptamers
|
|
BR112014001050B1
(pt)
|
2011-07-21 |
2017-12-05 |
Croda International Plc |
Polyester polyester block polymer, method for the preparation of the same, composition, controlled release and personal care products, and method for preparing a gel composition
|
|
US10030052B2
(en)
|
2011-07-25 |
2018-07-24 |
Glaxosmithkline Biologicals Sa |
Parvovirus Vp1 unique region polypeptides and compositions thereof
|
|
US9493549B2
(en)
|
2011-07-25 |
2016-11-15 |
The Rockefeller University |
Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth
|
|
CN103702687A
(zh)
|
2011-07-29 |
2014-04-02 |
西莱克塔生物科技公司 |
产生体液和细胞毒性t淋巴细胞（ctl）免疫应答的合成纳米载体
|
|
WO2013025834A2
(en)
|
2011-08-15 |
2013-02-21 |
The University Of Chicago |
Compositions and methods related to antibodies to staphylococcal protein a
|
|
US8932572B2
(en)
|
2011-08-26 |
2015-01-13 |
Arrowhead Madison Inc. |
Poly(vinyl ester) polymers for in vivo nucleic acid delivery
|
|
SI2750707T1
(sl)
|
2011-08-31 |
2019-02-28 |
Glaxosmithkline Biologicals Sa |
Pegilirani liposomi za dostavo imunogen-kodirajoče RNA
|
|
KR20140067070A
(ko)
|
2011-08-31 |
2014-06-03 |
말린크로트 엘엘씨 |
Ｈ-포스포네이트에 의한 나노입자 ｐｅｇ 개질
|
|
US9126966B2
(en)
|
2011-08-31 |
2015-09-08 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods of use thereof
|
|
WO2013033640A1
(en)
|
2011-09-01 |
2013-03-07 |
Allegro Diagnostics Corp. |
Methods and compositions for detecting cancer based on mirna expression profiles
|
|
KR20140105433A
(ko)
|
2011-09-01 |
2014-09-01 |
아이알엠 엘엘씨 |
Pdgfr 키나제 억제제로서의 화합물 및 조성물
|
|
EP2751272A2
(en)
|
2011-09-02 |
2014-07-09 |
Novartis AG |
Organic compositions to treat hsf1-related diseases
|
|
WO2013039857A1
(en)
|
2011-09-12 |
2013-03-21 |
modeRNA Therapeutics |
Engineered nucleic acids and methods of use thereof
|
|
EP3384938A1
(en)
|
2011-09-12 |
2018-10-10 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
TR201909110T4
(tr)
|
2011-09-14 |
2019-07-22 |
Glaxosmithkline Biologicals Sa |
Sakarit-protein glikokonjugatları yapmaya yönelik yöntemler.
|
|
AU2012308205A1
(en)
|
2011-09-16 |
2014-03-13 |
The Trustees Of The University Of Pennsylvania |
RNA engineered T cells for the treatment of cancer
|
|
US20150017245A1
(en)
|
2011-09-22 |
2015-01-15 |
Bind Therapeutics, Inc. |
Methods of treating cancers with therapeutic nanoparticles
|
|
US9375388B2
(en)
|
2011-09-23 |
2016-06-28 |
Indian Institute Of Technology, Bombay |
Nanoparticle based cosmetic composition
|
|
TWI593708B
(zh)
|
2011-09-26 |
2017-08-01 |
諾華公司 |
治療代謝病症之融合蛋白質
|
|
UY34347A
(es)
|
2011-09-26 |
2013-04-30 |
Novartis Ag |
Proteínas de función dual para tratar trastornos metabólicos
|
|
AU2012315965A1
(en)
|
2011-09-27 |
2014-04-03 |
Alnylam Pharmaceuticals, Inc. |
Di-aliphatic substituted PEGylated lipids
|
|
WO2013045505A1
(en)
|
2011-09-28 |
2013-04-04 |
Novartis Ag |
Biomarkers for raas combination therapy
|
|
EP3492109B1
(en)
|
2011-10-03 |
2020-03-04 |
ModernaTX, Inc. |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
|
WO2013055971A1
(en)
|
2011-10-11 |
2013-04-18 |
Arizona Board Of Regents For And On Behalf Of Arizona State University |
Polymers for delivering a substance into a cell
|
|
MX2014004214A
(es)
|
2011-10-11 |
2014-05-07 |
Novartis Ag |
Moleculas de acido ribonucleico policistronicas auto-replicantes recombinantes.
|
|
WO2013055331A1
(en)
|
2011-10-12 |
2013-04-18 |
The Curators Of The University Of Missouri |
Pentablock polymers
|
|
WO2014066811A1
(en)
|
2012-10-25 |
2014-05-01 |
The Johns Hopkins University |
Bioreducible poly (b-amino ester)s for sirna delivery
|
|
JP2014530816A
(ja)
|
2011-10-14 |
2014-11-20 |
ノバルティスアーゲー |
Ｗｎｔ経路関連疾患のための抗体および方法
|
|
MX2014004415A
(es)
|
2011-10-14 |
2015-06-05 |
Stc Unm |
Bicapas lipidicas soportadas por nanoparticulas porosas (protecelulas) para suministro dirigido, incluido el suministro transdermico de carga, y los metodos relacionados.
|
|
PT3597644T
(pt)
|
2011-10-18 |
2021-11-03 |
Dicerna Pharmaceuticals Inc |
Lípidos catiónicos de amina e suas utilizações
|
|
WO2013059509A1
(en)
|
2011-10-18 |
2013-04-25 |
Micell Technologies, Inc. |
Drug delivery medical device
|
|
JO3766B1
(ar)
|
2011-10-20 |
2021-01-31 |
Novartis Ag |
منشط مستقبل أسيتيل كولين الفا - 7 النيكوتيني
|
|
CA2852857A1
(en)
|
2011-10-20 |
2013-04-25 |
Novartis Ag |
Adjuvanted influenza b virus vaccines for pediatric priming
|
|
WO2013059922A1
(en)
|
2011-10-25 |
2013-05-02 |
The University Of British Columbia |
Limit size lipid nanoparticles and related methods
|
|
WO2013066678A1
(en)
|
2011-10-26 |
2013-05-10 |
Georgetown University |
Microrna expression profiling of thyroid cancer
|
|
US20130110043A1
(en)
|
2011-10-26 |
2013-05-02 |
Nanopass Technologies Ltd. |
Microneedle Intradermal Drug Delivery Device with Auto-Disable Functionality
|
|
CA3119789A1
(en)
|
2011-10-27 |
2013-05-02 |
Massachusetts Institute Of Technology |
Amino acid derivatives functionalized on the n-terminal capable of forming drug encapsulating microspheres
|
|
JP6100271B2
(ja)
|
2011-10-27 |
2017-03-22 |
キンバリー クラーク ワールドワイド インコーポレイテッド |
高粘性生理活性薬剤の経皮的送達
|
|
EP2771033A4
(en)
|
2011-10-28 |
2016-02-17 |
Integritybio Inc |
PROTEIN FORMULATIONS CONTAINING AMINO ACIDS
|
|
WO2013062140A1
(en)
|
2011-10-28 |
2013-05-02 |
Kyoto University |
Method for efficiently inducing differentiation of pluripotent stem cells into hepatic lineage cells
|
|
SG10201508662SA
(en)
|
2011-10-28 |
2015-11-27 |
Presage Biosciences Inc |
Methods for drug delivery
|
|
MX363226B
(es)
|
2011-10-31 |
2019-03-15 |
Genentech Inc |
Formulaciones de anticuerpos.
|
|
EP2773426B1
(en)
|
2011-10-31 |
2018-08-22 |
Mallinckrodt LLC |
Combinational liposome compositions for cancer therapy
|
|
AU2012332263A1
(en)
|
2011-11-04 |
2014-05-22 |
Novartis Ag |
Low density lipoprotein-related protein 6 (LRP6) - half life extender constructs
|
|
US9579338B2
(en)
|
2011-11-04 |
2017-02-28 |
Nitto Denko Corporation |
Method of producing lipid nanoparticles for drug delivery
|
|
WO2013066274A1
(en)
|
2011-11-04 |
2013-05-10 |
Agency For Science, Technology And Research |
Self-assembled composite ultrasmall peptide-polymer hydrogels
|
|
CN103906503B
(zh)
|
2011-11-04 |
2016-12-14 |
日东电工株式会社 |
用于无菌制备脂质-核酸颗粒的单次使用系统
|
|
WO2013067537A1
(en)
|
2011-11-04 |
2013-05-10 |
Univertiy Of Notre Dame Du Lac |
Nanoparticle-based drug delivery
|
|
US20130115247A1
(en)
|
2011-11-05 |
2013-05-09 |
Aura Biosciences, Inc. |
Virion Derived Protein Nanoparticles For Delivering Radioisotopes For The Diagnosis And Treatment Of Malignant And Systemic Disease And The Monitoring Of Therapy
|
|
US20130116408A1
(en)
|
2011-11-05 |
2013-05-09 |
Aura Biosciences, Inc. |
Virion Derived Protein Nanoparticles For Delivering Radioisotopes For The Diagnosis And Treatment Of Malignant And Systemic Disease And The Monitoring Of Therapy
|
|
WO2013068413A1
(en)
|
2011-11-08 |
2013-05-16 |
Novartis Forschungsstiftung, Zweigniederlassung, Friedrich Miescher Institute For Biomedical Research |
Rod cell-specific promoter
|
|
EP2776013B8
(en)
|
2011-11-08 |
2023-08-30 |
The Board of Trustees of the University of Arkansas |
Methods and compositions for x-ray induced release from ph sensitive liposomes
|
|
WO2013068432A1
(en)
|
2011-11-08 |
2013-05-16 |
Novartis Forschungsstiftung, Zweigniederlassung, Friedrich Miescher Institute For Biomedical Research |
Early diagnostic of neurodegenerative diseases
|
|
WO2013068431A1
(en)
|
2011-11-08 |
2013-05-16 |
Novartis Forschungsstiftung, Zweigniederlassung, Friedrich Miescher Institute For Biomedical Research |
New treatment for neurodegenerative diseases
|
|
WO2013070653A1
(en)
|
2011-11-09 |
2013-05-16 |
Board Of Trustees Michigan State University |
Metallic nanoparticle synthesis with carbohydrate capping agent
|
|
KR102301463B1
(ko)
|
2011-11-11 |
2021-09-14 |
배리에이션 바이오테크놀로지스 아이엔씨. |
사이토메갈로바이러스의 치료를 위한 조성물 및 방법
|
|
WO2013071047A1
(en)
|
2011-11-11 |
2013-05-16 |
Children's Medical Center Corporation |
Compositions and methods for in vitro transcription of rna
|
|
MX2014005548A
(es)
|
2011-11-14 |
2014-08-21 |
Novartis Ag |
Complejos inmunogenicos de carbomeros polianionicos y polipeptidos env y metodos de manufactura y usos de los mismos.
|
|
WO2013072392A1
(en)
|
2011-11-15 |
2013-05-23 |
Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research |
Combination of a phosphoinositide 3-kinase inhibitor and a modulator of the janus kinase 2-signal transducer and activator of transcription 5 pathway
|
|
AU2012340107B2
(en)
|
2011-11-18 |
2017-06-15 |
Regeneron Pharmaceuticals, Inc. |
Polymer protein microparticles
|
|
CN104011223A
(zh)
|
2011-11-21 |
2014-08-27 |
诺华股份有限公司 |
使用il-17拮抗剂及psa应答或非应答等位基因治疗银屑病性关节炎(psa)的方法
|
|
WO2013078199A2
(en)
|
2011-11-23 |
2013-05-30 |
Children's Medical Center Corporation |
Methods for enhanced in vivo delivery of synthetic, modified rnas
|
|
TR201111743A2
(tr)
|
2011-11-28 |
2012-04-24 |
Nesl�Han G�Rsoy Reyhan |
Kanser tedavisinde kullanılmak üzere yağ bazlı nanotaşıyıcı sistemler.
|
|
US20150037428A1
(en)
|
2011-11-29 |
2015-02-05 |
The University Of North Carolina At Chapel Hill |
Geometrically engineered particles and methods for modulating macrophage or immune responses
|
|
US9364549B2
(en)
|
2011-11-30 |
2016-06-14 |
Andreas Voigt |
Hydrophobic drug-delivery material, method for manufacturing thereof and methods for delivery of a drug-delivery composition
|
|
CN104080441B
(zh)
|
2011-11-30 |
2020-02-28 |
3M创新有限公司 |
包括肽治疗剂和氨基酸的微针装置、制备和使用其的方法
|
|
WO2013082590A1
(en)
|
2011-12-02 |
2013-06-06 |
Invivo Therapeutics Corporation |
Peg based hydrogel for peripheral nerve injury applications and compositions and method of use of synthetic hydrogel sealants
|
|
WO2013082470A1
(en)
|
2011-12-02 |
2013-06-06 |
Pegasus Laboratories, Inc. |
Amphipathic lipid-based sustained release compositions
|
|
WO2013082529A1
(en)
|
2011-12-02 |
2013-06-06 |
Yale University |
Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery
|
|
RU2624139C2
(ru)
|
2011-12-05 |
2017-06-30 |
Фэктор Байосайенс Инк. |
Способы и препараты для трансфекции клеток
|
|
WO2013085951A1
(en)
|
2011-12-05 |
2013-06-13 |
Nano Precision Medical, Inc. |
Device having titania nanotube membrane for drug delivery
|
|
US8497124B2
(en)
|
2011-12-05 |
2013-07-30 |
Factor Bioscience Inc. |
Methods and products for reprogramming cells to a less differentiated state
|
|
GB201121070D0
(en)
|
2011-12-07 |
2012-01-18 |
Isis Innovation |
composition for delivery of biotherapeutics
|
|
US20140308304A1
(en)
|
2011-12-07 |
2014-10-16 |
Alnylam Pharmaceuticals, Inc. |
Lipids for the delivery of active agents
|
|
US9463247B2
(en)
|
2011-12-07 |
2016-10-11 |
Alnylam Pharmaceuticals, Inc. |
Branched alkyl and cycloalkyl terminated biodegradable lipids for the delivery of active agents
|
|
CA3165769A1
(en)
|
2011-12-07 |
2013-06-13 |
Alnylam Pharmaceuticals, Inc. |
Biodegradable lipids for the delivery of active agents
|
|
US9725687B2
(en)
|
2011-12-09 |
2017-08-08 |
President And Fellows Of Harvard College |
Integrated human organ-on-chip microphysiological systems
|
|
WO2013086526A1
(en)
|
2011-12-09 |
2013-06-13 |
The Regents Of The University Of California |
Liposomal drug encapsulation
|
|
US10087422B2
(en)
|
2011-12-09 |
2018-10-02 |
President And Fellows Of Harvard College |
Organ chips and uses thereof
|
|
KR20140116095A
(ko)
|
2011-12-12 |
2014-10-01 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
Mrsa pbp2a 및 이의 단편들을 포함하는 단백질, 이를 인코딩한 핵산, 및 mrsa 감염을 예방 및 치료하기 위한 조성물 및 그의 용도
|
|
US20140045913A1
(en)
|
2011-12-12 |
2014-02-13 |
Kyowa Hakko Kirin Co., Ltd. |
Lipid nano particles comprising combination of cationic lipid
|
|
EP2792367A4
(en)
|
2011-12-12 |
2015-09-30 |
Kyowa Hakko Kirin Co Ltd |
LIPID NANOPARTICLES FOR A DRUG DELIVERY SYSTEM CONTAINING CATIONIC LIPIDS
|
|
EP2604253A1
(en)
|
2011-12-13 |
2013-06-19 |
Otto Glatter |
Water-in-oil emulsions and methods for their preparation
|
|
US9844598B2
(en)
|
2011-12-13 |
2017-12-19 |
Engeneic Molecular Delivery Pty Ltd |
Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors
|
|
US20150000936A1
(en)
|
2011-12-13 |
2015-01-01 |
Schlumberger Technology Corporation |
Energization of an element with a thermally expandable material
|
|
WO2013090186A1
(en)
|
2011-12-14 |
2013-06-20 |
modeRNA Therapeutics |
Modified nucleic acids, and acute care uses thereof
|
|
US20140378538A1
(en)
|
2011-12-14 |
2014-12-25 |
Moderma Therapeutics, Inc. |
Methods of responding to a biothreat
|
|
WO2013090897A1
(en)
|
2011-12-15 |
2013-06-20 |
The Trustees Of The University Of Pennsylvania |
Using adaptive immunity to detect drug resistance
|
|
US9636414B2
(en)
|
2011-12-15 |
2017-05-02 |
Biontech Ag |
Particles comprising single stranded RNA and double stranded RNA for immunomodulation
|
|
US9744318B2
(en)
|
2011-12-16 |
2017-08-29 |
Novartis Ag |
Aerosolization apparatus for inhalation profile-independent drug delivery
|
|
AU2012351948A1
(en)
|
2011-12-16 |
2014-07-10 |
Allergan, Inc. |
Ophthalmic compositions comprising polyvinyl capralactam - polyvinyl acetate - polyethylene glycol graft copolymer
|
|
WO2013090601A2
(en)
|
2011-12-16 |
2013-06-20 |
Massachusetts Institute Of Technology |
Compact nanoparticles for biological applications
|
|
WO2013087913A1
(en)
|
2011-12-16 |
2013-06-20 |
Synthon Biopharmaceuticals B.V. |
Compounds and methods for treating inflammatory diseases
|
|
JP2015501844A
(ja)
|
2011-12-16 |
2015-01-19 |
モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
修飾ヌクレオシド、ヌクレオチドおよび核酸組成物
|
|
CN104245794A
(zh)
|
2011-12-16 |
2014-12-24 |
麻省理工学院 |
α-氨基脒聚合物及其用途
|
|
ES2627856T3
(es)
|
2011-12-19 |
2017-07-31 |
The University Of Sydney |
Material compuesto de péptido-hidrogel
|
|
US9241829B2
(en)
|
2011-12-20 |
2016-01-26 |
Abbott Medical Optics Inc. |
Implantable intraocular drug delivery apparatus, system and method
|
|
AU2012358384A1
(en)
|
2011-12-21 |
2014-07-31 |
Moderna Therapeutics, Inc. |
Methods of increasing the viability or longevity of an organ or organ explant
|
|
EP2793941A1
(en)
|
2011-12-23 |
2014-10-29 |
F.Hoffmann-La Roche Ag |
Articles of manufacture and methods for co-administration of antibodies
|
|
WO2013101908A1
(en)
|
2011-12-27 |
2013-07-04 |
Massachusetts Institute Of Technology |
Microneedle devices and uses thereof
|
|
CA2862247A1
(en)
|
2011-12-29 |
2013-07-04 |
Novartis Ag |
Adjuvanted combinations of meningococcal factor h binding proteins
|
|
US20140371302A1
(en)
|
2011-12-29 |
2014-12-18 |
Modema Therapeutics, Inc. |
Modified mrnas encoding cell-penetrating polypeptides
|
|
CA2862377A1
(en)
|
2011-12-30 |
2013-07-04 |
Cellscript, Llc |
Making and using in vitro-synthesized ssrna for introducing into mammalian cells to induce a biological or biochemical effect
|
|
WO2013103659A1
(en)
*
|
2012-01-04 |
2013-07-11 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Stabilizing rna by incorporating chain-terminating nucleosides at the 3'-terminus
|
|
AU2013207423B2
(en)
|
2012-01-06 |
2017-10-12 |
Gemphire Therapeutics Inc. |
Methods of reducing risk of cardiovascular disease
|
|
US20150030576A1
(en)
|
2012-01-10 |
2015-01-29 |
Moderna Therapeutics, Inc. |
Methods and compositions for targeting agents into and across the blood-brain barrier
|
|
WO2013109713A1
(en)
|
2012-01-18 |
2013-07-25 |
The General Hospital Corporation |
Targeting rnas to microvesicles
|
|
CN108977412A
(zh)
|
2012-01-26 |
2018-12-11 |
生命科技公司 |
用于提高病毒感染性的方法
|
|
KR20140128966A
(ko)
|
2012-01-26 |
2014-11-06 |
라이프 테크놀로지스 코포레이션 |
바이러스의 감염성을 증가시키는 방법
|
|
EP2623121A1
(en)
|
2012-01-31 |
2013-08-07 |
Bayer Innovation GmbH |
Pharmaceutical composition comprising a polymeric carrier cargo complex and an antigen
|
|
WO2013113326A1
(en)
|
2012-01-31 |
2013-08-08 |
Curevac Gmbh |
Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
|
|
WO2013113325A1
(en)
|
2012-01-31 |
2013-08-08 |
Curevac Gmbh |
Negatively charged nucleic acid comprising complexes for immunostimulation
|
|
EP4116338A1
(en)
|
2012-02-09 |
2023-01-11 |
Life Technologies Corporation |
Hydrophilic polymeric particles and methods for making same
|
|
WO2013120498A1
(en)
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded allergenic antigen or an autoimmune self-antigen
|
|
WO2013120500A1
(en)
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen
|
|
WO2013120497A1
(en)
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
|
|
WO2013120499A1
(en)
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly (a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
|
|
EP3597209A1
(en)
|
2012-02-22 |
2020-01-22 |
Northwestern University |
Nanostructures for treating cancers and other conditions
|
|
EP2817345A1
(en)
|
2012-02-22 |
2014-12-31 |
Cerulean Pharma Inc. |
Conjugates, particles, compositions, and related methods
|
|
US20130243867A1
(en)
|
2012-02-23 |
2013-09-19 |
University Of South Florida (A Florida Non-Profit Corporation) |
Micelle compositions and methods for their use
|
|
EP2819651A1
(en)
|
2012-02-27 |
2015-01-07 |
Epitarget AS |
Use of an antibody and a particulate immunomodulator in therapy
|
|
US20130224268A1
(en)
|
2012-02-27 |
2013-08-29 |
Newgen Biopharma Corp. |
Topical delivery of hormonal and non hormonal nano formulations, methods of making and using the same
|
|
EP2819652A1
(en)
|
2012-02-27 |
2015-01-07 |
Epitarget As |
Use of a particulate immunomodulator in cancer therapy
|
|
JP6407726B2
(ja)
|
2012-03-01 |
2018-10-24 |
アムゲン リサーチ （ミュンヘン） ゲーエムベーハーＡＭＧＥＮ Ｒｅｓｅａｒｃｈ（Ｍｕｎｉｃｈ）ＧｍｂＨ |
長寿命ポリペプチド結合分子
|
|
US20130236504A1
(en)
|
2012-03-06 |
2013-09-12 |
Medical University Of South Carolina |
Delivery System for Enhancing Drug Efficacy
|
|
US20150094259A1
(en)
|
2012-03-13 |
2015-04-02 |
University Of Kwazulu-Natal |
Transdermal Delivery Devices
|
|
US10322089B2
(en)
|
2012-03-14 |
2019-06-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Nanoparticles, nanoparticle delivery methods, and systems of delivery
|
|
DK2825156T3
(en)
|
2012-03-16 |
2017-10-30 |
Merck Patent Gmbh |
TARGETED AMINO ACID LIPIDS
|
|
CN104394891B
(zh)
|
2012-03-16 |
2019-04-16 |
约翰霍普金斯大学 |
用于递送活性剂的非线性多嵌段共聚物-药物结合物
|
|
CA2867381C
(en)
|
2012-03-16 |
2016-09-20 |
The Johns Hopkins University |
Controlled release formulations for the delivery of hif-1 inhibitors
|
|
US9610346B2
(en)
|
2012-03-23 |
2017-04-04 |
International Aids Vaccine Initiative |
Recombinant viral vectors
|
|
WO2013142349A1
(en)
|
2012-03-23 |
2013-09-26 |
University Of Chicago |
Compositions and methods related to staphylococcal sbi
|
|
WO2013143555A1
(en)
|
2012-03-26 |
2013-10-03 |
Biontech Ag |
Rna formulation for immunotherapy
|
|
WO2013148186A1
(en)
|
2012-03-26 |
2013-10-03 |
President And Fellows Of Harvard College |
Lipid-coated nucleic acid nanostructures of defined shape
|
|
JP6301906B2
(ja)
|
2012-03-27 |
2018-03-28 |
キュアバック アーゲー |
５’ｔｏｐｕｔｒを含む人工核酸分子
|
|
CA2859452C
(en)
|
2012-03-27 |
2021-12-21 |
Curevac Gmbh |
Artificial nucleic acid molecules for improved protein or peptide expression
|
|
CN104220599A
(zh)
|
2012-03-27 |
2014-12-17 |
库瑞瓦格有限责任公司 |
人工核酸分子
|
|
WO2013148541A1
(en)
|
2012-03-27 |
2013-10-03 |
Merck Sharp & Dohme Corp. |
DIETHER BASED BIODEGRADABLE CATIONIC LIPIDS FOR siRNA DELIVERY
|
|
CA2868030C
(en)
|
2012-03-29 |
2021-05-25 |
Shire Human Genetic Therapies, Inc. |
Lipid-derived neutral nanoparticles
|
|
US20140275229A1
(en)
|
2012-04-02 |
2014-09-18 |
Moderna Therapeutics, Inc. |
Modified polynucleotides encoding udp glucuronosyltransferase 1 family, polypeptide a1
|
|
US20150050354A1
(en)
|
2012-04-02 |
2015-02-19 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the treatment of otic diseases and conditions
|
|
US9878056B2
(en)
|
2012-04-02 |
2018-01-30 |
Modernatx, Inc. |
Modified polynucleotides for the production of cosmetic proteins and peptides
|
|
EP2833923A4
(en)
|
2012-04-02 |
2016-02-24 |
Moderna Therapeutics Inc |
MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS
|
|
AU2013243949A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of biologics and proteins associated with human disease
|
|
US9107904B2
(en)
|
2012-04-05 |
2015-08-18 |
Massachusetts Institute Of Technology |
Immunostimulatory compositions and methods of use thereof
|
|
EP2833926A4
(en)
|
2012-04-05 |
2015-11-25 |
Univ Florida |
NEUROPHILIC NANOPARTICLES
|
|
WO2013152351A2
(en)
|
2012-04-06 |
2013-10-10 |
The Trustees Of Columbia University In The City Of New York |
Fusion polypeptides and methods of use thereof
|
|
RU2635466C2
(ru)
|
2012-04-08 |
2017-11-13 |
Теракоат Лтд |
Препараты термообратимого гидрогеля для применения при лечении нарушений уротелия
|
|
US20130296531A1
(en)
|
2012-04-11 |
2013-11-07 |
Intezyne Technologies, Inc. |
Block copolymers for stable micelles
|
|
EP3939572B1
(en)
|
2012-04-12 |
2024-03-27 |
Yale University |
Vehicles for controlled delivery of different pharmaceutical agents
|
|
US11001797B2
(en)
|
2012-04-13 |
2021-05-11 |
President And Fellows Of Harvard College |
Devices and methods for in vitro aerosol delivery
|
|
WO2013154766A1
(en)
|
2012-04-13 |
2013-10-17 |
New York University |
Microrna control of ldl receptor pathway
|
|
KR20150001710A
(ko)
|
2012-04-18 |
2015-01-06 |
애로우헤드 리서치 코오포레이션 |
Ｉｎ Ｖｉｖｏ 핵산 전달용 폴리(아크릴레이트) 고분자
|
|
AU2013249548A1
(en)
|
2012-04-19 |
2014-11-06 |
Sirna Therapeutics, Inc. |
Novel diester and triester based low molecular weight, biodegradable cationic lipids for oligonucleotide delivery
|
|
WO2013163234A1
(en)
|
2012-04-23 |
2013-10-31 |
Massachusetts Institute Of Technology |
Stable layer-by-layer coated particles
|
|
MY173600A
(en)
|
2012-04-25 |
2020-02-08 |
Sanofi Sa |
Microrna compounds and methods for modulating mir-21 activity
|
|
JP6360039B2
(ja)
|
2012-05-03 |
2018-07-18 |
カラ ファーマシューティカルズ インコーポレイテッド |
複数の被覆された粒子を含む組成物、医薬組成物、医薬製剤、及び当該粒子の形成方法
|
|
CA2872519C
(en)
|
2012-05-04 |
2017-09-05 |
The Johns Hopkins University |
Lipid-based drug carriers for rapid penetration through mucus linings
|
|
WO2013173657A1
(en)
|
2012-05-16 |
2013-11-21 |
Micell Technologies, Inc. |
Low burst sustained release lipophilic and biologic agent compositions
|
|
US9399672B2
(en)
|
2012-05-17 |
2016-07-26 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Services |
Hepatitis C virus neutralizing antibody
|
|
WO2013173693A1
(en)
|
2012-05-18 |
2013-11-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nanoparticles with enhanced entry into cancer cells
|
|
BR112014027834A2
(pt)
|
2012-05-23 |
2017-08-08 |
Univ Ohio State |
composições de nanopartícula lipídica para entrega de oligonucleotídeos antissenso
|
|
WO2013174409A1
(en)
|
2012-05-25 |
2013-11-28 |
Curevac Gmbh |
Reversible immobilization and/or controlled release of nucleic acid containing nanoparticles by (biodegradable) polymer coatings
|
|
KR102165138B1
(ko)
|
2012-06-06 |
2020-10-14 |
로마 비스타 메디컬, 인코포레이티드. |
팽창가능 의료용 디바이스
|
|
US20150126589A1
(en)
|
2012-06-08 |
2015-05-07 |
Ethris Gmbh |
Pulmonary Delivery of Messenger RNA
|
|
AU2013271392B2
(en)
|
2012-06-08 |
2018-02-15 |
Ethris Gmbh |
Pulmonary delivery of mRNA to non-lung target cells
|
|
HRP20211424T2
(hr)
|
2012-06-08 |
2022-02-18 |
Nitto Denko Corporation |
Lipidi za formulacije namijenjene unosu terapijskog sredstva
|
|
US20150218252A1
(en)
|
2012-06-20 |
2015-08-06 |
President And Fellows Of Harvard College |
Self-assembling peptides, peptide nanostructures and uses thereof
|
|
US20140005379A1
(en)
|
2012-06-20 |
2014-01-02 |
Frank GU |
Nanoparticle delivery system and components thereof
|
|
WO2014004436A2
(en)
|
2012-06-27 |
2014-01-03 |
Merck Sharp & Dohme Corp. |
Crystalline anti-human il-23 antibodies
|
|
US9150841B2
(en)
|
2012-06-29 |
2015-10-06 |
Shire Human Genetic Therapies, Inc. |
Cells for producing recombinant iduronate-2-sulfatase
|
|
US9956291B2
(en)
|
2012-07-10 |
2018-05-01 |
Shaker A. Mousa |
Nanoformulation and methods of use of thyroid receptor beta1 agonists for liver targeting
|
|
WO2014014890A1
(en)
|
2012-07-16 |
2014-01-23 |
Nanoderm Sciences, Inc. |
Targeted therapeutic nanoparticles
|
|
EP2687251A1
(en)
|
2012-07-17 |
2014-01-22 |
Sanofi-Aventis Deutschland GmbH |
Drug delivery device
|
|
EP2687252A1
(en)
|
2012-07-17 |
2014-01-22 |
Sanofi-Aventis Deutschland GmbH |
Drug delivery device
|
|
CN103566377A
(zh)
|
2012-07-18 |
2014-02-12 |
上海博笛生物科技有限公司 |
癌症的靶向免疫治疗
|
|
WO2014015334A1
(en)
|
2012-07-20 |
2014-01-23 |
Brown University |
System and methods for nanostructure protected delivery of treatment agent and selective release thereof
|
|
CN104781416B
(zh)
|
2012-07-24 |
2017-07-04 |
哈佛学院院长及董事 |
核酸纳米结构的自装配
|
|
WO2014015422A1
(en)
|
2012-07-27 |
2014-01-30 |
Ontario Institute For Cancer Research |
Cellulose-based nanoparticles for drug delivery
|
|
GB201213624D0
(en)
|
2012-07-27 |
2012-09-12 |
Univ Ulster The |
Method and system for production of conjugated nanoparticles
|
|
WO2014025795A1
(en)
|
2012-08-07 |
2014-02-13 |
Northeastern University |
Compositions for the delivery of rna and drugs into cells
|
|
WO2014024193A1
(en)
|
2012-08-07 |
2014-02-13 |
Prodel Pharma Ltd. |
Compositions and methods for rapid transmucosal delivery of pharmaceutical ingredients
|
|
SG11201500188YA
(en)
|
2012-08-08 |
2015-02-27 |
Univ Nanyang Tech |
Methods of manufacturing hydrogel microparticles having living cells, and compositions for manufacturing a scaffold for tissue engineering
|
|
WO2014026044A2
(en)
|
2012-08-08 |
2014-02-13 |
Presage Biosciences, Inc. |
Extrusion methods and devices for drug delivery
|
|
AU2013299641A1
(en)
|
2012-08-10 |
2015-03-19 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Drug delivery vehicle comprising conjugates between targeting polyamino acids and fatty acids
|
|
WO2014027006A1
(en)
|
2012-08-13 |
2014-02-20 |
Edko Pazarlama Tanitim Ticaret Limited Sirketi |
Bioadhesive formulations for use in drug delivery
|
|
WO2014028487A1
(en)
|
2012-08-13 |
2014-02-20 |
Massachusetts Institute Of Technology |
Amine-containing lipidoids and uses thereof
|
|
EP2885419A4
(en)
|
2012-08-14 |
2016-05-25 |
Moderna Therapeutics Inc |
ENZYMES AND POLYMERASES FOR RNA SYNTHESIS
|
|
US9775804B2
(en)
|
2012-08-14 |
2017-10-03 |
Aaron Froese |
Internal structured self assembling liposomes
|
|
US9827321B2
(en)
|
2012-08-14 |
2017-11-28 |
The Trustees Of The University Of Pennsylvania |
Stabilizing shear-thinning hydrogels
|
|
WO2014028763A1
(en)
|
2012-08-15 |
2014-02-20 |
The University Of Chicago |
Exosome-based therapeutics against neurodegenerative disorders
|
|
WO2014039185A1
(en)
|
2012-09-05 |
2014-03-13 |
Creighton University |
Polymeric nanoparticles in a thermosensitive gel for coital-independent vaginal prophylaxis of hiv
|
|
US8703197B2
(en)
|
2012-09-13 |
2014-04-22 |
International Business Machines Corporation |
Branched polyamines for delivery of biologically active materials
|
|
BR112015005940A2
(pt)
|
2012-09-17 |
2017-07-04 |
Bind Therapeutics Inc |
processo para a preparação de nanopartículas terapêuticas
|
|
WO2014047649A1
(en)
|
2012-09-24 |
2014-03-27 |
The Regents Of The University Of California |
Methods for arranging and packing nucleic acids for unusual resistance to nucleases and targeted delivery for gene therapy
|
|
WO2014052634A1
(en)
|
2012-09-27 |
2014-04-03 |
The University Of North Carolina At Chapel Hill |
Lipid coated nanoparticles containing agents having low aqueous and lipid solubilities and methods thereof
|
|
US20150307542A1
(en)
|
2012-10-03 |
2015-10-29 |
Moderna Therapeutics, Inc. |
Modified nucleic acid molecules and uses thereof
|
|
US20140100178A1
(en)
|
2012-10-04 |
2014-04-10 |
Aslam Ansari |
Composition and methods for site-specific drug delivery to treat malaria and other liver diseases
|
|
EP2903595A1
(en)
|
2012-10-04 |
2015-08-12 |
University Of The Witwatersrand, Johannesburg |
Liposomal drug delivery system
|
|
WO2014053881A1
(en)
|
2012-10-04 |
2014-04-10 |
Centre National De La Recherche Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
|
WO2014053879A1
(en)
|
2012-10-04 |
2014-04-10 |
Centre National De La Recherche Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
|
WO2014053882A1
(en)
|
2012-10-04 |
2014-04-10 |
Centre National De La Recherche Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
|
WO2014053880A1
(en)
|
2012-10-04 |
2014-04-10 |
Centre National De La Recherche Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
|
EP2716655A1
(en)
|
2012-10-04 |
2014-04-09 |
Institut Pasteur |
Neutralizing antibodies directed against Hepatitis C virus ectodomain glycoprotein E2
|
|
EP2716689A1
(en)
|
2012-10-05 |
2014-04-09 |
National University of Ireland, Galway |
Polymer comprising a plurality of branches having at least one disulfide group and/or at least one vinyl group
|
|
WO2014064534A2
(en)
|
2012-10-05 |
2014-05-01 |
Chrontech Pharma Ab |
Injection needle, device, immunogenic compositions and method of use
|
|
US9931410B2
(en)
|
2012-10-09 |
2018-04-03 |
The Brigham And Women's Hospital, Inc. |
Nanoparticles for targeted delivery of multiple therapeutic agents and methods of use
|
|
US20140106260A1
(en)
|
2012-10-11 |
2014-04-17 |
The Trustees Of The University Of Pennsylvania |
Core-shell nanoparticulate compositions and methods
|
|
SG11201502896XA
(en)
|
2012-10-16 |
2015-05-28 |
Endocyte Inc |
Drug delivery conjugates containing unnatural amino acids and methods for using
|
|
AU2013331049B2
(en)
|
2012-10-18 |
2018-11-15 |
California Institute Of Technology |
Broadly-neutralizing anti-HIV antibodies
|
|
AU2013336237A1
(en)
|
2012-10-22 |
2015-06-11 |
Sabag-Rfa Ltd |
A system for delivering therapeutic agents into living cells and cells nuclei
|
|
US9938525B2
(en)
|
2012-10-26 |
2018-04-10 |
Nlife Therapeutics, S.L. |
Compositions and methods for selective delivery of oligonucleotide molecules to cell types
|
|
US10172956B2
(en)
|
2012-10-26 |
2019-01-08 |
Vanderbilt University |
Polymeric nanoparticles
|
|
US20150272900A1
(en)
|
2012-10-26 |
2015-10-01 |
The Johns Hopkins University |
Layer-By-Layer Approach to Co-Deliver DNA and siRNA via AuNPs: A Potential Platform for Modifying Release Kinetics
|
|
WO2014067551A1
(en)
|
2012-10-29 |
2014-05-08 |
Technische Universität Dortmund |
T7 rna polymerase variants and methods of using the same
|
|
WO2014071219A1
(en)
|
2012-11-01 |
2014-05-08 |
Factor Bioscience Inc. |
Methods and products for expressing proteins in cells
|
|
WO2014071072A2
(en)
|
2012-11-02 |
2014-05-08 |
Pungente Michael D |
Novel cationic carotenoid-based lipids for cellular nucleic acid uptake
|
|
EP2914723B1
(en)
|
2012-11-05 |
2018-06-13 |
Fondazione Centro San Raffaele |
Novel targets in multiple myeloma and other disorders
|
|
NZ707855A
(en)
|
2012-11-06 |
2018-11-30 |
Rochal Ind Llc |
Delivery of biologically-active agents using volatile, hydrophobic solvents
|
|
WO2014074597A1
(en)
|
2012-11-06 |
2014-05-15 |
President And Fellows Of Harvard College |
Compositions and methods relating to complex nucleic acid nanostructures
|
|
WO2014072999A1
(en)
|
2012-11-07 |
2014-05-15 |
Council Of Scientific And Industrial Research |
Nanocomplex containing cationic peptide for biomolecule delivery
|
|
US9669104B2
(en)
|
2012-11-07 |
2017-06-06 |
Council Of Scientific And Industrial Research |
Nanocomplex containing amphipathic peptide useful for efficient transfection of biomolecules
|
|
MX2015005363A
(es)
|
2012-11-08 |
2015-11-06 |
Novozymes Biopharma Dk As |
Variantes de albumina.
|
|
TW201428101A
(zh)
|
2012-11-08 |
2014-07-16 |
Inviragen Inc |
登革熱病毒血清型４型之建構物的組成物、方法及用途
|
|
SG11201503637SA
(en)
|
2012-11-08 |
2015-06-29 |
Clearside Biomedical Inc |
Methods and devices for the treatment of ocular diseases in human subjects
|
|
CN104903349B
(zh)
|
2012-11-08 |
2018-10-19 |
十一生物治疗股份有限公司 |
Il-6拮抗剂及其应用
|
|
US9200119B2
(en)
|
2012-11-09 |
2015-12-01 |
Momentive Performance Materials Inc. |
Silicon-containing zwitterionic linear copolymer composition
|
|
WO2014072468A1
(en)
|
2012-11-09 |
2014-05-15 |
Velin-Pharma A/S |
Compositions for pulmonary delivery
|
|
AU2013343864B2
(en)
|
2012-11-09 |
2019-04-04 |
BioNTech SE |
Method for cellular RNA expression
|
|
WO2014071963A1
(en)
|
2012-11-09 |
2014-05-15 |
Biontech Ag |
Method for cellular rna expression
|
|
WO2014075047A2
(en)
|
2012-11-12 |
2014-05-15 |
Genvec, Inc. |
Malaria antigens and methods of use
|
|
JP2016500058A
(ja)
|
2012-11-12 |
2016-01-07 |
レッドウッド バイオサイエンス， インコーポレイテッド |
化合物および抱合体を生成するための方法
|
|
GB201220354D0
(en)
|
2012-11-12 |
2012-12-26 |
Medpharm Ltd |
Dermal compositions
|
|
US9943608B2
(en)
|
2012-11-13 |
2018-04-17 |
Baylor College Of Medicine |
Multi-arm biodegradable polymers for nucleic acid delivery
|
|
US9310374B2
(en)
|
2012-11-16 |
2016-04-12 |
Redwood Bioscience, Inc. |
Hydrazinyl-indole compounds and methods for producing a conjugate
|
|
WO2014078636A1
(en)
|
2012-11-16 |
2014-05-22 |
President And Fellows Of Harvard College |
Nucleic acid hydrogel self-assembly
|
|
EP2732825B1
(en)
|
2012-11-19 |
2015-07-01 |
Invivogen |
Conjugates of a TLR7 and/or TLR8 agonist and a TLR2 agonist
|
|
US9655848B2
(en)
|
2012-11-19 |
2017-05-23 |
Technion Research & Development Foundation Limited |
Liposomes for in-vivo delivery
|
|
US20140141037A1
(en)
|
2012-11-20 |
2014-05-22 |
Novartis Ag |
Rsv f prefusion trimers
|
|
US20150290328A1
(en)
|
2012-11-20 |
2015-10-15 |
Phasebio Pharmaceuticals, Inc. |
Formulations of active agents for sustained release
|
|
EP4245744A3
(en)
|
2012-11-22 |
2024-05-01 |
Tagworks Pharmaceuticals B.V. |
Chemically cleavable group
|
|
WO2014081300A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Channel protein activatable liposomes
|
|
WO2014081299A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Activatable liposomes
|
|
LT2922554T
(lt)
|
2012-11-26 |
2022-06-27 |
Modernatx, Inc. |
Terminaliai modifikuota rnr
|
|
WO2014093574A1
(en)
|
2012-12-13 |
2014-06-19 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for altering cell phenotype
|
|
JP2016506416A
(ja)
|
2013-01-10 |
2016-03-03 |
ノバルティス アーゲー |
インフルエンザウイルス免疫原性組成物およびその使用
|
|
WO2014113089A2
(en)
|
2013-01-17 |
2014-07-24 |
Moderna Therapeutics, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
|
EP2964234A4
(en)
|
2013-03-09 |
2016-12-07 |
Moderna Therapeutics Inc |
NON-TRANSLATED HETEROLOGOUS REGIONS FOR MRNA
|
|
EP2968397A4
(en)
|
2013-03-12 |
2016-12-28 |
Moderna Therapeutics Inc |
DIAGNOSIS AND TREATMENT OF FIBROSIS
|
|
US20160024181A1
(en)
|
2013-03-13 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
|
EP2971010B1
(en)
|
2013-03-14 |
2020-06-10 |
ModernaTX, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
|
EP4279610A3
(en)
|
2013-03-15 |
2024-01-03 |
ModernaTX, Inc. |
Ribonucleic acid purification
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
EP2983804A4
(en)
|
2013-03-15 |
2017-03-01 |
Moderna Therapeutics, Inc. |
Ion exchange purification of mrna
|
|
US20160032273A1
(en)
|
2013-03-15 |
2016-02-04 |
Moderna Therapeutics, Inc. |
Characterization of mrna molecules
|
|
US10077439B2
(en)
|
2013-03-15 |
2018-09-18 |
Modernatx, Inc. |
Removal of DNA fragments in mRNA production process
|
|
EP2971033B8
(en)
|
2013-03-15 |
2019-07-10 |
ModernaTX, Inc. |
Manufacturing methods for production of rna transcripts
|
|
WO2014144711A1
(en)
|
2013-03-15 |
2014-09-18 |
Moderna Therapeutics, Inc. |
Analysis of mrna heterogeneity and stability
|
|
JP7019233B2
(ja)
|
2013-07-11 |
2022-02-15 |
モデルナティエックス インコーポレイテッド |
ＣＲＩＳＰＲ関連タンパク質をコードする合成ポリヌクレオチドおよび合成ｓｇＲＮＡを含む組成物ならびに使用方法
|
|
WO2015007871A2
(en)
|
2013-07-17 |
2015-01-22 |
Ospedale San Raffaele S.R.L. |
Micrornas and autoimmune-immune mediated inflammatory disease
|
|
WO2015034925A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
EP3041934A1
(en)
|
2013-09-03 |
2016-07-13 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
EP3043826A4
(en)
|
2013-09-13 |
2017-05-24 |
Moderna Therapeutics, Inc. |
Polynucleotide compositions containing amino acids
|
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
EP3052521A1
(en)
|
2013-10-03 |
2016-08-10 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
|
US20160243221A1
(en)
|
2013-10-18 |
2016-08-25 |
Moderna Therapeutics, Inc. |
Compositions and methods for tolerizing cellular systems
|
|
CA2955375A1
(en)
|
2014-07-17 |
2016-01-21 |
Modernatx, Inc. |
Terminal modifications of polynucleotides
|
|
WO2016077125A1
(en)
*
|
2014-11-10 |
2016-05-19 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules containing reduced uracil content and uses thereof
|
|
EP3603661A3
(en)
|
2015-04-22 |
2020-04-01 |
CureVac AG |
Rna containing composition for treatment of tumor diseases
|
|
DK3394093T3
(da)
|
2015-12-23 |
2022-04-19 |
Modernatx Inc |
Fremgangsmåder til anvendelse af ox40-ligand-kodende polynukleotider
|